<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">69808</article-id><article-id pub-id-type="doi">10.7554/eLife.69808</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Evolutionary Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Common host variation drives malaria parasite fitness in healthy human red cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-148026"><name><surname>Ebel</surname><given-names>Emily R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3244-4250</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-237769"><name><surname>Kuypers</surname><given-names>Frans A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-237770"><name><surname>Lin</surname><given-names>Carrie</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-7314"><name><surname>Petrov</surname><given-names>Dmitri A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3664-9130</contrib-id><email>dpetrov@stanford.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-148029"><name><surname>Egan</surname><given-names>Elizabeth S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2112-7700</contrib-id><email>eegan@stanford.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Biology, Stanford University</institution><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Department of Pediatrics, Stanford University School of Medicine</institution><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Children's Hospital Oakland Research Institute</institution><addr-line><named-content content-type="city">Oakland</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Department of Microbiology &amp; Immunology, Stanford University School of Medicine</institution><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Tung</surname><given-names>Jenny</given-names></name><role>Reviewing Editor</role><aff><institution>Duke University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Perry</surname><given-names>George H</given-names></name><role>Senior Editor</role><aff><institution>Pennsylvania State University</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>23</day><month>09</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e69808</elocation-id><history><date date-type="received" iso-8601-date="2021-04-27"><day>27</day><month>04</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-09-22"><day>22</day><month>09</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2020-10-09"><day>09</day><month>10</month><year>2020</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2020.10.08.332494"/></event></pub-history><permissions><copyright-statement>Â© 2021, Ebel et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Ebel et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-69808-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-69808-figures-v2.pdf"/><abstract><p>The replication of <italic>Plasmodium falciparum</italic> parasites within red blood cells (RBCs) causes severe disease in humans, especially in Africa. Deleterious alleles like hemoglobin S are well-known to confer strong resistance to malaria, but the effects of common RBC variation are largely undetermined. Here, we collected fresh blood samples from 121 healthy donors, most with African ancestry, and performed exome sequencing, detailed RBC phenotyping, and parasite fitness assays. Over one-third of healthy donors unknowingly carried alleles for G6PD deficiency or hemoglobinopathies, which were associated with characteristic RBC phenotypes. Among non-carriers alone, variation in RBC hydration, membrane deformability, and volume was strongly associated with <italic>P. falciparum</italic> growth rate. Common genetic variants in <italic>PIEZO1</italic>, <italic>SPTA1/SPTB</italic>, and several <italic>P. falciparum</italic> invasion receptors were also associated with parasite growth rate. Interestingly, we observed little or negative evidence for divergent selection on non-pathogenic RBC variation between Africans and Europeans. These findings suggest a model in which globally widespread variation in a moderate number of genes and phenotypes modulates <italic>P. falciparum</italic> fitness in RBCs.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>malaria</kwd><kwd><italic>Plasmodium falciparum</italic></kwd><kwd>red blood cells</kwd><kwd>parasite fitness</kwd><kwd>natural variation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd><italic>P. falciparum</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006521</institution-id><institution>Stanford University School of Medicine</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Egan</surname><given-names>Elizabeth S</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006521</institution-id><institution>Stanford University School of Medicine</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Egan</surname><given-names>Elizabeth S</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100011099</institution-id><institution>Stanford Center for Computational, Evolutionary and Human Genomics</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ebel</surname><given-names>Emily R</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>5R35GM118165-05</award-id><principal-award-recipient><name><surname>Petrov</surname><given-names>Dmitri A</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100008982</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>DGE-1247312</award-id><principal-award-recipient><name><surname>Ebel</surname><given-names>Emily R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Human red blood cells from healthy donors display marked biophysical and genetic variation that impacts the growth of <italic>Plasmodium falciparum</italic> malaria parasites, outside of known disease alleles.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Malaria caused by the replication of <italic>Plasmodium falciparum</italic> parasites in red blood cells (RBCs) kills hundreds of thousands of children each year (<xref ref-type="bibr" rid="bib111">WHO, 2019</xref>). In each 48-hr cycle of blood-stage malaria, parasites must deform RBC membranes to invade them (<xref ref-type="bibr" rid="bib54">Koch, 2017</xref>; <xref ref-type="bibr" rid="bib50">Kariuki et al., 2020</xref>); consume hemoglobin and tolerate the resulting oxidative stress (<xref ref-type="bibr" rid="bib34">Francis et al., 1997</xref>); multiply to displace half the RBC volume (<xref ref-type="bibr" rid="bib44">Hanssen et al., 2012</xref>); and remodel the RBC membrane to avoid immune detection (<xref ref-type="bibr" rid="bib116">Zhang, 2015</xref>). Consequently, genetic disorders that alter aspects of RBC biology are well-known to influence malaria susceptibility (<xref ref-type="bibr" rid="bib56">Kwiatkowski, 2005</xref>). For example, sickle cell trait impairs parasite growth by altering hemoglobin polymerization at low oxygen tension (<xref ref-type="bibr" rid="bib84">Pasvol et al., 1978</xref>; <xref ref-type="bibr" rid="bib3">Archer et al., 2018</xref>), while deficiency of the G6PD enzyme involved in oxidative stress tolerance is thought to make parasitized RBCs more susceptible to breakdown (<xref ref-type="bibr" rid="bib93">Ruwende and Hill, 1998</xref>). Aside from these diseases, however, the genetic basis of RBC susceptibility to malaria remains mostly unknown.</p><p>Large genome-wide association studies (GWAS) have identified a few dozen loci that collectively explain up to 11% of the heritability of the risk of severe versus uncomplicated malaria (<xref ref-type="bibr" rid="bib103">Timmann et al., 2012</xref>; <xref ref-type="bibr" rid="bib70">Malaria Genomic Epidemiology Network, 2014</xref>; <xref ref-type="bibr" rid="bib6">Band et al., 2015</xref>; <xref ref-type="bibr" rid="bib57">Leffler et al., 2017</xref>; <xref ref-type="bibr" rid="bib77">Ndila et al., 2018</xref>; <xref ref-type="bibr" rid="bib71">Malaria Genomic Epidemiology Network, 2019</xref>). About 10 of the highest-confidence GWAS signals, including 6 loci known from earlier methods (<xref ref-type="bibr" rid="bib2">Allison, 1954</xref>; <xref ref-type="bibr" rid="bib32">Field et al., 1994</xref>; <xref ref-type="bibr" rid="bib93">Ruwende and Hill, 1998</xref>; <xref ref-type="bibr" rid="bib58">Lell et al., 1999</xref>; <xref ref-type="bibr" rid="bib92">Rowe, 2007</xref>; <xref ref-type="bibr" rid="bib12">Cao and Galanello, 2010</xref>; <xref ref-type="bibr" rid="bib36">Galanello and Cao, 2011</xref>), are in or near genes expressed predominantly in RBCs. One new GWAS variant has since been shown to regulate expression of the <italic>ATP2B4</italic> calcium channel (<xref ref-type="bibr" rid="bib115">ZÃ¡mbÃ³ et al., 2017</xref>) and to be associated with RBC dehydration (<xref ref-type="bibr" rid="bib62">Li et al., 2013b</xref>), although a functional link between <italic>ATP2B4</italic> and <italic>P. falciparum</italic> replication has yet to be demonstrated. Additional GWAS discoveries of RBC variation important for malaria are not expected without massive increases in sample size (<xref ref-type="bibr" rid="bib10">Boyle et al., 2017</xref>; <xref ref-type="bibr" rid="bib71">Malaria Genomic Epidemiology Network, 2019</xref>), in part because of the large number of hypotheses tested. Severe malaria is a complex phenotype that combines many factors from RBCs, the vascular endothelium, the immune system, the parasite, and the environment (<xref ref-type="bibr" rid="bib69">Mackinnon et al., 2005</xref>; <xref ref-type="bibr" rid="bib23">de MendonÃ§a et al., 2012</xref>). Alternate approaches are therefore needed to discover more genetic variation that impacts the replication of malaria parasites in human RBCs.</p><p>Heritable RBC phenotypes like mean cell volume (MCV), hemoglobin content (HGB/MCH), and antigenic blood type vary widely within and between human populations (<xref ref-type="bibr" rid="bib110">Whitfield et al., 1985</xref>; <xref ref-type="bibr" rid="bib29">Evans et al., 1999</xref>; <xref ref-type="bibr" rid="bib87">Pilia et al., 2006</xref>; <xref ref-type="bibr" rid="bib64">Lo et al., 2011</xref>; <xref ref-type="bibr" rid="bib19">Cooling, 2015</xref>; <xref ref-type="bibr" rid="bib11">Canela-Xandri et al., 2018</xref>). Large GWAS conducted mostly in Europeans have demonstrated that many blood cell phenotypes are shaped by hundreds of small-effect loci distributed throughout the genome, consistent with polygenic or omnigenic models of complex trait genetics (<xref ref-type="bibr" rid="bib105">van der Harst et al., 2012</xref>; <xref ref-type="bibr" rid="bib4">Astle et al., 2016</xref>; <xref ref-type="bibr" rid="bib13">Chami et al., 2016</xref>; <xref ref-type="bibr" rid="bib10">Boyle et al., 2017</xref>; <xref ref-type="bibr" rid="bib16">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="bib106">Vuckovic et al., 2020</xref>). Certain blood phenotypes like average hemoglobin levels, hematocrit, and RBC membrane fragility are also known to differ between African and European populations, although the differences are typically small in magnitude (<xref ref-type="bibr" rid="bib38">Garn, 1981</xref>; <xref ref-type="bibr" rid="bib86">Perry et al., 1992</xref>; <xref ref-type="bibr" rid="bib8">Beutler and West, 2005</xref>; <xref ref-type="bibr" rid="bib48">Kanias et al., 2017</xref>; <xref ref-type="bibr" rid="bib82">Page et al., 2021</xref>). This variation across populations can largely be explained by a few RBC disease alleles that have been widely selected across Africa for their protective effects on malaria (<xref ref-type="bibr" rid="bib8">Beutler and West, 2005</xref>; <xref ref-type="bibr" rid="bib64">Lo et al., 2011</xref>; <xref ref-type="bibr" rid="bib48">Kanias et al., 2017</xref>). Despite the importance of these population-specific variants, a much larger number of common variants with small individual effects on RBC phenotypes are expected to be globally widespread (<xref ref-type="bibr" rid="bib9">Biddanda et al., 2020</xref>; <xref ref-type="bibr" rid="bib16">Chen et al., 2020</xref>). It remains untested whether this extensive phenotypic and genetic diversity in RBCs influences malaria susceptibility and, if so, whether it has been shaped by malaria selection.</p><p>Here, we approach these questions by performing exome sequencing and extensive RBC phenotyping on blood samples from a diverse human cohort of 122 individuals. We show that <italic>P. falciparum</italic> fitness varies widely among donor cells in vitro, with the distribution of parasite phenotypes in âhealthyâ RBCs overlapping those from RBCs carrying classic disease alleles. We apply LASSO variable selection to identify a small set of genes and phenotypes that strongly predict parasite fitness outside of the context of RBC disease, highlighting RBC dehydration and membrane properties as key to modulating <italic>P. falciparum</italic> fitness. We find little evidence that non-pathogenic alleles or phenotypes that confer parasite protection are associated with African ancestry, perhaps because <italic>P. falciparum</italic> is susceptible to RBC variation that exists for other selective or demographic reasons. Overall, these findings advance our understanding of the origin and function of common RBC variation and suggest new targets for therapeutic intervention for malaria.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Many healthy blood donors with African ancestry carry alleles for RBC disease</title><p>We collected blood samples from 121 donors with no known history of blood disorders, most of whom self-identified as having recent African ancestry (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). As a positive control, we also sampled a patient with hereditary elliptocytosis (HE), a polygenic condition characterized by extremely fragile RBC membranes that strongly inhibit <italic>P. falciparum</italic> growth (<xref ref-type="bibr" rid="bib95">Schulman et al., 1990</xref>; <xref ref-type="bibr" rid="bib30">Facer, 1995</xref>; <xref ref-type="bibr" rid="bib24">Dhermy et al., 2007</xref>; <xref ref-type="bibr" rid="bib37">Gallagher, 2013</xref>). We performed whole-exome sequencing (<xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1âsource data 1</xref>), both to check for the presence of known RBC disease alleles and to confirm the population genetic ancestry of our donors. A principal component analysis of more than 35,000 exomic single-nucleotide polymorphisms (SNPs) showed that most donors fell along a continuum from African to European ancestry, as defined by data from the 1000 Genomes Project (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Pairwise kinship coefficients demonstrated that all donors were unrelated, apart from a six-member family with unique ancestry (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, light borders). We found that 16% of the healthy donors carried pathogenic hemoglobin alleles (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), including 5 heterozygotes for hemoglobin S (HbAS), 4 heterozygotes for hemoglobin C (HbAC), and 11 individuals with one or two copies of an <italic>HBA2</italic> deletion causing Î±-thalassemia (<xref ref-type="bibr" rid="bib36">Galanello and Cao, 2011</xref>). We also scored eight polymorphisms in <italic>G6PD</italic> that have been functionally associated with various degrees of G6PD deficiency (<xref ref-type="bibr" rid="bib114">Yoshida et al., 1971</xref>; <xref ref-type="bibr" rid="bib18">Clarke et al., 2017</xref>) and found that 32% of the study population carried at least one, including 12 of the 20 donors with hemoglobinopathies. Among those with wild-type hemoglobin, we identified 1 individual with polymorphisms associated with severe G6PD deficiency (&gt;60% loss of function) and 23 with polymorphisms associated with mild to medium deficiency (&lt;42% loss of function). We detected no alleles linked to other monogenic RBC disorders, including Î²-thalassemia or xerocytosis (<xref ref-type="bibr" rid="bib12">Cao and Galanello, 2010</xref>; <xref ref-type="bibr" rid="bib40">Glogowska et al., 2017</xref>). We therefore classified the remaining 68 unrelated donors as ânon-carriersâ of known disease alleles for the purposes of this work.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Overview of blood donors and study design.</title><p>(<bold>A</bold>) PCA of genetic variation across 35,759 unlinked exome SNPs. Donors from this study are plotted on coordinate space derived from 1000 Genomes reference populations. Points with white borders represent six related individuals, five of whom were excluded from the study. All exome variants passing quality filters are available in <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1âsource data 1</xref>. (<bold>B</bold>) Over a third of donors carried alleles for RBC disorders linked to <italic>Plasmodium falciparum</italic> resistance. Individuals with &gt;1 disease allele were classified by their most severe condition. non-carrier: Donor without any of the following alleles or conditions. G6PD<sup>â</sup><sub>low</sub>: Mild to medium G6PD deficiency (&lt;42% loss of function). G6PD<sup>â</sup><sub>high</sub>: Severe G6PD deficiency (&gt;60% loss of function). âÎ±/Î±Î±: heterozygous HBA2 deletion, or alpha thalassemia minima. âÎ±/âÎ±: homozygous HBA2 deletion, or Î±-thalassemia trait. HbAC: heterozygous HBB:E7K, or hemoglobin C trait. HbAS: heterozygous HBB:E7V, or sickle cell trait. HE: hereditary elliptocytosis. (<bold>C</bold>) Two components of <italic>P. falciparum</italic> fitness were measured with flow cytometry at three timepoints. Invasion is the change in parasitemia as schizonts egress from maintenance RBCs (green) and invade fresh acceptor RBCs from the blood donors (purple). Growth is the multiplication rate from a complete parasite cycle in the fresh acceptor RBCs. (<bold>D</bold>) RBC phenotypes were measured using complete blood counts with RBC indices, osmotic fragility tests, and ektacytometry on fresh samples. This figure was partially created with <ext-link ext-link-type="uri" xlink:href="https://biorender.com/">Biorender.com</ext-link>. RBC, red blood cell; SNP, single-nucleotide polymorphism.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1âsource data 1.</label><caption><title>Individual genotypes, population frequencies, and protein annotations for exome variants passing quality filters (N~160,000).</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-69808-fig1-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig1-v2.tif"/></fig></sec><sec id="s2-2"><title><italic>P. falciparum</italic> replication rates vary widely among non-carrier RBCs</title><p>To determine the variation in <italic>P. falciparum</italic> fitness among samples with different genotypes, we performed invasion and growth assays with two parasite strains. The genome reference strain 3D7, which was originally isolated from a European, has been continuously cultured in academic labs for at least 40 years (<xref ref-type="bibr" rid="bib107">Walliker et al., 1987</xref>; <xref ref-type="bibr" rid="bib75">Moser, 2020</xref>). Th.026.09 is a drug-resistant strain collected from Senegal in 2009 that is minimally adapted to lab culture (<xref ref-type="bibr" rid="bib22">Daniels et al., 2012</xref>). These divergent strains were selected in an attempt to balance biological realism with reliable in vitro data.</p><p>We observed a wide range of <italic>P. falciparum</italic> growth rates among RBC samples, especially among non-carriers that lacked known disease alleles (<xref ref-type="fig" rid="fig2">Figure 2AâC</xref>). Each strainâs growth rate is defined here as parasite multiplication over a full 48-hr cycle in donor RBCs (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), with the mean value for non-carriers set to 100% after normalization. Briefly, we used a repeated control RBC sample (<xref ref-type="fig" rid="fig2">Figure 2</xref>, gray points) and other batch-specific factors to correct for variation in parasite growth across multiple experiments (<xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1</xref>). Among non-carriers, growth rates ranged from 64% to 136% for 3D7 (SD=17.7%) and 76% to 128% for Th.026.09 (SD=10.6%) (<xref ref-type="fig" rid="fig2">Figure 2AâB</xref>). Per-sample growth rates were strongly correlated between the two strains (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, R<sup>2</sup>=0.69, p&lt;3Ã10<sup>â16</sup>) and positively correlated when measured in different weeks (p=0.35, <xref ref-type="fig" rid="fig2s2">Figure 2âfigure supplement 2</xref>), demonstrating that these data capture meaningful variation among donor RBCs. Furthermore, as expected (<xref ref-type="bibr" rid="bib35">Friedman, 1978</xref>; <xref ref-type="bibr" rid="bib45">Ifediba et al., 1985</xref>; <xref ref-type="bibr" rid="bib42">Greene, 1993</xref>; <xref ref-type="bibr" rid="bib30">Facer, 1995</xref>), we detected reductions in mean growth rate for both strains in RBCs carrying known disease alleles. These included individuals with Î±-thalassemia trait (3D7 p=0.027; Th.026.09 p=0.077), HbAS (3D7 p=1.05Ã10<sup>â7</sup>; Th.026.09 p=1.2Ã10<sup>â4</sup>), and the single carriers of HE and severe G6PD deficiency. Notably, the wide distribution of growth rates for non-carrier RBCs had considerable overlap with the growth rates in carrier RBCs. Only the HbAS and HE samples fell entirely outside the non-carrier range. This observation implies the existence of previously unknown RBC variation that impacts <italic>P. falciparum</italic> growth, which may have cumulative effect sizes comparable to known disease alleles.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Plasmodium falciparum</italic> replication rate varies widely among donor RBCs.</title><p>(<bold>A, B</bold>) Growth of <italic>P. falciparum</italic> lab strain 3D7 (<bold>A</bold>) or clinical isolate Th.026.09 (<bold>B</bold>) over a full 48-hr cycle in donor RBCs (see <xref ref-type="fig" rid="fig1">Figure 1C</xref>). Growth is presented relative to the average non-carrier rate after correction for batch effects (<xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1</xref>; see Materials and methods), including comparison to a repeated RBC control shown in gray. Each carrier group was compared to unrelated non-carriers using Studentâs t-test, except in cases where N=1, where asterisks instead indicate the percentile of the non-carrier distribution. Repeated measurements of 11 donors are shown in <xref ref-type="fig" rid="fig2s2">Figure 2âfigure supplement 2</xref>. (<bold>C</bold>) Per-sample growth rates are correlated between the two <italic>P. falciparum</italic> strains. (<bold>DâF</bold>) As in (<bold>AâC</bold>) but for <italic>P. falciparum</italic> invasion efficiency (see <xref ref-type="fig" rid="fig1">Figure 1C</xref>). R<sup>2</sup> and p-values are derived from OLS regression. <bold>*</bold>p&lt;0.1; <bold>**</bold>p&lt;0.05; <bold>***</bold>p&lt;0.01. RBC, red blood cell.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 1.</label><caption><title>Linear models of batch effects on parasite fitness.</title><p>PMR: parasite multiplication rate.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 2.</label><caption><title>Repeatability of parasite assays in the same donors over time.</title><p>Twelve participants (including the weekly control, 1111) donated blood in multiple weeks for independent experiments. Repeated donors were non-carriers except 6443, who carried the HbAC allele; and 7160, 8597, and 4278, who carried alleles for mild G6PD deficiency. Growth and invasion data are shown after standardization and batch correction, as described in Materials and methods. Pearsonâs rho is calculated between the first and second assays and can range from â1 to 1.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig2-figsupp2-v2.tif"/></fig></fig-group><p>We observed a similarly wide range in the efficiency of <italic>P. falciparum</italic> invasion into donor RBCs (<xref ref-type="fig" rid="fig2">Figure 2DâF</xref>). Invasion is defined here as the fold-change in parasitemia over the first 24 hours of the assay, when parasites previously maintained in standard culture conditions egressed and invaded new donor RBCs (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Among non-carriers, invasion rates ranged from 70% to 143% for 3D7 (SD=14.9%) and 41% to 193% for Th.026.09 (SD=29.1%) (<xref ref-type="fig" rid="fig2">Figure 2DâE</xref>). Compared to growth rates, no disease alleles conferred protection against invasion that was extreme enough to fall outside the broad non-carrier range. HbAC was associated with an 11% decrease in 3D7 invasion (p=0.008), while Î±-thalassemia trait was associated with a 22% increase in Th.026.09 invasion (p=0.091). Only HE had a strong effect on the invasion efficiency of both strains. The correlation of invasion efficiencies between strains was weaker than for growth (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, R<sup>2</sup>=0.10, p=6Ã10<sup>â4</sup>), potentially reflecting strain-specific differences in the pathways used for invasion (<xref ref-type="bibr" rid="bib113">Wright and Rayner, 2014</xref>). However, we also observed greater batch effects (<xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1</xref>) and greater variability between repeated samples (<xref ref-type="fig" rid="fig2s2">Figure 2âfigure supplement 2</xref>) for invasion than for growth, suggesting that invasion is influenced by greater experimental noise.</p></sec><sec id="s2-3"><title>RBC phenotypes vary widely among non-carriers</title><p>To assess phenotypic variation across donor RBCs, we measured 22 common indices of RBC size and hemoglobin content from complete blood counts using an ADVIA hematology analyzer (<xref ref-type="fig" rid="fig3">Figure 3AâD</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3âfigure supplements 1</xref>â<xref ref-type="fig" rid="fig3s2">2</xref>). Mean cellular volume (MCV) and hemoglobin mass (MCH) are closely related traits, which can be represented together as cellular hemoglobin concentration (CHCM) or the fraction of RBCs with ânormalâ hemoglobin and volume indices (M5). As expected, each known disease allele was associated with a distinct set of RBC abnormalities (<xref ref-type="fig" rid="fig3s3">Figure 3âfigure supplement 3</xref>). These included elevated CHCM for HbAC (p=0.033), consistent with dehydration, and very low MCV (p=6.8Ã10<sup>â5</sup>) and MCH (p=2.5Ã10<sup>â7</sup>) for Î±-thalassemia trait (âÎ±/âÎ±), consistent with microcytic anemia (<xref ref-type="bibr" rid="bib36">Galanello and Cao, 2011</xref>). RBCs from the HE patient also had very low MCV and MCH, reflecting the membrane breakage and volume loss characteristic of this disease. For all these phenotypic measures, we also observed broad distributions in non-carriers that overlapped the distributions of most carriers (<xref ref-type="fig" rid="fig3">Figure 3AâD</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3âfigure supplements 1</xref>â<xref ref-type="fig" rid="fig3s2">2</xref>). Notably, the breadth of the non-carrier distribution for each phenotype was large (e.g., 24 fl range for MCV) compared to the average difference between Africans and Europeans (e.g., 3â5 fl; <xref ref-type="bibr" rid="bib8">Beutler and West, 2005</xref>; <xref ref-type="bibr" rid="bib64">Lo et al., 2011</xref>). This wide diversity and substantial overlap between non-carrier and carrier traits suggest that healthy RBCs exist on the same phenotypic continuum as RBCs carrying known disease alleles.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Red cell phenotypes that are abnormal in carriers also vary widely among non-carriers.</title><p>(<bold>AâD</bold>) Red cell indices were measured by an ADVIA hematology analyzer. Additional indices are shown in <xref ref-type="fig" rid="fig3s1">Figure 3âfigure supplement 1</xref>. MCV: mean corpuscular (RBC) volume; MCH: mean cellular hemoglobin; CHCM: cellular hemoglobin concentration; M5: fraction of RBCs with normal volume and normal hemoglobin (see <xref ref-type="fig" rid="fig3s2">Figure 3âfigure supplement 2</xref>). Statistical tests as in <xref ref-type="fig" rid="fig2">Figure 2</xref>. (<bold>E, F</bold>) Osmotic fragility curves. Fragility is defined as the NaCl concentration at which 50% of RBCs lyse (see <xref ref-type="fig" rid="fig3s4">Figure 3âfigure supplement 4</xref>). (<bold>G, H</bold>) Ektacytometry curves characterize RBC deformability and dehydration under salt stress (<xref ref-type="fig" rid="fig3s5">Figure 3âfigure supplement 5</xref>). A heatmap of all phenotypes by carrier status is available in <xref ref-type="fig" rid="fig3s3">Figure 3âfigure supplement 3</xref>. RBC, red blood cell.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 1.</label><caption><title>RBC indices data from complete blood counts in donor RBCs.</title><p>Donor classifications and statistical tests as in <xref ref-type="fig" rid="fig3">Figure 3</xref>. HCT, hematocrit; HDW, hemoglobin distribution width; HGB, hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MPV, mean platelet volume; PLT, platelet count; RBC, red blood cell; RDW, red cell distribution width, .</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 2.</label><caption><title>RBC Matrix data from complete blood counts in donor RBCs.</title><p>Donor classifications and statistical tests as in <xref ref-type="fig" rid="fig3">Figure 3</xref>. RBC, red blood cell.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 3.</label><caption><title>Heatmap of RBC phenotypes by carrier status.</title><p>Phenotypes were scaled and centered at 0 with the preProcess function from the caret package in R using all sample data (i.e., not limited to non-carriers). The mean value for each carrier group is shown. RBC, red blood cell.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig3-figsupp3-v2.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 4.</label><caption><title>Osmotic fragility diagram and summary data.</title><p>Donor classifications and statistical tests as in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig3-figsupp4-v2.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 5.</label><caption><title>Ektacytometry diagram and summary data.</title><p>Donor classifications and statistical tests as in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig3-figsupp5-v2.tif"/></fig></fig-group><p>We observed similar patterns of variation in RBC membrane fragility (<xref ref-type="fig" rid="fig3">Figure 3EâF</xref>; <xref ref-type="fig" rid="fig3s4">Figure 3âfigure supplement 4</xref>) and membrane deformability (<xref ref-type="fig" rid="fig3">Figure 3GâH</xref>; <xref ref-type="fig" rid="fig3s5">Figure 3âfigure supplement 5</xref>), as measured with osmotic fragility tests and osmotic gradient ektacytometry. Both sets of curves represent RBC tolerance to osmotic stress, which can result in swelling and lysis (fragility, <xref ref-type="fig" rid="fig3">Figure 3EâF</xref>) or dehydration and decreased deformability (O<sub>hyper</sub>, <xref ref-type="fig" rid="fig3">Figure 3GâH</xref>). Specific hemoglobinopathies were associated with moderate to strong reductions in fragility, deformability, and/or resistance to loss of deformability when dehydrated (<xref ref-type="fig" rid="fig3s3">Figure 3âfigure supplements 3</xref>â<xref ref-type="fig" rid="fig3s5">5</xref>). HE cells were both extremely fragile and extremely non-deformable. In non-carriers, the distributions for all membrane measures were wide, continuous, and overlapped the distribution of most carriers (<xref ref-type="fig" rid="fig3">Figure 3EâH</xref>). Overall, these data demonstrate that multiple phenotypic alterations associated with RBC disease alleles are also present in non-carrier RBCs.</p></sec><sec id="s2-4"><title>Non-carrier variation in RBC phenotypes predicts <italic>P. falciparum</italic> replication rate</title><p>To identify sets of phenotypes associated with <italic>P. falciparum</italic> replication in non-carrier RBCs, we used a machine learning method called LASSO (Least Absolute Shrinkage and Selection Operator) that performs regularization and variable selection (<xref ref-type="bibr" rid="bib101">Tibshirani, 1994</xref>). Briefly, LASSO shrinks the regression coefficients for some possible predictors to zero to obtain a subset of predictors (in this case, phenotypes) that minimizes prediction error. This method is well-suited for data sets where predictors are correlated, as are RBC size, hemoglobin, and membrane dynamics; and for cases where the number of possible predictors is large compared to the number of measurements. To validate RBC phenotypes associated with <italic>P. falciparum</italic> replication by LASSO, we performed k-folds cross-validation (CV) on train and test sets derived from 10,000 divisions of the non-carrier data in 10-folds (see Materials and methods). To further control for overfitting, we also applied the same procedure to 1000 random permutations of the parasite data. Finally, for each trait selected by LASSO in at least 40% of training sets, we applied univariate OLS regression to estimate the sign of its effect on all measured components of parasite fitness. The highest-confidence results from this analysis are summarized in <xref ref-type="fig" rid="fig4">Figure 4A</xref>, with complete details provided in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4âsource data 1</xref>.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>RBC phenotypes predict <italic>Plasmodium falciparum</italic> fitness in non-carriers.</title><p>(<bold>A</bold>) Phenotypes selected by LASSO in at least 40% of train data sets (blue shading; see Materials and methods) in at least one of four models of parasite replication (columns). Each model was trained on ~90% of the data (<bold>B, C</bold>) and tested on the remaining 10% (<bold>B, C</bold>). (+/â) shows the direction of effect if the phenotype was significantly correlated (p&lt;0.1) with the parasite fitness component in a separate, univariate linear model (<xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1</xref><bold>;</bold> ). MCV: mean RBC volume (fl).MCH: mean corpuscular hemoglobin (pg/RBC). O<sub>50</sub>: Osmotic fragility (mM NaCl; see <xref ref-type="fig" rid="fig3s4">Figure 3âfigure supplement 4</xref>). DI<sub>max</sub>: Maximum membrane deformability (arbitrary units; see <xref ref-type="fig" rid="fig3s5">Figure 3âfigure supplement 5</xref>). O<sub>hyper</sub>: Tendency to resist osmotic dehydration and loss of deformability. M4: fraction of RBCs with normal volume and low hemoglobin (see <xref ref-type="fig" rid="fig3s2">Figure 3âfigure supplement 2</xref>). M6: fraction of RBCs with normal volume and high hemoglobin. M8: fraction of RBCs with low volume and normal hemoglobin. CHCM: cellular hemoglobin concentration mean (g/dl). MCHC: mean corpuscular hemoglobin concentration (g/dl). PLT: platelet number (Ã10<sup>3</sup>/Âµl). MPV: mean platelet volume (fl). RBC: red cell number (Ã10<sup>6</sup>/Âµl). HCT: hematocrit, or the fraction of blood volume composed of RBCs. RDW: red cell distribution width (%). (<bold>B, C</bold>) Variance in parasite fitness explained by RBC phenotypes in LASSO models. Dashed lines indicate average R<italic><sup>2</sup></italic> for the measured test data. Each histogram shows the same procedure on 1000 permutations of the measured test data. RBC, red blood cell.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4âsource data 1.</label><caption><title>Association statistics for individual phenotypic predictors with non-zero LASSO support.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69808-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 1.</label><caption><title>Scatterplots of RBC phenotypes against parasite fitness in non-carriers.</title><p>Phenotypes from <xref ref-type="fig" rid="fig4">Figure 4A</xref> are shown if at least one OLS test had p&lt;0.1. Lines of best fit are shown if p&lt;0.1. All phenotypes except Fragility and Donor Age are clustered around the median as a result of normalization, which equalized the median value across weeks (see Materials and methods). Pink: 3D7; Orange: Th.026.09. RBC, red blood cell.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig4-figsupp1-v2.tif"/></fig></fig-group><p><italic>P. falciparum</italic> fitness in non-carrier RBCs was strongly predicted by variation in traits related to volume, hemoglobin, deformability, and dehydration (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Among 25 tested phenotypes, the most strongly predictive was the ektacytometry parameter O<sub>hyper</sub>, which represents a cellâs tendency to retain deformability in the face of dehydration (<xref ref-type="fig" rid="fig3s4">Figure 3âfigure supplement 4</xref>). In univariate models, non-carrier RBCs with the largest O<sub>hyper</sub> valuesâthat is, those that retained more deformability when dehydratedâsupported 22â46% faster parasite growth (3D7 p=0.003, Th.026.09 p=0.007) and 31â83% more effective invasion (3D7 p=0.008, Th.026.09 p=0.005) than RBCs with the smallest O<sub>hyper</sub> values, which quickly lost deformability. Consistent with this result, <italic>P. falciparum</italic> replication was inhibited in RBCs that were more dehydrated at baseline (e.g., with higher CHCM; 3D7 invasion p=0.006, 3D7 growth p=0.024, Th.026.09 invasion p=0.004, Th.026.09 growth p=0.26). Parasites also grew faster in RBCs with larger mean volume (MCV; 3D7 p=0.001, Th.026.09 p=0.0009); a greater mass of hemoglobin per cell (MCH; 3D7 p=0.071, Th.026.09 p=0.016); and more deformable membranes (DI<sub>max</sub>; 3D7 p=0.0005, Th.026.09 p=0.008). 3D7 growth was also reduced in RBCs with more fragile membranes (O<sub>50</sub>; p=0.005). Additional phenotypes related to platelets and RBC density were selected for some models, but the direction of their effects was unclear when they were considered individually (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4âsource data 1</xref>). These results indicate that common, non-pathogenic variation in RBC size, membrane dynamics, and other correlated traits have meaningful effects on <italic>P. falciparum</italic> replication rate in RBCs.</p><p>Taken together, the non-carrier phenotypes selected by LASSO from training data (N~61, <xref ref-type="fig" rid="fig4">Figure 4A</xref>) explained 3â9% of the variation in parasite growth in separate test data (N~7, <xref ref-type="fig" rid="fig4">Figure 4B</xref>; 3D7 p=0.008 and RMSE=18.0%; Th.026.09 p=0.079 and RMSE=10.8%). This fraction was significantly greater than expected from random permutations, which were centered on R<italic><sup>2</sup></italic>=0 in the test data (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Notably, prediction error was greater for individuals with parasite growth values farther away from the mean. In contrast, for invasion, RBC phenotypes did not explain more variation in the test data than expected from permutations (<xref ref-type="fig" rid="fig4">Figure 4C</xref>; 3D7 p=0.79 and RMSE=15.0%; Th.026.09 p=0.53 and RMSE=29.5%). All phenotype models were less predictive for the clinical isolate Th.026.09 than the lab strain 3D7, perhaps because clinical isolates are less adapted to laboratory conditions. Overall, these results demonstrate that multiple, variable phenotypes impact <italic>P. falciparum</italic> susceptibility in healthy RBCs. Non-carrier cells that are less hospitable to parasites share specific traits with RBCs that carry disease alleles, including smaller size, decreased deformability, and an increased tendency to lose deformability when dehydrating.</p></sec><sec id="s2-5"><title>Common RBC alleles predict <italic>P. falciparum</italic> replication in non-carriers</title><p>Next, we tested whether non-carrier genotypes derived from exome sequencing could improve our predictions of <italic>P. falciparum</italic> replication rate. With a sample of 68 unrelated non-carriers, we lacked the power to perform the many thousands of tests that are typical in large genetic association studies (<xref ref-type="bibr" rid="bib31">Fadista et al., 2016</xref>). Instead, our study design focused on 23 RBC proteins previously associated with malaria (<xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5âsource data 1</xref>), which we hypothesized are enriched for common variants impacting <italic>P. falciparum</italic> fitness, as compared to random control sets of RBC proteins. We used the same LASSO procedure described above to test 106 unlinked genetic variants (pairwise r<sup>2</sup>&lt;0.1) in these 23 RBC proteins, along with RBC phenotypes, for association with <italic>P. falciparum</italic> fitness in non-carriers. To test for the effects of population structure, we also included the top 10 principal components (PCs) from 1000 Genomes as possible predictors. Notably, PC1 is equivalent to the exome-wide fraction of African ancestry, as determined by ADMIXTURE with K=4 from the 1000 Genomes reference populations (see Materials and methods). We again compared these results to permuted data, as well as to 1,000 sets of 23 genes drawn at random from the RBC proteome (<xref ref-type="supplementary-material" rid="fig5sdata2">Figure 5âsource data 2</xref>).</p><p>Taken together, genotypes and phenotypes selected by LASSO explained 7â15% of the variation in parasite growth rate in the test data (<xref ref-type="fig" rid="fig5">Figure 5B</xref>; 3D7 p=0.012 and RMSE=16.5%; Th.026.09 p=0.063 and RMSE=10.6%). Prediction error was greater for donors with parasite values farther away from the mean, though this trend was weaker than for phenotype-only models. The variance explained by models using real genotype and phenotype data was significantly larger than expected from permutation (<xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1A</xref>) and random sets of RBC genes (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), suggesting that the 23 malaria-related genes contain variation that influences <italic>P. falciparum</italic> development.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Common variation in malaria-associated genes predicts <italic>Plasmodium falciparum</italic> fitness in non-carrier RBCs.</title><p>(<bold>A</bold>) Variants in 23 malaria-related genes (<xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5âsource data 1</xref>) and genetic PCs selected by LASSO in at least &gt;40% of train data sets. Each model was trained on ~90% of the measured data (<bold>B C</bold>) and tested on the remaining 10% (<bold>B C</bold>). The following genes had no associated variants in non-carriers: <italic>CD55, EPB41, FPN, G6PD, GYPA, GYPE, HBA1/2, HBB,</italic> and <italic>HP</italic>. <bold>*</bold>The only significant PC association was driven by a single East Asian donor (<xref ref-type="fig" rid="fig5s5">Figure 5âfigure supplement 5</xref>). (<bold>B, C</bold>) Variance in parasite fitness explained by LASSO models including 23 malaria-related genes, the top 10 PCs, and RBC phenotypes. Dashed lines indicate average R<italic><sup>2</sup></italic> for models using the measured test data. Each histogram shows R<italic><sup>2</sup></italic> for models including variants from 23 random genes in the RBC proteome (<xref ref-type="supplementary-material" rid="fig5sdata2">Figure 5âsource data 2</xref>) instead of malaria-related genes. All predictors with non-zero LASSO support are shown in <xref ref-type="supplementary-material" rid="fig5sdata3">Figure 5âsource data 3</xref>. Additional histograms from permuted data are shown in <xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1</xref>. The variance explained by variants undiscovered by previous GWAS is shown in <xref ref-type="fig" rid="fig5s4">Figure 5âfigure supplement 4</xref>. GWAS, genome-wide association studies; PC, principal component; RBC, red blood cell.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5âsource data 1.</label><caption><title>Twenty-three RBC genes with strong links to malaria in the literature.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69808-fig5-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5âsource data 2.</label><caption><title>Proteins present in mature RBCs.</title><p>This list was derived from the Red Blood Cell Collection database (<ext-link ext-link-type="uri" xlink:href="http://rbcc.hegelab.org/">rbcc.hegelab.org</ext-link>) using a medium-confidence filter.</p></caption><media mime-subtype="csv" mimetype="application" xlink:href="elife-69808-fig5-data2-v2.csv"/></supplementary-material></p><p><supplementary-material id="fig5sdata3"><label>Figure 5âsource data 3.</label><caption><title>All genetic and phenotypic predictors with non-zero LASSO support.</title><p>Growth predictors selected in at least 40% of train data sets are indicated in bold. Genetic predictors are summarized in <xref ref-type="fig" rid="fig5">Figure 5A</xref>. NA indicates predictors that were only present as singletons in the smaller invasion data set.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69808-fig5-data3-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 1.</label><caption><title>Variance in parasite fitness explained by permuted data in LASSO models.</title><p>Each model was trained on ~90% of the measured data and tested on the remaining 10%. Dashed lines indicate average R<italic><sup>2</sup></italic> for the measured test data. Each histogram shows the same procedure on 1,000 permutations of the measured test data.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 2.</label><caption><title>Lack of association between RBC dehydration phenotypes and PIEZO1 rs59446030 or ATP2B4 rs1419114.</title><p>Each cell shows the p-value from a linear model between the genetic variant and trait in non-carriers. RBC, red blood cell.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig5-figsupp2-v2.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 3.</label><caption><title>Three non-carrier variants with potentially overdominant effects on 3D7 growth.</title><p>Homozygotes for the minor allele were ignored when estimating effect sizes for these alleles with OLS for <xref ref-type="fig" rid="fig6">Figure 6E</xref>. Effect size estimates that include all homozygotes are shown in <xref ref-type="supplementary-material" rid="fig5sdata3">Figure 5âsource data 3</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig5-figsupp3-v2.tif"/></fig><fig id="fig5s4" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 4.</label><caption><title>Variants undiscovered by previous GWAS drive most of the association signal between parasite replication rate and the 23 malaria-related genes.</title><p>âVariance explainedâ is the R<sup>2</sup> of a linear model in non-carriers (excluding using only these variants as predictors. Details on the variants and previous GWAS traits are provided in <xref ref-type="supplementary-material" rid="fig5sdata3">Figure 5âsource data 3</xref>). GWAS, genome-wide association studies.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig5-figsupp4-v2.tif"/></fig><fig id="fig5s5" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 5.</label><caption><title>An outlier individual for PC2 drives an apparent association between PC2 and 3D7 growth.</title><p>See also <xref ref-type="fig" rid="fig1">Figure 1A</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig5-figsupp5-v2.tif"/></fig><fig id="fig5s6" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 6.</label><caption><title>A six-member family has unique ancestry and parasite susceptibility compared to other non-carrier donors.</title><p>Only PCs that distinguish the family from other non-carriers are shown. P-values are derived from t-tests. PC, principal component.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig5-figsupp6-v2.tif"/></fig></fig-group><p>Nearly all of the 32 polymorphisms selected by LASSO in growth models occurred in (1) ion channel proteins, which regulate RBC hydration; (2) components of the flexible RBC membrane backbone; or (3) red cell plasma membrane proteins, including known invasion receptors (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). In the first category, the highly polymorphic ion channel <italic>PIEZO1</italic> contained seven polymorphisms associated with small (&lt;3.7%) to moderate (31%) reductions of <italic>P. falciparum</italic> growth rate. In practice, the smallest effect size that could be reliably determined for an allele with our data was Â±3.7% (<xref ref-type="supplementary-material" rid="fig5sdata3">Figure 5âsource data 3</xref>). The microsatellite variant <italic>PIEZO1</italic>-E756del, which has been a focus of several recent studies (<xref ref-type="bibr" rid="bib46">Ilboudo et al., 2018</xref>; <xref ref-type="bibr" rid="bib67">Ma et al., 2018</xref>; <xref ref-type="bibr" rid="bib89">Rooks et al., 2019</xref>; <xref ref-type="bibr" rid="bib78">Nguetse et al., 2020</xref>), predicted a moderate reduction in Th.026.09 growth (â7.9%, p=0.01) but was not related to RBC dehydration in these data (<xref ref-type="fig" rid="fig5s2">Figure 5âfigure supplement 2</xref>). For 3D7, we also detected one growth-associated variant in <italic>ATP2B4</italic> (â5.9%, p=0.075)<italic>,</italic> which encodes the primary RBC calcium channel PMCA4b. This variant tags an <italic>ATP2B4</italic> haplotype implicated by GWAS in protection from severe malaria and many RBC phenotypes (<xref ref-type="bibr" rid="bib105">van der Harst et al., 2012</xref>; <xref ref-type="bibr" rid="bib62">Li et al., 2013b</xref>; <xref ref-type="bibr" rid="bib59">Lessard et al., 2017</xref>; <xref ref-type="bibr" rid="bib63">Lin et al., 2020</xref>, <xref ref-type="bibr" rid="bib103">Timmann et al., 2012</xref>, <xref ref-type="bibr" rid="bib115">ZÃ¡mbÃ³ et al., 2017</xref>). Notably, however, this variant has never before been functionally demonstrated to be associated with <italic>P. falciparum</italic> fitness.</p><p><italic>SPTA1</italic> and <italic>SPTB,</italic> which encode the flexible spectrin backbone of RBCs, contained several variants associated with the growth of at least one <italic>P. falciparum</italic> strain, as did the structural linker genes <italic>ANK1</italic>, <italic>SLC4A1</italic>, and <italic>EPB42</italic> (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). We also identified a total of 10 polymorphisms in <italic>ABCB6, GYPB, GYPC, CR1, CD44</italic>, and basigin (<italic>BSG</italic>) that were associated with <italic>P. falciparum</italic> growth. These plasma membrane proteins have all been previously implicated in <italic>P. falciparum</italic> invasion by genetic deficiency studies (<xref ref-type="bibr" rid="bib72">Mayer et al., 2009</xref>; <xref ref-type="bibr" rid="bib20">Crosnier et al., 2011</xref>; <xref ref-type="bibr" rid="bib26">Egan et al., 2015</xref>; <xref ref-type="bibr" rid="bib27">Egan et al., 2018</xref>), and in some cases, studies of natural polymorphisms (<xref ref-type="bibr" rid="bib76">Nagayasu et al., 2001</xref>; <xref ref-type="bibr" rid="bib57">Leffler et al., 2017</xref>). Notably, two of the variants identified here are synonymous quantitative trait loci (QTL) for CD44 splicing (rs35356320) and BSG expression (rs4682) (<xref ref-type="bibr" rid="bib43">GTEx Consortium et al., 2017</xref>), further supporting the possibility that they are functional. No associated variants were detected in the other 10 tested genes, including 3 hemoglobin proteins, <italic>G6PD,</italic> 2 glycophorins, <italic>CD55</italic>, <italic>EPB41</italic>, <italic>FPN,</italic> and <italic>HP</italic>. Taken together, these data demonstrate that dozens of host genetic variants shape the phenotypic distribution of red cell susceptibility to <italic>P. falciparum</italic> in non-carriers.</p><p>Eighteen of the 32 variants selected by LASSO were synonymous, which was not significantly different from the input set of 106 variants (p=0.72, two-sided binomial test). Over half of the growth-associated variants have previously been associated with gene expression traits, GWAS traits, or GWAS loci through linkage (<xref ref-type="supplementary-material" rid="fig5sdata3">Figure 5âsource data 3</xref>), suggesting that they indeed tag functional polymorphisms. Novel variants nonetheless contribute substantially to the predictive power of these models (<xref ref-type="fig" rid="fig5s4">Figure 5âfigure supplement 4</xref>), and nearly all the variants are novel in terms of association with <italic>P. falciparum</italic> growth rate.</p><p>In contrast to growth, models of invasion that included genotypic predictors were no more accurate than expected by chance (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, pâ¥0.3; <xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1B</xref>, pâ¥0.15). However, six of the nine RBC invasion receptors contained variants associated with growth (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), including a SNP in glycophorin B (<italic>GYPB</italic>) that has been linked to malaria risk in Brazil (<xref ref-type="bibr" rid="bib100">Tarazona-Santos et al., 2011</xref>). These patterns likely stem from experimental noise in our measure of invasion (<xref ref-type="fig" rid="fig1">Figure 1C</xref>; <xref ref-type="fig" rid="fig2">Figure 2C and F</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplements 1</xref>â<xref ref-type="fig" rid="fig2s2">2</xref>), though we note that our definition of growth involves a re-invasion event (<xref ref-type="fig" rid="fig1">Figure 1C</xref>).</p><p>No PCs of population structure were significantly associated with <italic>P. falciparum</italic> growth rate (<xref ref-type="supplementary-material" rid="fig5sdata3">Figure 5âsource data 3</xref>), including the PC that distinguishes Africans from other populations (PC1, <xref ref-type="fig" rid="fig1">Figure 1A</xref>). One PC was selected by LASSO for 3D7 growth, but this association was driven by a single donor with East Asian ancestry and relatively high susceptibility (<xref ref-type="fig" rid="fig5s5">Figure 5âfigure supplement 5</xref>). We note that the unique ancestry and extreme phenotypes of the six-member family (<xref ref-type="fig" rid="fig5s6">Figure 5âfigure supplement 6</xref>) would have driven additional correlations if family members had not been excluded from the LASSO models. Although the present study is limited by sample size, these associations between global genetic PCs and <italic>P. falciparum</italic> growth suggest that additional functional variants remain to be discovered in many populations.</p></sec><sec id="s2-6"><title>African ancestry does not predict <italic>P. falciparum</italic> resistance in red cells</title><p>Based on evidence from balanced disease alleles like HbAS, it has been suggested that anti-malarial selection has shaped polygenic red cell phenotypes in African populations as a whole (<xref ref-type="bibr" rid="bib41">Goheen et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Kanias et al., 2017</xref>; <xref ref-type="bibr" rid="bib67">Ma et al., 2018</xref>; <xref ref-type="bibr" rid="bib82">Page et al., 2021</xref>). We tested this hypothesis by examining the correlation between African ancestry and <italic>P. falciparum</italic> fitness in non-carrier RBCs (<xref ref-type="fig" rid="fig6">Figure 6AâD</xref>). Surprisingly, we found no evidence that these traits were related, apart from a positive relationship between African ancestry and invasion rate of Th.026.09, the clinical Senegalese strain (p=0.004, R<sup>2</sup>=0.13, <xref ref-type="fig" rid="fig6">Figure 6D</xref>). To understand this result, we next examined how key RBC phenotypes identified in this study (<xref ref-type="fig" rid="fig4">Figure 4A</xref>) vary with African ancestry (<xref ref-type="fig" rid="fig6">Figure 6FâH</xref>; <xref ref-type="fig" rid="fig6s1">Figure 6âfigure supplement 1</xref>). We found that greater African ancestry predicts reduced osmotic fragility (p=1.2Ã10<sup>â6</sup>), reduced RBC dehydration (CHCM p=0.009; MCHC p=0.089), and a greater fraction of âoverhydratedâ RBCs with normal volume and low hemoglobin (M4 p=0.041). All of these traits actually predict <italic>greater</italic> red cell susceptibility to <italic>P. falciparum</italic> (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), although together they explain less than 13% of the non-carrier variation in 3D7 growth. The remaining key phenotypes do not vary with African ancestry, which may explain why African ancestry itself is only weakly associated with <italic>P. falciparum</italic> fitness in non-carrier RBCs (<xref ref-type="fig" rid="fig6">Figure 6AâD</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Little evidence of widespread selection in Africa for slower <italic>Plasmodium falciparum</italic> replication, protective alleles, or protective phenotypes in non-carriers.</title><p>(<bold>AâD</bold>) Parasite replication versus the exome-wide fraction of African ancestry in non-carriers, determined with ADMIXTURE by comparison to 1000 Genomes reference populations. R<italic><sup>2</sup></italic> and p-values are shown for OLS regression. (<bold>E</bold>) Alleles in 23 malaria-related genes that predict slower <italic>P. falciparum</italic> growth in non-carriers (<xref ref-type="fig" rid="fig5">Figure 5A</xref>) are not enriched for higher frequencies in Africa versus Europe. Effect sizes are shown for one allele copy for 3D7 or Th.026.09 growth, whichever was greater. Effect sizes were determined from additive models except for three alleles that appeared overdominant (<xref ref-type="fig" rid="fig5s3">Figure 5âfigure supplement 3</xref>). F<sub>ST</sub> was calculated from African and European samples in gnomAD (see Materials and methods). HbAS and the HBA2 deletion are shown for comparison. (<bold>FâH</bold>) RBC phenotypes associated with <italic>P. falciparum</italic> growth versus the exome-wide fraction of African ancestry in non-carriers. Slower <italic>P. falciparum</italic> growth in RBCs is predicted by greater fragility (<bold>F</bold>), greater dehydration (<bold>G</bold>), and lower O<sub>hyper</sub> (<bold>H</bold>) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Additional phenotypes are shown in <xref ref-type="fig" rid="fig6s1">Figure 6âfigure supplement 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6âfigure supplement 1.</label><caption><title>Scatterplots of RBC phenotypes versus African ancestry in non-carriers.</title><p>Phenotypes from <xref ref-type="fig" rid="fig4">Figure 4A</xref> are shown. R<italic><sup>2</sup></italic> and p-values were estimated from OLS regression. RBC, red blood cell.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69808-fig6-figsupp1-v2.tif"/></fig></fig-group><p>Next, we used allele frequency data from over 54,000 individuals in the gnomAD collection (<xref ref-type="bibr" rid="bib49">Karczewski et al., 2020</xref>) to test whether the polymorphisms we associated with <italic>P. falciparum</italic> growth occur at different frequencies in African and European populations. Geographical differences in malaria selection are sometimes hypothesized to have increased the frequency of hundreds or thousands of undiscovered anti-malarial alleles in Africa (<xref ref-type="bibr" rid="bib69">Mackinnon et al., 2005</xref>; <xref ref-type="bibr" rid="bib112">Williams, 2006</xref>), as has been shown for several variants causing common RBC disorders (<xref ref-type="bibr" rid="bib51">Kariuki and Williams, 2020</xref>). To address this hypothesis for non-carrier variation, we calculated F<sub>ST</sub> between Africans and Europeans for 22 alleles with protective effects large enough to be specified in our sample (â¥3.7%; <xref ref-type="supplementary-material" rid="fig5sdata3">Figure 5âsource data 3</xref>). We found that 11 of these protective alleles (50%) are more common in Africans, which is not more than expected by chance (p=0.5, one-sided binomial test). The three protective variants with the largest absolute F<sub>ST</sub> values are all more common in Europeans, including a synonymous <italic>SPTA1</italic> allele with GWAS associations to several RBC and white blood cell traits. Two protective <italic>PIEZO1</italic> variants are more common in Africans, including E756del and a synonymous variant of large effect. Overall, however, we find no evidence that African populations are enriched for non-pathogenic RBC polymorphisms or phenotypes associated with impaired <italic>P. falciparum</italic> growth in vitro.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Healthy RBCs harbor extensive phenotypic and proteomic variation, both within and between human populations. In this study, we demonstrate that this variation modulates a wide range of RBC susceptibility to <italic>P. falciparum</italic> parasites. Our findings add to a growing understanding of the genetic and phenotypic basis of RBC resistance to <italic>P. falciparum</italic>, especially for RBCs that lack population-specific disease alleles. These findings suggest new targets for future malaria interventions, in addition to challenging assumptions about the role of malaria selection in shaping human RBC diversity.</p><p>Exponential replication of <italic>P. falciparum</italic> is a significant driver of malaria disease progression (<xref ref-type="bibr" rid="bib7">Bejon et al., 2007</xref>). Therefore, the ample variation that we observed in this trait in vitro could be relevant for clinical outcomes in endemic regions. Growth inhibition from HbAS, for example, reduces the risk of death from malaria by reducing parasite density in the blood (<xref ref-type="bibr" rid="bib2">Allison, 1954</xref>; <xref ref-type="bibr" rid="bib66">Luzzatto, 2012</xref>). While HbAS has a uniquely extreme effect size, we found a threefold range of parasite replication rates among non-carrier RBCs that share substantial overlap with RBCs carrying other protective variants. Although the physiologically complex basis of severe malaria (<xref ref-type="bibr" rid="bib80">Okwa, 2012</xref>) makes it difficult to estimate the precise contribution of RBC factors to severe malaria risk, the genotypes and phenotypes we have associated with <italic>P. falciparum</italic> fitness may contribute to malaria susceptibility.</p><p>We have shown here that widespread, ânormalâ variation in RBC hydration and deformability traits are associated with <italic>P. falciparum</italic> fitness in non-carrier RBCs. Interestingly, the protective phenotypes we detect in non-carrier RBCs are also present in carriers, albeit to a stronger degree (<xref ref-type="bibr" rid="bib17">Clark et al., 1983</xref>; <xref ref-type="bibr" rid="bib74">Mockenhaupt, 2000</xref>; <xref ref-type="bibr" rid="bib85">Pengon et al., 2018</xref>). These results are consistent with experimental manipulations that reduce <italic>P. falciparum</italic> growth, such as chemical or genetic dehydration of RBCs (<xref ref-type="bibr" rid="bib102">Tiffert et al., 2005</xref>; <xref ref-type="bibr" rid="bib67">Ma et al., 2018</xref>). They are also consistent with the protective effect conferred by Dantu, a rare glycophorin variant associated with increased membrane tension (<xref ref-type="bibr" rid="bib32">Field et al., 1994</xref>; <xref ref-type="bibr" rid="bib57">Leffler et al., 2017</xref>; <xref ref-type="bibr" rid="bib50">Kariuki et al., 2020</xref>). Our data expand upon these prior findings by demonstrating for the first time that common, healthy phenotypic variation in RBC traits contributes meaningfully to <italic>P. falciparum</italic> growth.</p><p>In the last decade, several association studies have explored the genetic basis of common variation in RBC traits using large, mostly European cohorts (<xref ref-type="bibr" rid="bib105">van der Harst et al., 2012</xref>; <xref ref-type="bibr" rid="bib4">Astle et al., 2016</xref>; <xref ref-type="bibr" rid="bib13">Chami et al., 2016</xref>; <xref ref-type="bibr" rid="bib11">Canela-Xandri et al., 2018</xref>; <xref ref-type="bibr" rid="bib16">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="bib106">Vuckovic et al., 2020</xref>). These studies agree that the broad distribution of RBC phenotypes in humans is shaped by a large number of common alleles, similar to other complex traits (<xref ref-type="bibr" rid="bib10">Boyle et al., 2017</xref>). Although the effects of most individual alleles are likely too small to be considered pathogenic on their own, different combinations of alleles may underlie the broad phenotypic variation observed in non-carriers. We cannot rule out the possibility that some extreme phenotypes could be better explained by the presence of large-effect âdiseaseâ alleles that remain undiscovered. In particular, our study was not powered to detect rare alleles, which could be an important source of missing heritability (<xref ref-type="bibr" rid="bib39">GÃ©nin, 2020</xref>; <xref ref-type="bibr" rid="bib52">Kierczak, 2021</xref>). Some RBC phenotypes are also shaped by environmental variation, such as diet and time of day (<xref ref-type="bibr" rid="bib28">England et al., 1976</xref>; <xref ref-type="bibr" rid="bib96">Sennels et al., 2011</xref>), which likely diminishes correlations between repeated samples. Although this study cannot distinguish among these explanations for phenotypic variation among non-carrier RBCs, it does suggest that this broad variation is both healthy and functional.</p><p>In our linear models of <italic>P. falciparum</italic> growth, phenotypic variation among RBCs was outperformed by genetic variation in a small number of RBC proteins. This result implies the existence of protective RBC phenotypes that we did not measure (or did not measure with sufficient accuracy), such as quantitative proteomic, transcriptomic, and metabolomic traits that could be addressed by future studies. Approximately half of the polymorphisms we identified are non-synonymous and may therefore exert direct effects on phenotypes like RBC membrane structure or ion transport. The other half of associated polymorphisms were synonymous, which could be linked to coding variants but could also have direct effects on mRNA transcription, splicing, and stability (<xref ref-type="bibr" rid="bib94">Sauna and Kimchi-Sarfaty, 2011</xref>). Indeed, silent and coding SNPs are equally likely to be associated with human disease (<xref ref-type="bibr" rid="bib15">Chen et al., 2010</xref>), and many synonymous sites experience strong selection (<xref ref-type="bibr" rid="bib99">Supek et al., 2014</xref>; <xref ref-type="bibr" rid="bib68">Machado et al., 2020</xref>). Synonymous SNPs that impact splicing, like rs35356320 in CD44, may also impact protein structure. Some other conceivable RBC phenotypes, such as the dynamics of membrane modification during <italic>P. falciparum</italic> development, may only become evident in more detailed time course experiments. The true number of RBC phenotypes that impact <italic>P. falciparum</italic> may be effectively infinite (<xref ref-type="bibr" rid="bib53">Kinsler et al., 2020</xref>), making it useful in practice that genetic variation is more predictive of parasite growth.</p><p>One reason that our study could identify genetic associations with a modest sample size was because we focused on a relatively well-defined component of a larger disease that lends itself to controlled, in vitro experiments. Another important explanation is our use of LASSO variable selection on a restricted set of polymorphisms in genes with strong existing links to malaria (<xref ref-type="bibr" rid="bib33">Flynn et al., 2017</xref>). Focusing our tests on a limited number of hypotheses obviated the need to meet an exome-wide significance threshold, while still allowing for the discovery of novel alleles. This approach relies directly on prior knowledge (<xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5âsource data 1</xref>) and cannot readily be expanded to explicitly test large numbers of anonymous genetic variants. However, testing fewer hypotheses that are more likely to be true helps ensure that âsignificantâ results are reliable (<xref ref-type="bibr" rid="bib47">Ioannidis, 2005</xref>). Exome-wide data were still critical in this study for assessing population structure, as well as for performing permutation tests that confirmed an enrichment of signal in our 23 focal genes. However, future studies with many more than 68 non-carriers will be required to discover additional associations in unknown genes, non-genic regulatory variation, and any alleles with smaller effects. It is also important to note that genetic linkage complicates the identification of the exact functional polymorphisms in any population sample (<xref ref-type="bibr" rid="bib97">Sohail et al., 2019</xref>); as in GWAS, we cannot rule out that some associated variants are merely linked to the true functional variants. Indeed, about half of our associated variants occur in linkage blocks containing other SNPs associated with RBC traits by GWAS. In this way, our evidence most strongly supports the conclusion that 13 specific RBC genes are strongly enriched for polymorphisms with impacts on <italic>P. falciparum</italic> growth.</p><p>The associations we observed for parasite growth were stronger and more significant than the associations for parasite invasion. While batch effects clearly played a role, this may also be due to missing invasion data in 10 non-carrier samples (see Materials and methods) that reduced statistical power. Both technical and biological reasons may drive the relatively greater noise observed in our invasion data. For example, invasion success may depend on the length of time spent outside the incubator during assay set-up as well as the genotypes of both donor and acceptor red cells. The reproducibility of our invasion data is also constrained by low and variable starting parasitemia and a 24hr time point, which could be substantially improved in future studies using live-cell imaging focused on invasion. Despite these limitations, our âgrowthâ measurement includes a âre-invasionâ event and our growth and invasion measurements are correlated. RBC deformability and dehydration are associated with both fitness components, and SNPs in several canonical invasion receptors are only associated with growth. The invasion data also allow us to highlight unique and interesting trends in the Senegalese clinical strain and in carriers of hemoglobin C.</p><p>We also observed weaker associations for the clinical strain Th.026.09 than for the lab strain 3D7. These strains display large differences in absolute growth rate, possibly because Th.026.09 carries costly alleles for drug resistance and 3D7 has had decades longer to adapt to lab conditions (<xref ref-type="bibr" rid="bib107">Walliker et al., 1987</xref>; <xref ref-type="bibr" rid="bib22">Daniels et al., 2012</xref>; <xref ref-type="bibr" rid="bib75">Moser, 2020</xref>). Interestingly, African ancestry predicted higher invasion only for Th.026.09, which might indicate that this strain is better adapted to African RBCs. Despite these differences, we showed that normalized fitness values were significantly correlated between the two strains across donors. Several RBC phenotypes and genotypes that predicted fitness in one strain were also replicated in the other. These results suggest that our findings may be generalizable across divergent strains of <italic>P. falciparum</italic>, although future studies would benefit by testing many more lab strains and clinical isolates.</p><p>One of the unique aspects of our study is the participation of individuals with a range of African ancestry, defined by similarity to donors from five 1000 Genomes reference populations. We found that African ancestry was unexpectedly associated with RBC phenotypes that <italic>improved</italic> parasite fitness, particularly for Th.026.09. In the future, it would be very interesting to test for local parasite adaptation to human RBCs using <italic>P. falciparum</italic> strains and RBC samples from around the globe. We also found that the total set of polymorphisms associated with <italic>P. falciparum</italic> growth by LASSO are not enriched in African populations included in the gnomAD database of human variation. Notably, a recent test of data from a large GWAS for severe malaria (<xref ref-type="bibr" rid="bib71">Malaria Genomic Epidemiology Network, 2019</xref>) was also unable to demonstrate that natural selection has driven many malaria-protective alleles to higher frequencies in African versus European populations. Therefore, for the total set of alleles detectable in this study, we offer at least four possible explanations for this unexpected result. First, compared to large-effect disease alleles, the majority of non-pathogenic variants may not have had sufficient time to increase in frequency since <italic>P. falciparum</italic> began expanding in humans some 5000â10,000 years ago (<xref ref-type="bibr" rid="bib98">Sundararaman et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">Otto et al., 2018</xref>). Second, the complexity of severe malaria could mean that the variants discovered here do not substantially impact disease outcome, especially relative to known disease variants. Third, the variants discovered here may have pleiotropic effects on other phenotypes, which are themselves subject to other selective pressures besides malaria resistance. Finally, human adaptation may be too local to detect with coarse-grain sampling of sub-Saharan African genetic diversity (e.g., <xref ref-type="bibr" rid="bib83">Pankratov et al., 2020</xref>). Overall, however, our data suggest that few RBC alleles remain to be discovered that are both particularly common in Africa and have large effects on <italic>P. falciparum</italic> proliferation in RBCs.</p><p>More broadly, these data show that it may be inaccurate to make assumptions about RBC susceptibility to <italic>P. falciparum</italic> based on a personâs race or continental ancestry. These kinds of hypotheses (<xref ref-type="bibr" rid="bib112">Williams, 2006</xref>; <xref ref-type="bibr" rid="bib41">Goheen et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Kanias et al., 2017</xref>; <xref ref-type="bibr" rid="bib67">Ma et al., 2018</xref>) are based on well-known examples of balanced disease alleles, which are notable exceptions to the overwhelming genetic similarity of all human populations (<xref ref-type="bibr" rid="bib90">Rosenberg et al., 2002</xref>; <xref ref-type="bibr" rid="bib79">Novembre and Di Rienzo, 2009</xref>). In our data, RBC variation that is associated with reduced <italic>P. falciparum</italic> fitness is clearly not limited to individuals with recent African ancestry. This result is an important reminder that &gt;90% of the total genetic variation among humans occurs within populations, rather than across them (<xref ref-type="bibr" rid="bib60">Lewontin, 1972</xref>; <xref ref-type="bibr" rid="bib91">Rosenberg, 2011</xref>); and that the majority of common genetic variation is shared among all human populations (<xref ref-type="bibr" rid="bib9">Biddanda et al., 2020</xref>).</p><p>In conclusion, this study demonstrates that substantial phenotypic and genetic diversity in healthy human RBCs impacts the replication of malaria parasites. Whether or not this diversity is shaped by malaria selection, a better understanding of how <italic>P. falciparum</italic> biology is impacted by natural RBC variation could help lead to new therapies for one of humanityâs most important infectious diseases.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Biological sample (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Primary whole blood samples</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Freshly drawn from de-identified human subjects into CPDA tubes (IRB #40479)</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Plasmodium falciparum</italic>)</td><td align="char" char="." valign="bottom">3D7</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/3299700/">3299700</ext-link>; Obtained from Walter and Eliza Hall Institute, Melbourne, Australia</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>P. falciparum</italic>)</td><td align="left" valign="bottom">Th026.09</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22430961/">22430961</ext-link>; Gift from Daouda Ndiaye and Sarah Volkman, Senegal</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">DNeasy Blood and Tissue Kit</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">KAPA Hyperplus Kit</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">SeqCap EZ Prime Exome Kit</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Primers amplifying <italic>PIEZO1</italic> exon 17</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32265284/">32265284</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">bwa mem</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/1303.3997">http://arxiv.org/abs/1303.3997</ext-link></td><td align="left" valign="bottom">0.7.17-r1188</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GATK</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://gatk.broadinstitute.org/hc/en-us">https://gatk.broadinstitute.org/hc/en-us</ext-link></td><td align="left" valign="bottom">4.0.0.0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">vcftools</td><td align="left" valign="bottom">doi:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btr330">10.1093/bioinformatics/btr330</ext-link></td><td align="left" valign="bottom">0.1.15</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ANNOVAR</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20601685/">20601685</ext-link></td><td align="left" valign="bottom">2018-04-16</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">PLINK</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/17701901/">17701901</ext-link></td><td align="left" valign="bottom">v1.90b6.8 64-bit</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ADMIXTURE</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21682921/">21682921</ext-link></td><td align="left" valign="bottom">1.3.0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link></td><td align="left" valign="bottom">3.5.1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">SYBR Green I nucleic acid stain</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">S7563</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Drabkinâs Reagent</td><td align="left" valign="bottom">Ricca Chemical</td><td align="left" valign="bottom">2660â32</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Sample collection and preparation</title><p>One-hundred and twenty-one subjects with no known history of RBC disorders were recruited to donate blood at the Stanford Clinical and Translational Research Unit. This study size was designed to sample multiple individuals carrying alleles of moderate frequency (5% or higher). Written informed consent was obtained from each subject and/or their parent as part of a protocol approved by the Stanford University Institutional Review Board (#40479). To help control for weekly batch effects, subject 1111 donated fresh blood for each parasite assay. Eleven other subjects donated blood on at least 2 different weeks, constituting biological replicates. Whole blood samples from a HE patient were obtained from Dr. Bertil Glader under a separate approved protocol (Stanford IRB #14004) that permitted sample sharing among researchers. All samples were de-identified upon collection by labeling with a random four-to-six digit code. Two samples were eventually removed from analysis based on a failed sequencing library (6449KD) and history of stem cell transplant (8715).</p><p>Whole blood was drawn into CPDA tubes and spun down within 36 hr to separate serum, buffy coat, and RBCs. RBCs were washed and stored in RPMI-1640 medium (Sigma-Aldrich) supplemented with 25 mM HEPES, 50 mg/L hypoxanthine, and 2.42 mM sodium bicarbonate at 4Â°C. Buffy coat was transferred directly to cryotubes and stored at â80Â°C.</p></sec><sec id="s4-2"><title>Exome sequencing and genotype calling</title><p>Genomic DNA was isolated from frozen buffy coats using a DNeasy Blood and Tissue Kit (QIAGEN). Libraries were prepared using a KAPA Hyperplus Kit (Roche) and hybridized to human exome probes using the SeqCap EZ Prime Exome Kit (Roche). The resulting exome libraries were sequenced with paired-end 150 bp Illumina reads on the HiSeq or NextSeq platforms at Admera Health (South Plainfield, NJ).</p><p>Reads were aligned to the hg38 human reference genome using bwa mem (<xref ref-type="bibr" rid="bib61">Li, 2013a</xref>), yielding an average coverage of 42X across targeted exome regions (excluding sample 6449KD). Variants were called using GATK best practices (<xref ref-type="bibr" rid="bib104">Van der Auwera et al., 2013</xref>) and hard filtered with the following parameters: QD&lt;2.0, FS&gt;60.0, ReadPosRankSum&lt;â2.5, SOR&gt;2.5, MQ&lt;55.0, MQRankSum&lt;â1.0, and DP&lt;500. To minimize the effects of sequencing errors, variants not present in 1000 Genomes, dbSNP_138, or the Mills indel collection (<xref ref-type="bibr" rid="bib73">Mills et al., 2006</xref>) were discarded. Variants that were significantly more frequent in our sample than in gnomAD African and European populations (<xref ref-type="bibr" rid="bib49">Karczewski et al., 2020</xref>) were also discarded, in order to avoid false associations from miscalled variants. We also excluded singleton variants from all association analyses, potentially including some variants unique to other populations. With the remaining variants, we calculated kinship coefficients among all pairs of donors using vcftools --<monospace>relatedness2</monospace>. Only the six members of the known family had pairwise coefficients &gt;0.044, confirming that no other donors were related.</p><p>PIEZO1 E756del was genotyped via PCR and Sanger sequencing according to a previously published protocol (<xref ref-type="bibr" rid="bib78">Nguetse et al., 2020</xref>). To call deletion variants that cause Î±-thalassemia in the paralogous genes HBA2 and HBA1, we extracted reads from each.bam file that lacked any mismatches or soft-clipping and had MAPQâ¥13 (i.e., &lt;5% chance of mapping error). Coverage with these well-mapped reads was calculated over the 73 and 81 bp of unique sequence in HBA2 and HBA1 and normalized to each sampleâs exome-wide coverage. To determine which samples has unusually low coverage, we formed an ad hoc reference panel of seven donors who were unlikely to carry deletion alleles based on their normal MCH, MCV, and HGB and &gt;96% exome-wide European ancestry (<xref ref-type="bibr" rid="bib109">Weatherall, 2001</xref>). We called heterozygous HBA2 deletions when normalized coverage across three unique regions of the HBA2 gene was below the minimum reference value. Similarly, we called homozygous HBA2 deletions when normalized coverage across three unique regions of the HBA2 gene was less than half of the minimum reference value. This approach resulted in an estimated HBA2 copy number of 2.0 in the reference panel, 0.95 in eight putative heterozygotes and 0.12 in four putative homozygotes. The same method produced no evidence of HBA1 deletion in any sample.</p></sec><sec id="s4-3"><title>Variant classification and linkage pruning</title><p>Exonic variants in RefSeq genes were identified using ANNOVAR (<xref ref-type="bibr" rid="bib108">Wang et al., 2010</xref>). Variants were classified into three categories: those within 23 malaria-related genes (<xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5âsource data 1</xref>); those within 887 other RBC proteins (<xref ref-type="supplementary-material" rid="fig5sdata2">Figure 5âsource data 2</xref>) derived with a medium-confidence filter from the Red Blood Cell Collection database (<ext-link ext-link-type="uri" xlink:href="http://rbcc.hegelab.org/">rbcc.hegelab.org</ext-link>); and those within any other gene.</p><p>Linkage between all pairs of bi-allelic, exonic variants in our 121 genotyped samples was calculated using the --<monospace>geno-r2 and --interchrom-geno-r2</monospace> functions in vcftools (<xref ref-type="bibr" rid="bib21">Danecek et al., 2011</xref>). Variants in RBC genes that shared r<sup>2</sup> &gt;0.1 with any variant in the 23-gene set were removed. Within the 23-gene set and RBC-gene set separately, non-carrier variants were ranked by the p-values of their OLS regression with all four parasite measures. Then, one variant was removed from each pair with r<sup>2</sup>&gt;0.1, prioritizing retention in the following order: greater significance across models; non-synonymous protein change; higher frequency in our sample; and finally by random sampling. We report results from additive genetic models (genotypes coded 0/1/2), which performed as well or better than recessive (0/0/2) and dominant (0/2/2) models. For three variants, overdominant models (0/1/â) provided the best fit and were used to estimate effect sizes (<xref ref-type="fig" rid="fig5s3">Figure 5âfigure supplement 3</xref>).</p></sec><sec id="s4-4"><title>Population analysis</title><p>The population ancestry of our donors was assessed by comparison with African, European, East Asian, and South Asian reference populations from the 1000 Genomes Project (<xref ref-type="bibr" rid="bib5">Auton et al., 2015</xref>). Briefly, variants called from an hg38 alignment of the 1000 Genomes data (<xref ref-type="bibr" rid="bib65">Lowy-Gallego et al., 2019</xref>) were filtered for concordance with the variants genotyped in this study. The --<monospace>indep-pairwise</monospace> command in PLINK (<xref ref-type="bibr" rid="bib88">Purcell et al., 2007</xref>) was used to prune SNPs with r<sup>2</sup>&gt;0.1 with any other SNP in a 50-SNP sliding window, producing 35,759 unlinked variants. These variants were analyzed in both PLINK --<monospace>pca</monospace> and in ADMIXTURE (<xref ref-type="bibr" rid="bib1">Alexander and Lange, 2011</xref>) with K=4 for the 121 genotyped individuals in this study, alongside 2458 individuals from 1000 Genomes. Pan-African and pan-European allele frequencies were obtained from gnomAD v3 (<xref ref-type="bibr" rid="bib49">Karczewski et al., 2020</xref>). F<sub>ST</sub> for specific alleles was calculated as (H<sub>T</sub>âH<sub>S</sub>)/H<sub>T</sub> and then polarized, such that positive values indicate variants more common in Africa.</p></sec><sec id="s4-5"><title><italic>P. falciparum</italic> culture and assays</title><p>Our 3D7 strain of <italic>P. falciparum</italic> was obtained from the Walter and Eliza Hall Institute (Melbourne, Australia) and routinely cultured in human erythrocytes obtained from the Stanford Blood Center. Th.026.09 is a clinical strain isolated from a patient in Senegal in 2009 and kindly provided by Daouda Ndiaye and Sarah Volkman. 3D7 is drug-sensitive and has been lab-adapted for over 40 years, whereas Th.026.09 is drug-resistant and minimally lab-adapted (<xref ref-type="bibr" rid="bib107">Walliker et al., 1987</xref>; <xref ref-type="bibr" rid="bib22">Daniels et al., 2012</xref>; <xref ref-type="bibr" rid="bib75">Moser, 2020</xref>). 3D7 was maintained at 2% hematocrit in RPMI-1640 supplemented with 25 mM HEPES, 50 mg/L hypoxanthine, 2.42 mM sodium bicarbonate, and 4.31 mg/ml Albumax (Invitrogen) at 37Â°C in 5% CO<sub>2</sub> and 1% O<sub>2</sub>. Th.026.09 was maintained in the same conditions, except that half the Albumax was replaced with heat-inactivated human AB serum.</p><p>Parasite growth and invasion assays were performed using schizont-stage parasites isolated from routine culture using a MACS magnet (Miltenyi). Parasites were added at ~0.5% initial parasitemia to fresh erythrocytes suspended at 1% hematocrit in complete RPMI, as above. Parasites were cultured in each erythrocyte sample for 3â5 days in triplicate 100 Âµl wells. Parasitemia was determined as the average of the three technical replicates, excluding single outlier points, on day 0, day 1 (24 hr), day 3 (72 hr), and in some cases day 5 (120 hr). The fraction of infected RBCs was measured by staining with SYBR Green one nucleic acid stain (Invitrogen, Thermo Fisher Scientific, Eugene, OR) at 1:2000 dilution in PBS/0.3% BSA for 20 min, followed by flow cytometry analysis on a MACSQuant flow cytometer (Miltenyi). Raw invasion rate was defined as the day 1 parasitemia divided by the day 0 parasitemia; raw growth rate was defined as the day 3 (or day 5) parasitemia divided by the day 1 (or day 3) parasitemia. Day 0 parasitemia was not measured in weeks 1â3, so invasion rate estimates are absent for these samples (N=58 unrelated non-carriers with invasion data). The parasite assays failed for both strains in week 9 and for Th.026.09 in week 10, and so were repeated in weeks 10 and 11 with RBCs that had been stored for 1 or 2 weeks.</p><p>To correct for batch effects, including substantial week-to-week variation in <italic>P. falciparum</italic> replication rate, we extracted the residuals from a linear regression of the raw parasite values against up to four significantly related batch variables: (1) the raw values for control donor 1111 each week; (2) the parasitemia measured at the previous time point; (3) the age in weeks of the RBCs being measured; and (4) the experimenter performing the assays. Notably, there was no additional effect of âWeekâ or the length of the experiment (i.e., 3 or 5 days) once the above variables were regressed out. To convert these residuals (mean 0%) to relative percentages (mean 100%), we first trained linear models for growth and invasion in each strain with data from control donor 1111 and carriers with extreme parasite values (HbAS and HE for growth; G6PD<sup>â</sup><sub>high</sub> and HE for invasion). For these models, relative percentages were calculated by normalizing the raw multiplication rates in these samples to the raw multiplication rate in the 1111 control from that week. These linear models were used to convert residuals to relative percentages for all samples. Finally, the relative percentages were arithmetically adjusted so that the mean invasion and growth values for non-carriers was 100%. Code for this normalization is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/emily-ebel/RBC">https://github.com/emily-ebel/RBC</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:936eeefd426d26efb71dfd49bea1ccafaa03ac3f;origin=https://github.com/emily-ebel/RBC;visit=swh:1:snp:4e53482ed5ff50b01ed3179d405ec1ac9387b7a5;anchor=swh:1:rev:31f953428a4ec5f0fa83201085ada0a0995facb2">swh:1:rev:31f953428a4ec5f0fa83201085ada0a0995facb2</ext-link>), <xref ref-type="bibr" rid="bib25">Ebel, 2021</xref>.</p></sec><sec id="s4-6"><title>Red cell phenotyping and normalization</title><p>Complete blood count (CBC) data for RBCs, reticulocytes, and platelets were obtained with an ADVIA 120 hematology analyzer (Siemens, Laguna Hills, CA) at the Red Cell Laboratory at Childrenâs Hospital Oakland Research Institute. These data were: RBC, HGB, HCT, MCV, MCH, MCHC, CHCM, RDW, HDW, PLT, MPV, Reticulocyte number and percentage, and the fraction of RBCs in each of nine cells of the RBC matrix (see <xref ref-type="fig" rid="fig3s2">Figure 3âfigure supplement 2</xref>). Systematic biases were evident for some measures in certain weeks, but data from control donor 1111 were not available for all weeks. Therefore, CBC data were normalized such that the median value for non-carrier samples was equal across weeks.</p><p>Osmotic fragility tests were performed in duplicate by incubating 20 Î¼l of washed erythrocytes for 5 min in 500 Î¼l solutions of NaCl in 14 concentrations: 7.17, 6.14, 5.73, 5.32, 4.91, 4.50, 4.30, 4.09, 3.89, 3.68, 3.27, 3.07, 2.66, and 2.46 g/L. Tubes were spun for 5 min at 1000 g and 100 Î¼l of supernatant was transferred to a 96-well plate. Hemoglobin concentration was determined by adding 100 Î¼l of Drabkinâs reagent (Ricca Chemical) to each well and measuring absorbance at OD<sub>540nm</sub> with a Synergy H1 Plate Reader (Biotek). Relative lysis was determined by normalizing to the maximum hemoglobin concentration in the 14-tube series for each sample. After outlier points were manually removed, sigmoidal osmotic fragility curves were estimated under a self-starting logistic model in the nls package in R. Curves were summarized by the relative tonicity at which 50% lysis occurred (see <xref ref-type="fig" rid="fig3s4">Figure 3âfigure supplement 4</xref>) and normalized within weekly batches, such that this value was equal for control sample 1111 across weeks.</p><p>Osmotic gradient ektacytometry (<xref ref-type="bibr" rid="bib17">Clark et al., 1983</xref>; <xref ref-type="bibr" rid="bib55">Kuypers, 1990</xref>) was performed at the Red Cell Laboratory at Childrenâs Hospital Oakland Research Institute. Red cell deformability estimates across a gradient of NaCl concentrations were fitted to a 20-parameter polynomial model to generate a smooth curve, which was manually verified to closely fit the data. Each curve was summarized with three standard points (<xref ref-type="fig" rid="fig3s5">Figure 3âfigure supplement 5</xref>; <xref ref-type="bibr" rid="bib17">Clark et al., 1983</xref>), which were normalized such that the median x- and y-values of the three points was equal for non-carrier samples across weeks.</p></sec><sec id="s4-7"><title>Statistical analysis</title><p>Studentâs t-test was used to compare trait values between non-carriers and carriers where N&gt;1. Given our modest sample sizes and the expected noise in parasite data, we defined statistical significance as p&lt;0.1. Where N=1 (i.e., for G6PD<sup>â</sup><sub>high</sub> and HE), significance was assessed with the percentile of the non-carrier distribution. For all comparisons of two continuous variables, OLS linear regression was performed with the lm function in R unless otherwise specified. Adjusted R<italic><sup>2</sup></italic> values are reported.</p><p>LASSO regression (<xref ref-type="bibr" rid="bib101">Tibshirani, 1994</xref>; <xref ref-type="bibr" rid="bib14">Chatterjee, 2013</xref>) was performed in a k-folds CV framework with the glmnet and caret packages in R. For each of 1000 iterations, we used the createFolds function with k=10 to split the non-carrier data into 10-folds of roughly equal size. Each fold was used as a âtest setâ for a LASSO model trained on the remaining nine folds. For each of the 1000 iterations in which 10-folds were created, we collected 10 sets of predictors from the 10 train sets; one average R<italic><sup>2</sup></italic> value for the 10 train sets; and one average R<italic><sup>2</sup></italic> for the 10 test sets. Each set of 1000 resulting R<italic><sup>2</sup></italic> values were normally distributed, and their average is reported in <xref ref-type="fig" rid="fig4">Figures 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>. The fraction of k-folds CV support per predictor is based on 10,000 total train models (1000 iterations*10 folds each) and is reported in <xref ref-type="fig" rid="fig4">Figure 4A</xref> and <xref ref-type="supplementary-material" rid="fig5sdata3">Figure 5âsource data 3</xref>.</p><p>To perform LASSO with each training set, we used the cv.glmnet function with Î±=1. This function split the train data into 10 folds 11 times, the first to estimate a lambda sequence and the rest to compute the fit with one fold omitted. The lambda value that produced minimal error in the training data was then used to predict values in the independent test data described above. Since cv.glmnet selects folds at random, we performed this procedure five times for each train/test set (which we term âinternal cross-validationâ). We retained R<italic><sup>2</sup></italic> values and selected predictors from the median model of these five internal CVs. Internal CVs did not otherwise contribute to the k-folds CV support reported in the main text.</p><p>To assess the significance of each LASSO result, we applied the same modeling procedure to 1000 data sets with randomly permuted parasite values, which preserved the original correlations among RBC predictors. We performed 10 iterations of fold creation for each permuted data set and retained the average R<italic><sup>2</sup></italic> for each set of 10-folds, which generated 1000 fold-averaged R<italic><sup>2</sup></italic> values for train sets and 1000 fold-averaged R<italic><sup>2</sup></italic> values for train sets. Significance was determined by the percentile of the permuted distribution in which the real data fell. We also applied this same procedure to 1000 sets of 23 genes chosen at random from the RBC proteome (<xref ref-type="supplementary-material" rid="fig5sdata2">Figure 5âsource data 2</xref>).</p><p>We noticed that LASSO effect size estimates for each predictor varied considerably across models. Therefore, we used univariate OLS regression on all non-carrier data (excluding five of the six family members) to estimate the effect size of each predictor selected at least once by LASSO. OLS p-values are reported as a measure of confidence in these effect size estimates, with p&lt;0.1 considered sufficient evidence to report the effect size. However, because OLS regression was only performed for variants pre-selected by LASSO, these p-values cannot be interpreted on their own as evidence of significant associations.</p><p>We compared groups of selected genetic variants using the binom.test function in R. For synonymous alleles, we used the proportion of synonymous alleles in the input set of 106 variants (53%) as the null hypothesis. For allele frequencies in Africa and Europe, we categorized protective variants as more common (to any absolute degree) among Africans (N=21,042) or non-Finnish Europeans (N=32,399) in the gnomAD database. The null hypothesis was that 50% of the alleles would be more common in Africans.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Visualization, Writing â original draft, Writing â review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Methodology, Resources, Writing â review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Methodology, Resources, Supervision, Writing â review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Investigation, Methodology, Resources, Supervision, Writing â review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Written informed consent and consent to publish was obtained from each subject and/or their parent as part of a protocol approved by the Stanford University Institutional Review Board (#40479).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-69808-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1, 4, and 5 and other raw data and normalization scripts are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/emily-ebel/RBC">https://github.com/emily-ebel/RBC</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:rev:31f953428a4ec5f0fa83201085ada0a0995facb2">https://archive.softwareheritage.org/swh:1:rev:31f953428a4ec5f0fa83201085ada0a0995facb2</ext-link>).</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Ebel</surname><given-names>ER</given-names></name><name><surname>Kuypers</surname><given-names>FA</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Petrov</surname><given-names>DA</given-names></name><name><surname>Egan</surname><given-names>ES</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Exome Sequencing from Participants in RBC/Malaria Study</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA683732/">PRJNA683732</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors gratefully acknowledge the invaluable participation of all volunteer blood donors. Nick Bondy, Bertil Glader, Sandra Larkin, Brian Fleischer, Ashley Dunn, Talal Seddik, Trung Pham, David Vu, and Spectrum Child Health provided crucial assistance in donor coordination and sample processing. <italic>P. falciparum</italic> strain Th.026.09 was kindly provided by Daouda Ndiaye and Sarah Volkman. For quantitative advice, the authors thank Grant Kinsler, Jonathan Pritchard, Susan Holmes, and the Stanford Statistics Consulting Group. This study was primarily supported by a Pilot Early Career award from the Stanford Maternal Child Health Research Institute and a Gabilan Faculty Award from the Stanford University School of Medicine Office of Faculty Development and Diversity (ESE). ERE was an NSF Graduate Research Fellow (DGE-1247312) and received additional support from the Stanford Center for Computational, Evolutionary, and Human Genomics. DAP was funded through an NIH MIRA award 5R35GM118165-05. ESE is a Tashia and John Morgridge Endowed Faculty Scholar in Pediatric Translational Medicine through the Stanford Maternal Child Health Research Institute. Local blood samples were drawn at the Stanford Clinical and Translational Research Unit, which is supported by CTSA Grant UL1 TR001085.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>DH</given-names></name><name><surname>Lange</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Enhancements to the admixture algorithm for individual ancestry estimation</article-title><source>BMC Bioinformatics</source><volume>12</volume><elocation-id>246</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-12-246</pub-id><pub-id pub-id-type="pmid">21682921</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="1954">1954</year><article-title>Protection afforded by sickle-cell trait against subtertian malareal infection</article-title><source>British Medical Journal</source><volume>1</volume><fpage>290</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1136/bmj.1.4857.290</pub-id><pub-id pub-id-type="pmid">13115700</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Archer</surname><given-names>NM</given-names></name><name><surname>Petersen</surname><given-names>N</given-names></name><name><surname>Clark</surname><given-names>MA</given-names></name><name><surname>Buckee</surname><given-names>CO</given-names></name><name><surname>Childs</surname><given-names>LM</given-names></name><name><surname>Duraisingh</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Resistance to <italic>Plasmodium falciparum</italic> in sickle cell trait erythrocytes is driven by oxygen-dependent growth inhibition</article-title><source>PNAS</source><volume>115</volume><fpage>7350</fpage><lpage>7355</lpage><pub-id pub-id-type="doi">10.1073/pnas.1804388115</pub-id><pub-id pub-id-type="pmid">29946035</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astle</surname><given-names>WJ</given-names></name><name><surname>Elding</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Allen</surname><given-names>D</given-names></name><name><surname>Ruklisa</surname><given-names>D</given-names></name><name><surname>Mann</surname><given-names>AL</given-names></name><name><surname>Mead</surname><given-names>D</given-names></name><name><surname>Bouman</surname><given-names>H</given-names></name><name><surname>Riveros-Mckay</surname><given-names>F</given-names></name><name><surname>Kostadima</surname><given-names>MA</given-names></name><name><surname>Lambourne</surname><given-names>JJ</given-names></name><name><surname>Sivapalaratnam</surname><given-names>S</given-names></name><name><surname>Downes</surname><given-names>K</given-names></name><name><surname>Kundu</surname><given-names>K</given-names></name><name><surname>Bomba</surname><given-names>L</given-names></name><name><surname>Berentsen</surname><given-names>K</given-names></name><name><surname>Bradley</surname><given-names>JR</given-names></name><name><surname>Daugherty</surname><given-names>LC</given-names></name><name><surname>Delaneau</surname><given-names>O</given-names></name><name><surname>Freson</surname><given-names>K</given-names></name><name><surname>Garner</surname><given-names>SF</given-names></name><name><surname>Grassi</surname><given-names>L</given-names></name><name><surname>Guerrero</surname><given-names>J</given-names></name><name><surname>Haimel</surname><given-names>M</given-names></name><name><surname>Janssen-Megens</surname><given-names>EM</given-names></name><name><surname>Kaan</surname><given-names>A</given-names></name><name><surname>Kamat</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><name><surname>Mandoli</surname><given-names>A</given-names></name><name><surname>Marchini</surname><given-names>J</given-names></name><name><surname>Martens</surname><given-names>JHA</given-names></name><name><surname>Meacham</surname><given-names>S</given-names></name><name><surname>Megy</surname><given-names>K</given-names></name><name><surname>OâConnell</surname><given-names>J</given-names></name><name><surname>Petersen</surname><given-names>R</given-names></name><name><surname>Sharifi</surname><given-names>N</given-names></name><name><surname>Sheard</surname><given-names>SM</given-names></name><name><surname>Staley</surname><given-names>JR</given-names></name><name><surname>Tuna</surname><given-names>S</given-names></name><name><surname>van der Ent</surname><given-names>M</given-names></name><name><surname>Walter</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>SY</given-names></name><name><surname>Wheeler</surname><given-names>E</given-names></name><name><surname>Wilder</surname><given-names>SP</given-names></name><name><surname>Iotchkova</surname><given-names>V</given-names></name><name><surname>Moore</surname><given-names>C</given-names></name><name><surname>Sambrook</surname><given-names>J</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>Di Angelantonio</surname><given-names>E</given-names></name><name><surname>Kaptoge</surname><given-names>S</given-names></name><name><surname>Kuijpers</surname><given-names>TW</given-names></name><name><surname>Carrillo-de-Santa-Pau</surname><given-names>E</given-names></name><name><surname>Juan</surname><given-names>D</given-names></name><name><surname>Rico</surname><given-names>D</given-names></name><name><surname>Valencia</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Ge</surname><given-names>B</given-names></name><name><surname>Vasquez</surname><given-names>L</given-names></name><name><surname>Kwan</surname><given-names>T</given-names></name><name><surname>Garrido-MartÃ­n</surname><given-names>D</given-names></name><name><surname>Watt</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Guigo</surname><given-names>R</given-names></name><name><surname>Beck</surname><given-names>S</given-names></name><name><surname>Paul</surname><given-names>DS</given-names></name><name><surname>Pastinen</surname><given-names>T</given-names></name><name><surname>Bujold</surname><given-names>D</given-names></name><name><surname>Bourque</surname><given-names>G</given-names></name><name><surname>Frontini</surname><given-names>M</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><name><surname>Ouwehand</surname><given-names>WH</given-names></name><name><surname>Butterworth</surname><given-names>AS</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease</article-title><source>Cell</source><volume>167</volume><fpage>1415</fpage><lpage>1429</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.042</pub-id><pub-id pub-id-type="pmid">27863252</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auton</surname><given-names>A</given-names></name><name><surname>Brooks</surname><given-names>LD</given-names></name><name><surname>Durbin</surname><given-names>RM</given-names></name><name><surname>Garrison</surname><given-names>EP</given-names></name><name><surname>Kang</surname><given-names>HM</given-names></name><name><surname>Korbel</surname><given-names>JO</given-names></name><name><surname>Marchini</surname><given-names>JL</given-names></name><name><surname>McCarthy</surname><given-names>S</given-names></name><name><surname>McVean</surname><given-names>GA</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><collab>1000 Genomes Project Consortium</collab></person-group><year iso-8601-date="2015">2015</year><article-title>A global reference for human genetic variation</article-title><source>Nature</source><volume>526</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/nature15393</pub-id><pub-id pub-id-type="pmid">26432245</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Band</surname><given-names>G</given-names></name><name><surname>Rockett</surname><given-names>KA</given-names></name><name><surname>Spencer</surname><given-names>CCA</given-names></name><name><surname>Kwiatkowski</surname><given-names>DP</given-names></name><collab>Malaria Genomic Epidemiology Network</collab></person-group><year iso-8601-date="2015">2015</year><article-title>A novel locus of resistance to severe malaria in a region of ancient balancing selection</article-title><source>Nature</source><volume>526</volume><fpage>253</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1038/nature15390</pub-id><pub-id pub-id-type="pmid">26416757</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bejon</surname><given-names>P</given-names></name><name><surname>Berkley</surname><given-names>JA</given-names></name><name><surname>Mwangi</surname><given-names>T</given-names></name><name><surname>Ogada</surname><given-names>E</given-names></name><name><surname>Mwangi</surname><given-names>I</given-names></name><name><surname>Maitland</surname><given-names>K</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Scott</surname><given-names>JAG</given-names></name><name><surname>English</surname><given-names>M</given-names></name><name><surname>Lowe</surname><given-names>BS</given-names></name><name><surname>Peshu</surname><given-names>N</given-names></name><name><surname>Newton</surname><given-names>CRJC</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Defining childhood severe falciparum malaria for intervention studies</article-title><source>PLOS Medicine</source><volume>4</volume><elocation-id>e251</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.0040251</pub-id><pub-id pub-id-type="pmid">17713980</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beutler</surname><given-names>E</given-names></name><name><surname>West</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume</article-title><source>Blood</source><volume>106</volume><fpage>740</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1182/blood-2005-02-0713</pub-id><pub-id pub-id-type="pmid">15790781</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biddanda</surname><given-names>A</given-names></name><name><surname>Rice</surname><given-names>DP</given-names></name><name><surname>Novembre</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A variant-centric perspective on geographic patterns of human allele frequency variation</article-title><source>eLife</source><volume>9</volume><elocation-id>e60107</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.60107</pub-id><pub-id pub-id-type="pmid">33350384</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>EA</given-names></name><name><surname>Li</surname><given-names>YI</given-names></name><name><surname>Pritchard</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An Expanded View of Complex Traits: From Polygenic to Omnigenic</article-title><source>Cell</source><volume>169</volume><fpage>1177</fpage><lpage>1186</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.05.038</pub-id><pub-id pub-id-type="pmid">28622505</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canela-Xandri</surname><given-names>O</given-names></name><name><surname>Rawlik</surname><given-names>K</given-names></name><name><surname>Tenesa</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>An atlas of genetic associations in UK Biobank</article-title><source>Nature Genetics</source><volume>50</volume><fpage>1593</fpage><lpage>1599</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0248-z</pub-id><pub-id pub-id-type="pmid">30349118</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>A</given-names></name><name><surname>Galanello</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Beta-thalassemia</article-title><source>Genetics in Medicine</source><volume>12</volume><fpage>61</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1097/GIM.0b013e3181cd68ed</pub-id><pub-id pub-id-type="pmid">20098328</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chami</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>MH</given-names></name><name><surname>Slater</surname><given-names>AJ</given-names></name><name><surname>Eicher</surname><given-names>JD</given-names></name><name><surname>Evangelou</surname><given-names>E</given-names></name><name><surname>Tajuddin</surname><given-names>SM</given-names></name><name><surname>Love-Gregory</surname><given-names>L</given-names></name><name><surname>Kacprowski</surname><given-names>T</given-names></name><name><surname>Schick</surname><given-names>UM</given-names></name><name><surname>Nomura</surname><given-names>A</given-names></name><name><surname>Giri</surname><given-names>A</given-names></name><name><surname>Lessard</surname><given-names>S</given-names></name><name><surname>Brody</surname><given-names>JA</given-names></name><name><surname>Schurmann</surname><given-names>C</given-names></name><name><surname>Pankratz</surname><given-names>N</given-names></name><name><surname>Yanek</surname><given-names>LR</given-names></name><name><surname>Manichaikul</surname><given-names>A</given-names></name><name><surname>Pazoki</surname><given-names>R</given-names></name><name><surname>Mihailov</surname><given-names>E</given-names></name><name><surname>Hill</surname><given-names>WD</given-names></name><name><surname>Raffield</surname><given-names>LM</given-names></name><name><surname>Burt</surname><given-names>A</given-names></name><name><surname>Bartz</surname><given-names>TM</given-names></name><name><surname>Becker</surname><given-names>DM</given-names></name><name><surname>Becker</surname><given-names>LC</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Bork-Jensen</surname><given-names>J</given-names></name><name><surname>Bottinger</surname><given-names>EP</given-names></name><name><surname>OâDonoghue</surname><given-names>ML</given-names></name><name><surname>Crosslin</surname><given-names>DR</given-names></name><name><surname>de Denus</surname><given-names>S</given-names></name><name><surname>DubÃ©</surname><given-names>MP</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>EngstrÃ¶m</surname><given-names>G</given-names></name><name><surname>Evans</surname><given-names>MK</given-names></name><name><surname>Floyd</surname><given-names>JS</given-names></name><name><surname>Fornage</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Greinacher</surname><given-names>A</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Hernesniemi</surname><given-names>J</given-names></name><name><surname>Highland</surname><given-names>HM</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Irvin</surname><given-names>MR</given-names></name><name><surname>KÃ¤hÃ¶nen</surname><given-names>M</given-names></name><name><surname>Lange</surname><given-names>E</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>LehtimÃ¤ki</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Liewald</surname><given-names>DCM</given-names></name><name><surname>Linneberg</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>LyytikÃ¤inen</surname><given-names>LP</given-names></name><name><surname>MÃ¤gi</surname><given-names>R</given-names></name><name><surname>Mathias</surname><given-names>RA</given-names></name><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Mononen</surname><given-names>N</given-names></name><name><surname>Nalls</surname><given-names>MA</given-names></name><name><surname>Nickerson</surname><given-names>DA</given-names></name><name><surname>Nikus</surname><given-names>K</given-names></name><name><surname>OâDonnell</surname><given-names>CJ</given-names></name><name><surname>Orho-Melander</surname><given-names>M</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Petersmann</surname><given-names>A</given-names></name><name><surname>Polfus</surname><given-names>L</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Raitoharju</surname><given-names>E</given-names></name><name><surname>Richard</surname><given-names>M</given-names></name><name><surname>Rice</surname><given-names>KM</given-names></name><name><surname>Rivadeneira</surname><given-names>F</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Schmidt</surname><given-names>F</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Starr</surname><given-names>JM</given-names></name><name><surname>Taylor</surname><given-names>KD</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Thuesen</surname><given-names>BH</given-names></name><name><surname>Torstenson</surname><given-names>ES</given-names></name><name><surname>Tracy</surname><given-names>RP</given-names></name><name><surname>Tzoulaki</surname><given-names>I</given-names></name><name><surname>Zakai</surname><given-names>NA</given-names></name><name><surname>Vacchi-Suzzi</surname><given-names>C</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name><name><surname>van Rooij</surname><given-names>FJA</given-names></name><name><surname>Cushman</surname><given-names>M</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name><name><surname>Velez Edwards</surname><given-names>DR</given-names></name><name><surname>Vergnaud</surname><given-names>AC</given-names></name><name><surname>Wallentin</surname><given-names>L</given-names></name><name><surname>Waterworth</surname><given-names>DM</given-names></name><name><surname>White</surname><given-names>HD</given-names></name><name><surname>Wilson</surname><given-names>JG</given-names></name><name><surname>Zonderman</surname><given-names>AB</given-names></name><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Grarup</surname><given-names>N</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Lange</surname><given-names>LA</given-names></name><name><surname>Faraday</surname><given-names>N</given-names></name><name><surname>Abumrad</surname><given-names>NA</given-names></name><name><surname>Edwards</surname><given-names>TL</given-names></name><name><surname>Ganesh</surname><given-names>SK</given-names></name><name><surname>Auer</surname><given-names>PL</given-names></name><name><surname>Johnson</surname><given-names>AD</given-names></name><name><surname>Reiner</surname><given-names>AP</given-names></name><name><surname>Lettre</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>EXOME genotyping identifies pleiotropic variants associated with red blood cell traits</article-title><source>American Journal of Human Genetics</source><volume>99</volume><fpage>8</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2016.05.007</pub-id><pub-id pub-id-type="pmid">27346685</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Assumptionless Consistency of the Lasso</article-title><source>arXiv</source><ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/1303.5817">http://arxiv.org/abs/1303.5817</ext-link></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Davydov</surname><given-names>EV</given-names></name><name><surname>Sirota</surname><given-names>M</given-names></name><name><surname>Butte</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Non-synonymous and synonymous coding snps show similar likelihood and effect size of human disease association</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e13574</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0013574</pub-id><pub-id pub-id-type="pmid">21042586</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>MH</given-names></name><name><surname>Raffield</surname><given-names>LM</given-names></name><name><surname>Mousas</surname><given-names>A</given-names></name><name><surname>Sakaue</surname><given-names>S</given-names></name><name><surname>Huffman</surname><given-names>JE</given-names></name><name><surname>Moscati</surname><given-names>A</given-names></name><name><surname>Trivedi</surname><given-names>B</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Akbari</surname><given-names>P</given-names></name><name><surname>Vuckovic</surname><given-names>D</given-names></name><name><surname>Bao</surname><given-names>EL</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Manansala</surname><given-names>R</given-names></name><name><surname>Laplante</surname><given-names>V</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Lo</surname><given-names>KS</given-names></name><name><surname>Qian</surname><given-names>H</given-names></name><name><surname>Lareau</surname><given-names>CA</given-names></name><name><surname>Beaudoin</surname><given-names>M</given-names></name><name><surname>Hunt</surname><given-names>KA</given-names></name><name><surname>Akiyama</surname><given-names>M</given-names></name><name><surname>Bartz</surname><given-names>TM</given-names></name><name><surname>Ben-Shlomo</surname><given-names>Y</given-names></name><name><surname>Beswick</surname><given-names>A</given-names></name><name><surname>Bork-Jensen</surname><given-names>J</given-names></name><name><surname>Bottinger</surname><given-names>EP</given-names></name><name><surname>Brody</surname><given-names>JA</given-names></name><name><surname>van Rooij</surname><given-names>FJA</given-names></name><name><surname>Chitrala</surname><given-names>K</given-names></name><name><surname>Cho</surname><given-names>K</given-names></name><name><surname>Choquet</surname><given-names>H</given-names></name><name><surname>Correa</surname><given-names>A</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Di Angelantonio</surname><given-names>E</given-names></name><name><surname>Dimou</surname><given-names>N</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Evans</surname><given-names>MK</given-names></name><name><surname>Floyd</surname><given-names>JS</given-names></name><name><surname>Broer</surname><given-names>L</given-names></name><name><surname>Grarup</surname><given-names>N</given-names></name><name><surname>Guo</surname><given-names>MH</given-names></name><name><surname>Greinacher</surname><given-names>A</given-names></name><name><surname>Haessler</surname><given-names>J</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Howson</surname><given-names>JMM</given-names></name><name><surname>Huang</surname><given-names>QQ</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Jorgenson</surname><given-names>E</given-names></name><name><surname>Kacprowski</surname><given-names>T</given-names></name><name><surname>KÃ¤hÃ¶nen</surname><given-names>M</given-names></name><name><surname>Kamatani</surname><given-names>Y</given-names></name><name><surname>Kanai</surname><given-names>M</given-names></name><name><surname>Karthikeyan</surname><given-names>S</given-names></name><name><surname>Koskeridis</surname><given-names>F</given-names></name><name><surname>Lange</surname><given-names>LA</given-names></name><name><surname>LehtimÃ¤ki</surname><given-names>T</given-names></name><name><surname>Lerch</surname><given-names>MM</given-names></name><name><surname>Linneberg</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>LyytikÃ¤inen</surname><given-names>LP</given-names></name><name><surname>Manichaikul</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>HC</given-names></name><name><surname>Matsuda</surname><given-names>K</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Mononen</surname><given-names>N</given-names></name><name><surname>Murakami</surname><given-names>Y</given-names></name><name><surname>Nadkarni</surname><given-names>GN</given-names></name><name><surname>Nauck</surname><given-names>M</given-names></name><name><surname>Nikus</surname><given-names>K</given-names></name><name><surname>Ouwehand</surname><given-names>WH</given-names></name><name><surname>Pankratz</surname><given-names>N</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Preuss</surname><given-names>M</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><name><surname>Rich</surname><given-names>SS</given-names></name><name><surname>Rodriguez</surname><given-names>BAT</given-names></name><name><surname>Rosen</surname><given-names>JD</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Schubert</surname><given-names>P</given-names></name><name><surname>Spracklen</surname><given-names>CN</given-names></name><name><surname>Surendran</surname><given-names>P</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Tardif</surname><given-names>JC</given-names></name><name><surname>Trembath</surname><given-names>RC</given-names></name><name><surname>Ghanbari</surname><given-names>M</given-names></name><name><surname>VÃ¶lker</surname><given-names>U</given-names></name><name><surname>VÃ¶lzke</surname><given-names>H</given-names></name><name><surname>Watkins</surname><given-names>NA</given-names></name><name><surname>Zonderman</surname><given-names>AB</given-names></name><collab>VA Million Veteran Program</collab><name><surname>Wilson</surname><given-names>PWF</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Butterworth</surname><given-names>AS</given-names></name><name><surname>Gauchat</surname><given-names>JF</given-names></name><name><surname>Chiang</surname><given-names>CWK</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Astle</surname><given-names>WJ</given-names></name><name><surname>Evangelou</surname><given-names>E</given-names></name><name><surname>van Heel</surname><given-names>DA</given-names></name><name><surname>Sankaran</surname><given-names>VG</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name><name><surname>Johnson</surname><given-names>AD</given-names></name><name><surname>Reiner</surname><given-names>AP</given-names></name><name><surname>Auer</surname><given-names>PL</given-names></name><name><surname>Lettre</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations</article-title><source>Cell</source><volume>182</volume><fpage>1198</fpage><lpage>1213</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.06.045</pub-id><pub-id pub-id-type="pmid">32888493</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>MR</given-names></name><name><surname>Mohandas</surname><given-names>N</given-names></name><name><surname>Shohet</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Osmotic gradient ektacytometry: Comprehensive characterization of red cell volume and surface maintenance</article-title><source>Blood</source><volume>61</volume><fpage>899</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1182/blood.V61.5.899.899</pub-id><pub-id pub-id-type="pmid">6831052</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>GM</given-names></name><name><surname>Rockett</surname><given-names>K</given-names></name><name><surname>Kivinen</surname><given-names>K</given-names></name><name><surname>Hubbart</surname><given-names>C</given-names></name><name><surname>Jeffreys</surname><given-names>AE</given-names></name><name><surname>Rowlands</surname><given-names>K</given-names></name><name><surname>Jallow</surname><given-names>M</given-names></name><name><surname>Conway</surname><given-names>DJ</given-names></name><name><surname>Bojang</surname><given-names>KA</given-names></name><name><surname>Pinder</surname><given-names>M</given-names></name><name><surname>Usen</surname><given-names>S</given-names></name><name><surname>Sisay-Joof</surname><given-names>F</given-names></name><name><surname>Sirugo</surname><given-names>G</given-names></name><name><surname>Toure</surname><given-names>O</given-names></name><name><surname>Thera</surname><given-names>MA</given-names></name><name><surname>Konate</surname><given-names>S</given-names></name><name><surname>Sissoko</surname><given-names>S</given-names></name><name><surname>Niangaly</surname><given-names>A</given-names></name><name><surname>Poudiougou</surname><given-names>B</given-names></name><name><surname>Mangano</surname><given-names>VD</given-names></name><name><surname>Bougouma</surname><given-names>EC</given-names></name><name><surname>Sirima</surname><given-names>SB</given-names></name><name><surname>Modiano</surname><given-names>D</given-names></name><name><surname>Amenga-Etego</surname><given-names>LN</given-names></name><name><surname>Ghansah</surname><given-names>A</given-names></name><name><surname>Koram</surname><given-names>KA</given-names></name><name><surname>Wilson</surname><given-names>MD</given-names></name><name><surname>Enimil</surname><given-names>A</given-names></name><name><surname>Evans</surname><given-names>J</given-names></name><name><surname>Amodu</surname><given-names>OK</given-names></name><name><surname>Olaniyan</surname><given-names>S</given-names></name><name><surname>Apinjoh</surname><given-names>T</given-names></name><name><surname>Mugri</surname><given-names>R</given-names></name><name><surname>Ndi</surname><given-names>A</given-names></name><name><surname>Ndila</surname><given-names>CM</given-names></name><name><surname>Uyoga</surname><given-names>S</given-names></name><name><surname>Macharia</surname><given-names>A</given-names></name><name><surname>Peshu</surname><given-names>N</given-names></name><name><surname>Williams</surname><given-names>TN</given-names></name><name><surname>Manjurano</surname><given-names>A</given-names></name><name><surname>SepÃºlveda</surname><given-names>N</given-names></name><name><surname>Clark</surname><given-names>TG</given-names></name><name><surname>Riley</surname><given-names>E</given-names></name><name><surname>Drakeley</surname><given-names>C</given-names></name><name><surname>Reyburn</surname><given-names>H</given-names></name><name><surname>Nyirongo</surname><given-names>V</given-names></name><name><surname>Kachala</surname><given-names>D</given-names></name><name><surname>Molyneux</surname><given-names>M</given-names></name><name><surname>Dunstan</surname><given-names>SJ</given-names></name><name><surname>Phu</surname><given-names>NH</given-names></name><name><surname>Quyen</surname><given-names>NN</given-names></name><name><surname>Thai</surname><given-names>CQ</given-names></name><name><surname>Hien</surname><given-names>TT</given-names></name><name><surname>Manning</surname><given-names>L</given-names></name><name><surname>Laman</surname><given-names>M</given-names></name><name><surname>Siba</surname><given-names>P</given-names></name><name><surname>Karunajeewa</surname><given-names>H</given-names></name><name><surname>Allen</surname><given-names>S</given-names></name><name><surname>Allen</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>TM</given-names></name><name><surname>Michon</surname><given-names>P</given-names></name><name><surname>Mueller</surname><given-names>I</given-names></name><name><surname>Molloy</surname><given-names>SF</given-names></name><name><surname>Campino</surname><given-names>S</given-names></name><name><surname>Kerasidou</surname><given-names>A</given-names></name><name><surname>Cornelius</surname><given-names>VJ</given-names></name><name><surname>Hart</surname><given-names>L</given-names></name><name><surname>Shah</surname><given-names>SS</given-names></name><name><surname>Band</surname><given-names>G</given-names></name><name><surname>Spencer</surname><given-names>CC</given-names></name><name><surname>Agbenyega</surname><given-names>T</given-names></name><name><surname>Achidi</surname><given-names>E</given-names></name><name><surname>Doumbo</surname><given-names>OK</given-names></name><name><surname>Farrar</surname><given-names>J</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Taylor</surname><given-names>T</given-names></name><name><surname>Kwiatkowski</surname><given-names>DP</given-names></name><collab>MalariaGEN Consortium</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Characterisation of the opposing effects of g6pd deficiency on cerebral malaria and severe malarial anaemia</article-title><source>eLife</source><volume>6</volume><elocation-id>e15085</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.15085</pub-id><pub-id pub-id-type="pmid">28067620</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooling</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Blood groups in infection and host susceptibility</article-title><source>Clinical Microbiology Reviews</source><volume>28</volume><fpage>801</fpage><lpage>870</lpage><pub-id pub-id-type="doi">10.1128/CMR.00109-14</pub-id><pub-id pub-id-type="pmid">26085552</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crosnier</surname><given-names>C</given-names></name><name><surname>Bustamante</surname><given-names>LY</given-names></name><name><surname>Bartholdson</surname><given-names>SJ</given-names></name><name><surname>Bei</surname><given-names>AK</given-names></name><name><surname>Theron</surname><given-names>M</given-names></name><name><surname>Uchikawa</surname><given-names>M</given-names></name><name><surname>Mboup</surname><given-names>S</given-names></name><name><surname>Ndir</surname><given-names>O</given-names></name><name><surname>Kwiatkowski</surname><given-names>DP</given-names></name><name><surname>Duraisingh</surname><given-names>MT</given-names></name><name><surname>Rayner</surname><given-names>JC</given-names></name><name><surname>Wright</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Basigin is a receptor essential for erythrocyte invasion by <italic>plasmodium falciparum</italic></article-title><source>Nature</source><volume>480</volume><fpage>534</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1038/nature10606</pub-id><pub-id pub-id-type="pmid">22080952</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danecek</surname><given-names>P</given-names></name><name><surname>Auton</surname><given-names>A</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name><name><surname>Albers</surname><given-names>CA</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>DePristo</surname><given-names>MA</given-names></name><name><surname>Handsaker</surname><given-names>RE</given-names></name><name><surname>Lunter</surname><given-names>G</given-names></name><name><surname>Marth</surname><given-names>GT</given-names></name><name><surname>Sherry</surname><given-names>ST</given-names></name><name><surname>McVean</surname><given-names>G</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name><collab>1000 Genomes Project Analysis Group</collab></person-group><year iso-8601-date="2011">2011</year><article-title>The variant call format and vcftools</article-title><source>Bioinformatics</source><volume>27</volume><fpage>2156</fpage><lpage>2158</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr330</pub-id><pub-id pub-id-type="pmid">21653522</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniels</surname><given-names>R</given-names></name><name><surname>Ndiaye</surname><given-names>D</given-names></name><name><surname>Wall</surname><given-names>M</given-names></name><name><surname>McKinney</surname><given-names>J</given-names></name><name><surname>SÃ©ne</surname><given-names>PD</given-names></name><name><surname>Sabeti</surname><given-names>PC</given-names></name><name><surname>Volkman</surname><given-names>SK</given-names></name><name><surname>Mboup</surname><given-names>S</given-names></name><name><surname>Wirth</surname><given-names>DF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Rapid, field-deployable method for genotyping and discovery of single-nucleotide polymorphisms associated with drug resistance in <italic>Plasmodium falciparum</italic></article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>56</volume><fpage>2976</fpage><lpage>2986</lpage><pub-id pub-id-type="doi">10.1128/AAC.05737-11</pub-id><pub-id pub-id-type="pmid">22430961</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de MendonÃ§a</surname><given-names>VRR</given-names></name><name><surname>Goncalves</surname><given-names>MS</given-names></name><name><surname>Barral-Netto</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The host genetic diversity in malaria infection</article-title><source>Journal of Tropical Medicine</source><volume>2012</volume><elocation-id>940616</elocation-id><pub-id pub-id-type="doi">10.1155/2012/940616</pub-id><pub-id pub-id-type="pmid">23316245</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhermy</surname><given-names>D</given-names></name><name><surname>SchrÃ©vel</surname><given-names>J</given-names></name><name><surname>Lecomte</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Spectrin-based skeleton in red blood cells and malaria</article-title><source>Current Opinion in Hematology</source><volume>14</volume><fpage>198</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1097/MOH.0b013e3280d21afd</pub-id><pub-id pub-id-type="pmid">17414207</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Ebel</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>RBC</data-title><version designator="swh:1:rev:31f953428a4ec5f0fa83201085ada0a0995facb2">swh:1:rev:31f953428a4ec5f0fa83201085ada0a0995facb2</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:936eeefd426d26efb71dfd49bea1ccafaa03ac3f;origin=https://github.com/emily-ebel/RBC;visit=swh:1:snp:4e53482ed5ff50b01ed3179d405ec1ac9387b7a5;anchor=swh:1:rev:31f953428a4ec5f0fa83201085ada0a0995facb2">https://archive.softwareheritage.org/swh:1:dir:936eeefd426d26efb71dfd49bea1ccafaa03ac3f;origin=https://github.com/emily-ebel/RBC;visit=swh:1:snp:4e53482ed5ff50b01ed3179d405ec1ac9387b7a5;anchor=swh:1:rev:31f953428a4ec5f0fa83201085ada0a0995facb2</ext-link></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>ES</given-names></name><name><surname>Jiang</surname><given-names>RHY</given-names></name><name><surname>Moechtar</surname><given-names>MA</given-names></name><name><surname>Barteneva</surname><given-names>NS</given-names></name><name><surname>Weekes</surname><given-names>MP</given-names></name><name><surname>Nobre</surname><given-names>LV</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Paulo</surname><given-names>JA</given-names></name><name><surname>Frantzreb</surname><given-names>C</given-names></name><name><surname>Tani</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>J</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Goldberg</surname><given-names>J</given-names></name><name><surname>Paul</surname><given-names>AS</given-names></name><name><surname>Brugnara</surname><given-names>C</given-names></name><name><surname>Root</surname><given-names>DE</given-names></name><name><surname>Wiegand</surname><given-names>RC</given-names></name><name><surname>Doench</surname><given-names>JG</given-names></name><name><surname>Duraisingh</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Malaria. A forward genetic screen identifies erythrocyte CD55 as essential for <italic>plasmodium falciparum</italic> invasion</article-title><source>Science</source><volume>348</volume><fpage>711</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1126/science.aaa3526</pub-id><pub-id pub-id-type="pmid">25954012</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>ES</given-names></name><name><surname>Weekes</surname><given-names>MP</given-names></name><name><surname>Kanjee</surname><given-names>U</given-names></name><name><surname>Manzo</surname><given-names>J</given-names></name><name><surname>Srinivasan</surname><given-names>A</given-names></name><name><surname>Lomas-Francis</surname><given-names>C</given-names></name><name><surname>Westhoff</surname><given-names>C</given-names></name><name><surname>Takahashi</surname><given-names>J</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Brugnara</surname><given-names>C</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Tani</surname><given-names>Y</given-names></name><name><surname>Duraisingh</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Erythrocytes lacking the langereis blood group protein abcb6 are resistant to the malaria parasite <italic>plasmodium falciparum</italic></article-title><source>Communications Biology</source><volume>1</volume><elocation-id>45</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-018-0046-2</pub-id><pub-id pub-id-type="pmid">30271928</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>England</surname><given-names>JM</given-names></name><name><surname>Ward</surname><given-names>SM</given-names></name><name><surname>Down</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="1976">1976</year><article-title>Microcytosis, anisocytosis and the red cell indices in iron deficiency</article-title><source>British Journal of Haematology</source><volume>34</volume><fpage>589</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2141.1976.tb03605.x</pub-id><pub-id pub-id-type="pmid">990192</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>DM</given-names></name><name><surname>Frazer</surname><given-names>IH</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Genetic and environmental causes of variation in basal levels of blood cells</article-title><source>Twin Research</source><volume>2</volume><fpage>250</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1375/136905299320565735</pub-id><pub-id pub-id-type="pmid">10723803</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Facer</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Erythrocytes carrying mutations in spectrin and protein 4.1 show differing sensitivities to invasion by <italic>plasmodium falciparum</italic></article-title><source>Parasitology Research</source><volume>81</volume><fpage>52</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1007/BF00932417</pub-id><pub-id pub-id-type="pmid">7724514</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fadista</surname><given-names>J</given-names></name><name><surname>Manning</surname><given-names>AK</given-names></name><name><surname>Florez</surname><given-names>JC</given-names></name><name><surname>Groop</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The (in)famous GWAS P-value threshold revisited and updated for low-frequency variants</article-title><source>European Journal of Human Genetics</source><volume>24</volume><fpage>1202</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1038/ejhg.2015.269</pub-id><pub-id pub-id-type="pmid">26733288</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Field</surname><given-names>SP</given-names></name><name><surname>Hempelmann</surname><given-names>E</given-names></name><name><surname>Mendelow</surname><given-names>BV</given-names></name><name><surname>Fleming</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Glycophorin variants and <italic>plasmodium falciparum</italic>: Protective effect of the dantu phenotype in vitro</article-title><source>Human Genetics</source><volume>93</volume><fpage>148</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1007/BF00210600</pub-id><pub-id pub-id-type="pmid">8112738</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>CJ</given-names></name><name><surname>Hurvich</surname><given-names>CM</given-names></name><name><surname>Simonoff</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>On the sensitivity of the lasso to the number of predictor variables</article-title><source>Statistical Science. Institute of Mathematical Statistics</source><volume>32</volume><fpage>88</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1214/16-STS586</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>SE</given-names></name><name><surname>Sullivan</surname><given-names>DJ</given-names></name><name><surname>Goldberg</surname><given-names>D. E</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Hemoglobin metabolism in the malaria parasite <italic>Plasmodium falciparum</italic></article-title><source>Annual Review of Microbiology</source><volume>51</volume><fpage>97</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.51.1.97</pub-id><pub-id pub-id-type="pmid">9343345</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>Erythrocytic mechanism of sickle cell resistance to malaria</article-title><source>PNAS</source><volume>75</volume><fpage>1994</fpage><lpage>1997</lpage><pub-id pub-id-type="doi">10.1073/pnas.75.4.1994</pub-id><pub-id pub-id-type="pmid">347452</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galanello</surname><given-names>R</given-names></name><name><surname>Cao</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Alpha-thalassemia</article-title><source>Genetics in Medicine</source><volume>13</volume><fpage>83</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1097/GIM.0b013e3181fcb468</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallagher</surname><given-names>PG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Abnormalities of the erythrocyte membrane</article-title><source>Pediatric Clinics of North America</source><volume>60</volume><fpage>1349</fpage><lpage>1362</lpage><pub-id pub-id-type="doi">10.1016/j.pcl.2013.09.001</pub-id><pub-id pub-id-type="pmid">24237975</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garn</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>Lower hematocrit levels in blacks are not due to diet or socioeconomic factors</article-title><source>Pediatrics</source><volume>67</volume><elocation-id>580</elocation-id><pub-id pub-id-type="pmid">7254983</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>GÃ©nin</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Missing heritability of complex diseases: case solved?</article-title><source>Human Genetics</source><volume>139</volume><fpage>103</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1007/s00439-019-02034-4</pub-id><pub-id pub-id-type="pmid">31165258</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glogowska</surname><given-names>E</given-names></name><name><surname>Schneider</surname><given-names>ER</given-names></name><name><surname>Maksimova</surname><given-names>Y</given-names></name><name><surname>Schulz</surname><given-names>VP</given-names></name><name><surname>Lezon-Geyda</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Radhakrishnan</surname><given-names>K</given-names></name><name><surname>Keel</surname><given-names>SB</given-names></name><name><surname>Mahoney</surname><given-names>D</given-names></name><name><surname>Freidmann</surname><given-names>AM</given-names></name><name><surname>Altura</surname><given-names>RA</given-names></name><name><surname>Gracheva</surname><given-names>EO</given-names></name><name><surname>Bagriantsev</surname><given-names>SN</given-names></name><name><surname>Kalfa</surname><given-names>TA</given-names></name><name><surname>Gallagher</surname><given-names>PG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Novel mechanisms of piezo1 dysfunction in hereditary xerocytosis</article-title><source>Blood</source><volume>130</volume><fpage>1845</fpage><lpage>1856</lpage><pub-id pub-id-type="doi">10.1182/blood-2017-05-786004</pub-id><pub-id pub-id-type="pmid">28716860</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goheen</surname><given-names>MM</given-names></name><name><surname>WegmÃ¼ller</surname><given-names>R</given-names></name><name><surname>Bah</surname><given-names>A</given-names></name><name><surname>Darboe</surname><given-names>B</given-names></name><name><surname>Danso</surname><given-names>E</given-names></name><name><surname>Affara</surname><given-names>M</given-names></name><name><surname>Gardner</surname><given-names>D</given-names></name><name><surname>Patel</surname><given-names>JC</given-names></name><name><surname>Prentice</surname><given-names>AM</given-names></name><name><surname>Cerami</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Anemia offers stronger protection than sickle cell trait against the erythrocytic stage of falciparum malaria and this protection is reversed by iron supplementation</article-title><source>EBioMedicine</source><volume>14</volume><fpage>123</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2016.11.011</pub-id><pub-id pub-id-type="pmid">27852523</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greene</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>G6pd deficiency as protection againstfalciparum malaria: An epidemiologic critique of population and experimental studies</article-title><source>American Journal of Physical Anthropology</source><volume>36</volume><fpage>153</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1002/ajpa.1330360609</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>GTEx Consortium</collab><collab>Laboratory, Data Analysis &amp;Coordinating Center (LDACC)âAnalysis Working Group</collab><collab>Statistical Methods groupsâAnalysis Working Group</collab><collab>Enhancing GTEx (eGTEx) groups</collab><collab>NIH Common Fund</collab><collab>NIH/NCI</collab><collab>NIH/NHGRI</collab><collab>NIH/NIMH</collab><collab>NIH/NIDA</collab><collab>Biospecimen Collection Source SiteâNDRI</collab><collab>Biospecimen Collection Source SiteâRPCI</collab><collab>Biospecimen Core ResourceâVARI</collab><collab>Brain Bank RepositoryâUniversity of Miami Brain Endowment Bank</collab><collab>Leidos BiomedicalâProject Management</collab><collab>ELSI Study</collab><collab>Genome Browser Data Integration &amp;VisualizationâEBI</collab><collab>Genome Browser Data Integration &amp;VisualizationâUCSC Genomics Institute, University of California Santa Cruz</collab><collab>Lead analysts</collab><collab>Laboratory, Data Analysis &amp;Coordinating Center (LDACC)</collab><collab>NIH program management</collab><collab>Biospecimen collection</collab><collab>Pathology</collab><collab>eQTL manuscript working group</collab><name><surname>Battle</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>CD</given-names></name><name><surname>Engelhardt</surname><given-names>BE</given-names></name><name><surname>Montgomery</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genetic effects on gene expression across human tissues</article-title><source>Nature</source><volume>550</volume><fpage>204</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1038/nature24277</pub-id><pub-id pub-id-type="pmid">29022597</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanssen</surname><given-names>E</given-names></name><name><surname>Knoechel</surname><given-names>C</given-names></name><name><surname>Dearnley</surname><given-names>M</given-names></name><name><surname>Dixon</surname><given-names>MWA</given-names></name><name><surname>Le Gros</surname><given-names>M</given-names></name><name><surname>Larabell</surname><given-names>C</given-names></name><name><surname>Tilley</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Soft x-ray microscopy analysis of cell volume and hemoglobin content in erythrocytes infected with asexual and sexual stages of <italic>Plasmodium falciparum</italic></article-title><source>Journal of Structural Biology</source><volume>177</volume><fpage>224</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2011.09.003</pub-id><pub-id pub-id-type="pmid">21945653</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ifediba</surname><given-names>TC</given-names></name><name><surname>Stern</surname><given-names>A</given-names></name><name><surname>Ibrahim</surname><given-names>A</given-names></name><name><surname>Rieder</surname><given-names>RF</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title><italic>Plasmodium falciparum</italic> in vitro: Diminished growth in hemoglobin h disease erythrocytes</article-title><source>Blood</source><volume>65</volume><fpage>452</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1182/blood.V65.2.452.452</pub-id><pub-id pub-id-type="pmid">3881144</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilboudo</surname><given-names>Y</given-names></name><name><surname>Bartolucci</surname><given-names>P</given-names></name><name><surname>Garrett</surname><given-names>ME</given-names></name><name><surname>Ashley-Koch</surname><given-names>A</given-names></name><name><surname>Telen</surname><given-names>M</given-names></name><name><surname>Brugnara</surname><given-names>C</given-names></name><name><surname>GalactÃ©ros</surname><given-names>F</given-names></name><name><surname>Lettre</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A common functional piezo1 deletion allele associates with red blood cell density in sickle cell disease patients</article-title><source>American Journal of Hematology</source><volume>93</volume><fpage>E362</fpage><lpage>E365</lpage><pub-id pub-id-type="doi">10.1002/ajh.25245</pub-id><pub-id pub-id-type="pmid">30105803</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ioannidis</surname><given-names>JPA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Why most published research findings are false</article-title><source>PLOS Medicine</source><volume>2</volume><elocation-id>e124</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.0020124</pub-id><pub-id pub-id-type="pmid">16060722</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanias</surname><given-names>T</given-names></name><name><surname>Lanteri</surname><given-names>MC</given-names></name><name><surname>Page</surname><given-names>GP</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Endres</surname><given-names>SM</given-names></name><name><surname>Stone</surname><given-names>M</given-names></name><name><surname>Keating</surname><given-names>S</given-names></name><name><surname>Mast</surname><given-names>AE</given-names></name><name><surname>Cable</surname><given-names>RG</given-names></name><name><surname>Triulzi</surname><given-names>DJ</given-names></name><name><surname>Kiss</surname><given-names>JE</given-names></name><name><surname>Murphy</surname><given-names>EL</given-names></name><name><surname>Kleinman</surname><given-names>S</given-names></name><name><surname>Busch</surname><given-names>MP</given-names></name><name><surname>Gladwin</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ethnicity, sex, and age are determinants of red blood cell storage and stress hemolysis: Results of the REDS-III Rbc-omics study</article-title><source>Blood Advances</source><volume>1</volume><fpage>1132</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1182/bloodadvances.2017004820</pub-id><pub-id pub-id-type="pmid">29034365</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karczewski</surname><given-names>KJ</given-names></name><name><surname>Francioli</surname><given-names>LC</given-names></name><name><surname>Tiao</surname><given-names>G</given-names></name><name><surname>Cummings</surname><given-names>BB</given-names></name><name><surname>AlfÃ¶ldi</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Collins</surname><given-names>RL</given-names></name><name><surname>Laricchia</surname><given-names>KM</given-names></name><name><surname>Ganna</surname><given-names>A</given-names></name><name><surname>Birnbaum</surname><given-names>DP</given-names></name><name><surname>Gauthier</surname><given-names>LD</given-names></name><name><surname>Brand</surname><given-names>H</given-names></name><name><surname>Solomonson</surname><given-names>M</given-names></name><name><surname>Watts</surname><given-names>NA</given-names></name><name><surname>Rhodes</surname><given-names>D</given-names></name><name><surname>Singer-Berk</surname><given-names>M</given-names></name><name><surname>England</surname><given-names>EM</given-names></name><name><surname>Seaby</surname><given-names>EG</given-names></name><name><surname>Kosmicki</surname><given-names>JA</given-names></name><name><surname>Walters</surname><given-names>RK</given-names></name><name><surname>Tashman</surname><given-names>K</given-names></name><name><surname>Farjoun</surname><given-names>Y</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>Poterba</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Seed</surname><given-names>C</given-names></name><name><surname>Whiffin</surname><given-names>N</given-names></name><name><surname>Chong</surname><given-names>JX</given-names></name><name><surname>Samocha</surname><given-names>KE</given-names></name><name><surname>Pierce-Hoffman</surname><given-names>E</given-names></name><name><surname>Zappala</surname><given-names>Z</given-names></name><name><surname>OâDonnell-Luria</surname><given-names>AH</given-names></name><name><surname>Minikel</surname><given-names>EV</given-names></name><name><surname>Weisburd</surname><given-names>B</given-names></name><name><surname>Lek</surname><given-names>M</given-names></name><name><surname>Ware</surname><given-names>JS</given-names></name><name><surname>Vittal</surname><given-names>C</given-names></name><name><surname>Armean</surname><given-names>IM</given-names></name><name><surname>Bergelson</surname><given-names>L</given-names></name><name><surname>Cibulskis</surname><given-names>K</given-names></name><name><surname>Connolly</surname><given-names>KM</given-names></name><name><surname>Covarrubias</surname><given-names>M</given-names></name><name><surname>Donnelly</surname><given-names>S</given-names></name><name><surname>Ferriera</surname><given-names>S</given-names></name><name><surname>Gabriel</surname><given-names>S</given-names></name><name><surname>Gentry</surname><given-names>J</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Jeandet</surname><given-names>T</given-names></name><name><surname>Kaplan</surname><given-names>D</given-names></name><name><surname>Llanwarne</surname><given-names>C</given-names></name><name><surname>Munshi</surname><given-names>R</given-names></name><name><surname>Novod</surname><given-names>S</given-names></name><name><surname>Petrillo</surname><given-names>N</given-names></name><name><surname>Roazen</surname><given-names>D</given-names></name><name><surname>Ruano-Rubio</surname><given-names>V</given-names></name><name><surname>Saltzman</surname><given-names>A</given-names></name><name><surname>Schleicher</surname><given-names>M</given-names></name><name><surname>Soto</surname><given-names>J</given-names></name><name><surname>Tibbetts</surname><given-names>K</given-names></name><name><surname>Tolonen</surname><given-names>C</given-names></name><name><surname>Wade</surname><given-names>G</given-names></name><name><surname>Talkowski</surname><given-names>ME</given-names></name><collab>Genome Aggregation Database Consortium</collab><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>MacArthur</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The mutational constraint spectrum quantified from variation in 141,456 humans</article-title><source>Nature</source><volume>581</volume><fpage>434</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2308-7</pub-id><pub-id pub-id-type="pmid">32461654</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kariuki</surname><given-names>SN</given-names></name><name><surname>Marin-Menendez</surname><given-names>A</given-names></name><name><surname>Introini</surname><given-names>V</given-names></name><name><surname>Ravenhill</surname><given-names>BJ</given-names></name><name><surname>Lin</surname><given-names>Y-C</given-names></name><name><surname>Macharia</surname><given-names>A</given-names></name><name><surname>Makale</surname><given-names>J</given-names></name><name><surname>Tendwa</surname><given-names>M</given-names></name><name><surname>Nyamu</surname><given-names>W</given-names></name><name><surname>Kotar</surname><given-names>J</given-names></name><name><surname>Carrasquilla</surname><given-names>M</given-names></name><name><surname>Rowe</surname><given-names>JA</given-names></name><name><surname>Rockett</surname><given-names>K</given-names></name><name><surname>Kwiatkowski</surname><given-names>D</given-names></name><name><surname>Weekes</surname><given-names>MP</given-names></name><name><surname>Cicuta</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>TN</given-names></name><name><surname>Rayner</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Red blood cell tension protects against severe malaria in the Dantu blood group</article-title><source>Nature</source><volume>585</volume><fpage>579</fpage><lpage>583</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2726-6</pub-id><pub-id pub-id-type="pmid">32939086</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kariuki</surname><given-names>SN</given-names></name><name><surname>Williams</surname><given-names>TN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Human genetics and malaria resistance</article-title><source>Human Genetics</source><volume>139</volume><fpage>801</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1007/s00439-020-02142-6</pub-id><pub-id pub-id-type="pmid">32130487</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kierczak</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The contribution of rare whole genome sequencing variants to plasma protein levels and to the missing heritability</article-title><source>Research Square</source><volume>1</volume><elocation-id>625433/v1</elocation-id><pub-id pub-id-type="doi">10.21203/rs.3.rs-625433/v1</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Kinsler</surname><given-names>G</given-names></name><name><surname>Geiler-Samerotte</surname><given-names>K</given-names></name><name><surname>Petrov</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A Genotype-Phenotype-Fitness Map Reveals Local Modularity and Global Pleiotropy of Adaptation</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.06.25.172197</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title><italic>Plasmodium falciparum</italic> erythrocyte-binding antigen 175 triggers a biophysical change in the red blood cell that facilitates invasion</article-title><source>PNAS</source><volume>114</volume><fpage>4225</fpage><lpage>4230</lpage><pub-id pub-id-type="doi">10.1073/pnas.1620843114</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuypers</surname><given-names>FA</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Use of ektacytometry to determine red cell susceptibility to oxidative stress</article-title><source>The Journal of Laboratory and Clinical Medicine</source><volume>116</volume><fpage>527</fpage><lpage>534</lpage></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwiatkowski</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>How malaria has affected the human genome and what human genetics can teach us about malaria</article-title><source>American Journal of Human Genetics</source><volume>77</volume><fpage>171</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1086/432519</pub-id><pub-id pub-id-type="pmid">16001361</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leffler</surname><given-names>EM</given-names></name><name><surname>Band</surname><given-names>G</given-names></name><name><surname>Busby</surname><given-names>GBJ</given-names></name><name><surname>Kivinen</surname><given-names>K</given-names></name><name><surname>Le</surname><given-names>QS</given-names></name><name><surname>Clarke</surname><given-names>GM</given-names></name><name><surname>Bojang</surname><given-names>KA</given-names></name><name><surname>Conway</surname><given-names>DJ</given-names></name><name><surname>Jallow</surname><given-names>M</given-names></name><name><surname>Sisay-Joof</surname><given-names>F</given-names></name><name><surname>Bougouma</surname><given-names>EC</given-names></name><name><surname>Mangano</surname><given-names>VD</given-names></name><name><surname>Modiano</surname><given-names>D</given-names></name><name><surname>Sirima</surname><given-names>SB</given-names></name><name><surname>Achidi</surname><given-names>E</given-names></name><name><surname>Apinjoh</surname><given-names>TO</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Ndila</surname><given-names>CM</given-names></name><name><surname>Peshu</surname><given-names>N</given-names></name><name><surname>Williams</surname><given-names>TN</given-names></name><name><surname>Drakeley</surname><given-names>C</given-names></name><name><surname>Manjurano</surname><given-names>A</given-names></name><name><surname>Reyburn</surname><given-names>H</given-names></name><name><surname>Riley</surname><given-names>E</given-names></name><name><surname>Kachala</surname><given-names>D</given-names></name><name><surname>Molyneux</surname><given-names>M</given-names></name><name><surname>Nyirongo</surname><given-names>V</given-names></name><name><surname>Taylor</surname><given-names>T</given-names></name><name><surname>Thornton</surname><given-names>N</given-names></name><name><surname>Tilley</surname><given-names>L</given-names></name><name><surname>Grimsley</surname><given-names>S</given-names></name><name><surname>Drury</surname><given-names>E</given-names></name><name><surname>Stalker</surname><given-names>J</given-names></name><name><surname>Cornelius</surname><given-names>V</given-names></name><name><surname>Hubbart</surname><given-names>C</given-names></name><name><surname>Jeffreys</surname><given-names>AE</given-names></name><name><surname>Rowlands</surname><given-names>K</given-names></name><name><surname>Rockett</surname><given-names>KA</given-names></name><name><surname>Spencer</surname><given-names>CCA</given-names></name><name><surname>Kwiatkowski</surname><given-names>DP</given-names></name><collab>Malaria Genomic Epidemiology Network</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Resistance to malaria through structural variation of red blood cell invasion receptors</article-title><source>Science</source><volume>356</volume><fpage>1140</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1126/science.aam6393</pub-id><pub-id pub-id-type="pmid">28522690</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lell</surname><given-names>B</given-names></name><name><surname>May</surname><given-names>J</given-names></name><name><surname>Schmidt-Ott</surname><given-names>RJ</given-names></name><name><surname>Lehman</surname><given-names>LG</given-names></name><name><surname>Luckner</surname><given-names>D</given-names></name><name><surname>Greve</surname><given-names>B</given-names></name><name><surname>Matousek</surname><given-names>P</given-names></name><name><surname>Schmid</surname><given-names>D</given-names></name><name><surname>Herbich</surname><given-names>K</given-names></name><name><surname>Mockenhaupt</surname><given-names>FP</given-names></name><name><surname>Meyer</surname><given-names>CG</given-names></name><name><surname>Bienzle</surname><given-names>U</given-names></name><name><surname>Kremsner</surname><given-names>PG</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The role of red blood cell polymorphisms in resistance and susceptibility to malaria</article-title><source>Clinical Infectious Diseases</source><volume>28</volume><fpage>794</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1086/515193</pub-id><pub-id pub-id-type="pmid">10825041</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lessard</surname><given-names>S</given-names></name><name><surname>Gatof</surname><given-names>ES</given-names></name><name><surname>Beaudoin</surname><given-names>M</given-names></name><name><surname>Schupp</surname><given-names>PG</given-names></name><name><surname>Sher</surname><given-names>F</given-names></name><name><surname>Ali</surname><given-names>A</given-names></name><name><surname>Prehar</surname><given-names>S</given-names></name><name><surname>Kurita</surname><given-names>R</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Baena</surname><given-names>E</given-names></name><name><surname>Ledoux</surname><given-names>J</given-names></name><name><surname>Oceandy</surname><given-names>D</given-names></name><name><surname>Bauer</surname><given-names>DE</given-names></name><name><surname>Lettre</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An erythroid-specific atp2b4 enhancer mediates red blood cell hydration and malaria susceptibility</article-title><source>The Journal of Clinical Investigation</source><volume>127</volume><fpage>3065</fpage><lpage>3074</lpage><pub-id pub-id-type="doi">10.1172/JCI94378</pub-id><pub-id pub-id-type="pmid">28714864</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewontin</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="1972">1972</year><article-title>The apportionment of human diversityâ, in evolutionary biology</article-title><source>Taylor and Francis</source><volume>6</volume><fpage>381</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1007/978-1-4684-9063-3_14</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title>Aligning Sequence Reads, Clone Sequences and Assembly Contigs with BWA-MEM</article-title><source>arXiv</source><ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/1303.3997">http://arxiv.org/abs/1303.3997</ext-link></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Glessner</surname><given-names>JT</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Hou</surname><given-names>C</given-names></name><name><surname>Wei</surname><given-names>Z</given-names></name><name><surname>Bradfield</surname><given-names>JP</given-names></name><name><surname>Mentch</surname><given-names>FD</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Xia</surname><given-names>Q</given-names></name><name><surname>Chiavacci</surname><given-names>RM</given-names></name><name><surname>Thomas</surname><given-names>KA</given-names></name><name><surname>Qiu</surname><given-names>H</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Furth</surname><given-names>SL</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name><name><surname>Sleiman</surname><given-names>PMA</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>GWAS of blood cell Traits identifies novel associated loci and epistatic interactions in caucasian and african-american children</article-title><source>Human Molecular Genetics</source><volume>22</volume><fpage>1457</fpage><lpage>1464</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds534</pub-id><pub-id pub-id-type="pmid">23263863</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>S-H</given-names></name><name><surname>Brown</surname><given-names>DW</given-names></name><name><surname>Machiela</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>LDTRAIT: An online tool for identifying published phenotype associations in linkage disequilibrium</article-title><source>Cancer Research</source><volume>80</volume><fpage>3443</fpage><lpage>3446</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-20-0985</pub-id><pub-id pub-id-type="pmid">32606005</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>KS</given-names></name><name><surname>Wilson</surname><given-names>JG</given-names></name><name><surname>Lange</surname><given-names>LA</given-names></name><name><surname>Folsom</surname><given-names>AR</given-names></name><name><surname>Galarneau</surname><given-names>G</given-names></name><name><surname>Ganesh</surname><given-names>SK</given-names></name><name><surname>Grant</surname><given-names>SFA</given-names></name><name><surname>Keating</surname><given-names>BJ</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>OâDonnell</surname><given-names>CJ</given-names></name><name><surname>Palmas</surname><given-names>W</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Tracy</surname><given-names>RP</given-names></name><name><surname>Reiner</surname><given-names>AP</given-names></name><name><surname>Lettre</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Genetic association analysis highlights new loci that modulate hematological trait variation in Caucasians and african Americans</article-title><source>Human Genetics</source><volume>129</volume><fpage>307</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1007/s00439-010-0925-1</pub-id><pub-id pub-id-type="pmid">21153663</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowy-Gallego</surname><given-names>E</given-names></name><name><surname>Fairley</surname><given-names>S</given-names></name><name><surname>Zheng-Bradley</surname><given-names>X</given-names></name><name><surname>Ruffier</surname><given-names>M</given-names></name><name><surname>Clarke</surname><given-names>L</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><collab>1000 Genomes Project Consortium</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Variant calling on the GRCH38 assembly with the data from phase three of the 1000 Genomes project</article-title><source>Wellcome Open Research</source><volume>4</volume><elocation-id>50</elocation-id><pub-id pub-id-type="doi">10.12688/wellcomeopenres.15126.2</pub-id><pub-id pub-id-type="pmid">32175479</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luzzatto</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Sickle cell anaemia and malaria</article-title><source>Mediterranean Journal of Hematology and Infectious Diseases</source><volume>4</volume><elocation-id>e2012065</elocation-id><pub-id pub-id-type="doi">10.4084/MJHID.2012.065</pub-id><pub-id pub-id-type="pmid">23170194</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>S</given-names></name><name><surname>Cahalan</surname><given-names>S</given-names></name><name><surname>LaMonte</surname><given-names>G</given-names></name><name><surname>Grubaugh</surname><given-names>ND</given-names></name><name><surname>Zeng</surname><given-names>W</given-names></name><name><surname>Murthy</surname><given-names>SE</given-names></name><name><surname>Paytas</surname><given-names>E</given-names></name><name><surname>Gamini</surname><given-names>R</given-names></name><name><surname>Lukacs</surname><given-names>V</given-names></name><name><surname>Whitwam</surname><given-names>T</given-names></name><name><surname>Loud</surname><given-names>M</given-names></name><name><surname>Lohia</surname><given-names>R</given-names></name><name><surname>Berry</surname><given-names>L</given-names></name><name><surname>Khan</surname><given-names>SM</given-names></name><name><surname>Janse</surname><given-names>CJ</given-names></name><name><surname>Bandell</surname><given-names>M</given-names></name><name><surname>Schmedt</surname><given-names>C</given-names></name><name><surname>Wengelnik</surname><given-names>K</given-names></name><name><surname>Su</surname><given-names>AI</given-names></name><name><surname>Honore</surname><given-names>E</given-names></name><name><surname>Winzeler</surname><given-names>EA</given-names></name><name><surname>Andersen</surname><given-names>KG</given-names></name><name><surname>Patapoutian</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Common piezo1 allele in african populations causes rbc dehydration and attenuates plasmodium infection</article-title><source>Cell</source><volume>173</volume><fpage>443</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.02.047</pub-id><pub-id pub-id-type="pmid">29576450</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>HE</given-names></name><name><surname>Lawrie</surname><given-names>DS</given-names></name><name><surname>Petrov</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pervasive strong selection at the level of codon usage bias in <italic>Drosophila melanogaster</italic></article-title><source>Genetics</source><volume>214</volume><fpage>511</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1534/genetics.119.302542</pub-id><pub-id pub-id-type="pmid">31871131</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackinnon</surname><given-names>MJ</given-names></name><name><surname>Mwangi</surname><given-names>TW</given-names></name><name><surname>Snow</surname><given-names>RW</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Williams</surname><given-names>TN</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Heritability of malaria in Africa</article-title><source>PLOS Medicine</source><volume>2</volume><elocation-id>20340</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.0020340</pub-id><pub-id pub-id-type="pmid">16259530</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Malaria Genomic Epidemiology Network</collab></person-group><year iso-8601-date="2014">2014</year><article-title>Reappraisal of known malaria resistance loci in a large multicenter study</article-title><source>Nature Genetics</source><volume>46</volume><fpage>1197</fpage><lpage>1204</lpage><pub-id pub-id-type="doi">10.1038/ng.3107</pub-id><pub-id pub-id-type="pmid">25261933</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Malaria Genomic Epidemiology Network</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>5732</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-13480-z</pub-id><pub-id pub-id-type="pmid">31844061</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer</surname><given-names>DCG</given-names></name><name><surname>Cofie</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Hartl</surname><given-names>DL</given-names></name><name><surname>Tracy</surname><given-names>E</given-names></name><name><surname>Kabat</surname><given-names>J</given-names></name><name><surname>Mendoza</surname><given-names>LH</given-names></name><name><surname>Miller</surname><given-names>LH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Glycophorin B is the erythrocyte receptor of <italic>Plasmodium falciparum</italic> erythrocyte-binding ligand, EBL-1</article-title><source>PNAS</source><volume>106</volume><fpage>5348</fpage><lpage>5352</lpage><pub-id pub-id-type="doi">10.1073/pnas.0900878106</pub-id><pub-id pub-id-type="pmid">19279206</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>RE</given-names></name><name><surname>Luttig</surname><given-names>CT</given-names></name><name><surname>Larkins</surname><given-names>CE</given-names></name><name><surname>Beauchamp</surname><given-names>A</given-names></name><name><surname>Tsui</surname><given-names>C</given-names></name><name><surname>Pittard</surname><given-names>WS</given-names></name><name><surname>Devine</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>An initial map of insertion and deletion (INDEL) variation in the human genome</article-title><source>Genome Research</source><volume>16</volume><fpage>1182</fpage><lpage>1190</lpage><pub-id pub-id-type="doi">10.1101/gr.4565806</pub-id><pub-id pub-id-type="pmid">16902084</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mockenhaupt</surname><given-names>FP</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Anaemia in pregnant Ghanaian women: importance of malaria, iron deficiency, and haemoglobinopathiesâ, Transactions of the Royal Society of Tropical Medicine and Hygiene</article-title><source>Royal Society of Tropical Medicine and Hygiene</source><volume>94</volume><fpage>477</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1016/S0035-9203(00)90057-9</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>âstrains used in whole organism <italic>Plasmodium falciparum</italic> vaccine trials differ in genome structure, sequence, and immunogenic potentialâ, genome medicine 2020 12:1</article-title><source>BioMed Central</source><volume>12</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1186/S13073-019-0708-9</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagayasu</surname><given-names>E</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Akaki</surname><given-names>M</given-names></name><name><surname>Nakano</surname><given-names>Y</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Looareesuwan</surname><given-names>S</given-names></name><name><surname>Aikawa</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>CR1 density polymorphism on erythrocytes of falciparum malaria patients in Thailand</article-title><source>The American Journal of Tropical Medicine and Hygiene</source><volume>64</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2001.64.1.11425154</pub-id><pub-id pub-id-type="pmid">11425154</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ndila</surname><given-names>CM</given-names></name><name><surname>Uyoga</surname><given-names>S</given-names></name><name><surname>Macharia</surname><given-names>AW</given-names></name><name><surname>Nyutu</surname><given-names>G</given-names></name><name><surname>Peshu</surname><given-names>N</given-names></name><name><surname>Ojal</surname><given-names>J</given-names></name><name><surname>Shebe</surname><given-names>M</given-names></name><name><surname>Awuondo</surname><given-names>KO</given-names></name><name><surname>Mturi</surname><given-names>N</given-names></name><name><surname>Tsofa</surname><given-names>B</given-names></name><name><surname>SepÃºlveda</surname><given-names>N</given-names></name><name><surname>Clark</surname><given-names>TG</given-names></name><name><surname>Band</surname><given-names>G</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Rowlands</surname><given-names>K</given-names></name><name><surname>Hubbart</surname><given-names>C</given-names></name><name><surname>Jeffreys</surname><given-names>A</given-names></name><name><surname>Kariuki</surname><given-names>S</given-names></name><name><surname>Marsh</surname><given-names>K</given-names></name><name><surname>Mackinnon</surname><given-names>M</given-names></name><name><surname>Maitland</surname><given-names>K</given-names></name><name><surname>Kwiatkowski</surname><given-names>DP</given-names></name><name><surname>Rockett</surname><given-names>KA</given-names></name><name><surname>Williams</surname><given-names>TN</given-names></name><collab>MalariaGEN Consortium</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: A case-control association study</article-title><source>The Lancet</source><volume>5</volume><fpage>e333</fpage><lpage>e345</lpage><pub-id pub-id-type="doi">10.1016/S2352-3026(18)30107-8</pub-id><pub-id pub-id-type="pmid">30033078</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguetse</surname><given-names>CN</given-names></name><name><surname>Purington</surname><given-names>N</given-names></name><name><surname>Ebel</surname><given-names>ER</given-names></name><name><surname>Shakya</surname><given-names>B</given-names></name><name><surname>Tetard</surname><given-names>M</given-names></name><name><surname>Kremsner</surname><given-names>PG</given-names></name><name><surname>Velavan</surname><given-names>TP</given-names></name><name><surname>Egan</surname><given-names>ES</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A common polymorphism in the mechanosensitive ion channel piezo1 is associated with protection from severe malaria in humans</article-title><source>PNAS</source><volume>117</volume><fpage>9074</fpage><lpage>9081</lpage><pub-id pub-id-type="doi">10.1073/pnas.1919843117</pub-id><pub-id pub-id-type="pmid">32265284</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novembre</surname><given-names>J</given-names></name><name><surname>Di Rienzo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Spatial patterns of variation due to natural selection in humans</article-title><source>Nature Reviews. Genetics</source><volume>10</volume><fpage>745</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1038/nrg2632</pub-id><pub-id pub-id-type="pmid">19823195</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Okwa</surname><given-names>OO</given-names></name></person-group><year iso-8601-date="2012">2012</year><conf-name>Malaria parasites, malaria parasites</conf-name><article-title>InTech</article-title><pub-id pub-id-type="doi">10.5772/1477</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otto</surname><given-names>TD</given-names></name><name><surname>Gilabert</surname><given-names>A</given-names></name><name><surname>Crellen</surname><given-names>T</given-names></name><name><surname>BÃ¶hme</surname><given-names>U</given-names></name><name><surname>Arnathau</surname><given-names>C</given-names></name><name><surname>Sanders</surname><given-names>M</given-names></name><name><surname>Oyola</surname><given-names>SO</given-names></name><name><surname>Okouga</surname><given-names>AP</given-names></name><name><surname>Boundenga</surname><given-names>L</given-names></name><name><surname>Willaume</surname><given-names>E</given-names></name><name><surname>Ngoubangoye</surname><given-names>B</given-names></name><name><surname>Moukodoum</surname><given-names>ND</given-names></name><name><surname>Paupy</surname><given-names>C</given-names></name><name><surname>Durand</surname><given-names>P</given-names></name><name><surname>Rougeron</surname><given-names>V</given-names></name><name><surname>Ollomo</surname><given-names>B</given-names></name><name><surname>Renaud</surname><given-names>F</given-names></name><name><surname>Newbold</surname><given-names>C</given-names></name><name><surname>Berriman</surname><given-names>M</given-names></name><name><surname>Prugnolle</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genomes of all known members of a plasmodium subgenus reveal paths to virulent human malaria</article-title><source>Nature Microbiology</source><volume>3</volume><fpage>687</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1038/s41564-018-0162-2</pub-id><pub-id pub-id-type="pmid">29784978</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>GP</given-names></name><name><surname>Kanias</surname><given-names>T</given-names></name><name><surname>Guo</surname><given-names>YJ</given-names></name><name><surname>Lanteri</surname><given-names>MC</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Mast</surname><given-names>AE</given-names></name><name><surname>Cable</surname><given-names>RG</given-names></name><name><surname>Spencer</surname><given-names>BR</given-names></name><name><surname>Kiss</surname><given-names>JE</given-names></name><name><surname>Fang</surname><given-names>F</given-names></name><name><surname>Endres-Dighe</surname><given-names>SM</given-names></name><name><surname>Brambilla</surname><given-names>D</given-names></name><name><surname>Nouraie</surname><given-names>M</given-names></name><name><surname>Gordeuk</surname><given-names>VR</given-names></name><name><surname>Kleinman</surname><given-names>S</given-names></name><name><surname>Busch</surname><given-names>MP</given-names></name><name><surname>Gladwin</surname><given-names>MT</given-names></name><collab>National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology Donor Evaluation StudyâIII (REDS-III) program</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Multiple-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>146077</elocation-id><pub-id pub-id-type="doi">10.1172/JCI146077</pub-id><pub-id pub-id-type="pmid">34014839</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pankratov</surname><given-names>V</given-names></name><name><surname>Montinaro</surname><given-names>F</given-names></name><name><surname>Kushniarevich</surname><given-names>A</given-names></name><name><surname>Hudjashov</surname><given-names>G</given-names></name><name><surname>Jay</surname><given-names>F</given-names></name><name><surname>Saag</surname><given-names>L</given-names></name><name><surname>Flores</surname><given-names>R</given-names></name><name><surname>Marnetto</surname><given-names>D</given-names></name><name><surname>Seppel</surname><given-names>M</given-names></name><name><surname>Kals</surname><given-names>M</given-names></name><name><surname>VÃµsa</surname><given-names>U</given-names></name><name><surname>Taccioli</surname><given-names>C</given-names></name><name><surname>MÃ¶ls</surname><given-names>M</given-names></name><name><surname>Milani</surname><given-names>L</given-names></name><name><surname>Aasa</surname><given-names>A</given-names></name><name><surname>Lawson</surname><given-names>DJ</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>MÃ¤gi</surname><given-names>R</given-names></name><name><surname>Pagani</surname><given-names>L</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Metspalu</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Differences in local population history at the finest level: The case of the estonian population</article-title><source>European Journal of Human Genetics</source><volume>28</volume><fpage>1580</fpage><lpage>1591</lpage><pub-id pub-id-type="doi">10.1038/s41431-020-0699-4</pub-id><pub-id pub-id-type="pmid">32712624</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasvol</surname><given-names>G</given-names></name><name><surname>Weatherall</surname><given-names>DJ</given-names></name><name><surname>Wilson</surname><given-names>RJM</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>Cellular mechanism for the protective effect of haemoglobin S against <italic>P. falciparum</italic> malaria</article-title><source>Nature</source><volume>274</volume><fpage>701</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1038/274701a0</pub-id><pub-id pub-id-type="pmid">353566</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pengon</surname><given-names>J</given-names></name><name><surname>Svasti</surname><given-names>S</given-names></name><name><surname>Kamchonwongpaisan</surname><given-names>S</given-names></name><name><surname>Vattanaviboon</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Hematological parameters and red blood cell morphological abnormality of glucose-6-phosphate dehydrogenase deficiency co-inherited with thalassemia</article-title><source>Hematology/Oncology and Stem Cell Therapy</source><volume>11</volume><fpage>18</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.hemonc.2017.05.029</pub-id><pub-id pub-id-type="pmid">28641093</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>GS</given-names></name><name><surname>Byers</surname><given-names>T</given-names></name><name><surname>Yip</surname><given-names>R</given-names></name><name><surname>Margen</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Iron nutrition does not account for the hemoglobin differences between blacks and whites</article-title><source>The Journal of Nutrition</source><volume>122</volume><fpage>1417</fpage><lpage>1424</lpage><pub-id pub-id-type="doi">10.1093/jn/122.7.1417</pub-id><pub-id pub-id-type="pmid">1619469</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilia</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>W-M</given-names></name><name><surname>Scuteri</surname><given-names>A</given-names></name><name><surname>OrrÃº</surname><given-names>M</given-names></name><name><surname>Albai</surname><given-names>G</given-names></name><name><surname>Dei</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>S</given-names></name><name><surname>Usala</surname><given-names>G</given-names></name><name><surname>Lai</surname><given-names>M</given-names></name><name><surname>Loi</surname><given-names>P</given-names></name><name><surname>Mameli</surname><given-names>C</given-names></name><name><surname>Vacca</surname><given-names>L</given-names></name><name><surname>Deiana</surname><given-names>M</given-names></name><name><surname>Olla</surname><given-names>N</given-names></name><name><surname>Masala</surname><given-names>M</given-names></name><name><surname>Cao</surname><given-names>A</given-names></name><name><surname>Najjar</surname><given-names>SS</given-names></name><name><surname>Terracciano</surname><given-names>A</given-names></name><name><surname>Nedorezov</surname><given-names>T</given-names></name><name><surname>Sharov</surname><given-names>A</given-names></name><name><surname>Zonderman</surname><given-names>AB</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Costa</surname><given-names>P</given-names></name><name><surname>Lakatta</surname><given-names>E</given-names></name><name><surname>Schlessinger</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Heritability of cardiovascular and personality traits in 6,148 Sardinians</article-title><source>PLOS Genetics</source><volume>2</volume><elocation-id>e132</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.0020132</pub-id><pub-id pub-id-type="pmid">16934002</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Todd-Brown</surname><given-names>K</given-names></name><name><surname>Thomas</surname><given-names>L</given-names></name><name><surname>Ferreira</surname><given-names>MAR</given-names></name><name><surname>Bender</surname><given-names>D</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>de Bakker</surname><given-names>PIW</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Sham</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>PLINK: A tool set for whole-genome association and population-based linkage analyses</article-title><source>American Journal of Human Genetics</source><volume>81</volume><fpage>559</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1086/519795</pub-id><pub-id pub-id-type="pmid">17701901</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rooks</surname><given-names>H</given-names></name><name><surname>Brewin</surname><given-names>J</given-names></name><name><surname>Gardner</surname><given-names>K</given-names></name><name><surname>Chakravorty</surname><given-names>S</given-names></name><name><surname>Menzel</surname><given-names>S</given-names></name><name><surname>Hannemann</surname><given-names>A</given-names></name><name><surname>Gibson</surname><given-names>J</given-names></name><name><surname>Rees</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A gain of function variant in piezo1 (E756DEL) and sickle cell disease</article-title><source>Haematologica</source><volume>104</volume><fpage>e91</fpage><lpage>e93</lpage><pub-id pub-id-type="doi">10.3324/haematol.2018.202697</pub-id><pub-id pub-id-type="pmid">30237267</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>NA</given-names></name><name><surname>Pritchard</surname><given-names>JK</given-names></name><name><surname>Weber</surname><given-names>JL</given-names></name><name><surname>Cann</surname><given-names>HM</given-names></name><name><surname>Kidd</surname><given-names>KK</given-names></name><name><surname>Zhivotovsky</surname><given-names>LA</given-names></name><name><surname>Feldman</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Genetic structure of human populations</article-title><source>Science</source><volume>298</volume><fpage>2381</fpage><lpage>2385</lpage><pub-id pub-id-type="doi">10.1126/science.1078311</pub-id><pub-id pub-id-type="pmid">12493913</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A population-genetic perspective on the similarities and differences among worldwide human populations</article-title><source>Human Biology</source><volume>83</volume><fpage>659</fpage><lpage>684</lpage><pub-id pub-id-type="doi">10.3378/027.083.0601</pub-id><pub-id pub-id-type="pmid">22276967</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowe</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Blood group O protects against severe <italic>Plasmodium falciparum</italic> malaria through the mechanism of reduced rosetting</article-title><source>PNAS</source><volume>104</volume><fpage>17471</fpage><lpage>17476</lpage><pub-id pub-id-type="doi">10.1073/pnas.0705390104</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruwende</surname><given-names>C</given-names></name><name><surname>Hill</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Glucose-6-phosphate dehydrogenase deficiency and malaria</article-title><source>Journal of Molecular Medicine</source><volume>76</volume><fpage>581</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1007/s001090050253</pub-id><pub-id pub-id-type="pmid">9694435</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauna</surname><given-names>ZE</given-names></name><name><surname>Kimchi-Sarfaty</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Understanding the contribution of synonymous mutations to human disease</article-title><source>Nature Reviews. Genetics</source><volume>12</volume><fpage>683</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1038/nrg3051</pub-id><pub-id pub-id-type="pmid">21878961</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulman</surname><given-names>S</given-names></name><name><surname>Roth</surname><given-names>EF</given-names><suffix>Jr</suffix></name><name><surname>Cheng</surname><given-names>B</given-names></name><name><surname>Rybicki</surname><given-names>AC</given-names></name><name><surname>Sussman</surname><given-names>II</given-names></name><name><surname>Wong</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Ranney</surname><given-names>HM</given-names></name><name><surname>Nagel</surname><given-names>RL</given-names></name><name><surname>Schwartz</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Growth of <italic>Plasmodium falciparum</italic> in human erythrocytes containing abnormal membrane proteins</article-title><source>PNAS</source><volume>87</volume><fpage>7339</fpage><lpage>7343</lpage><pub-id pub-id-type="doi">10.1073/pnas.87.18.7339</pub-id><pub-id pub-id-type="pmid">2205856</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sennels</surname><given-names>HP</given-names></name><name><surname>JÃ¸rgensen</surname><given-names>HL</given-names></name><name><surname>Hansen</surname><given-names>ALS</given-names></name><name><surname>Goetze</surname><given-names>JP</given-names></name><name><surname>Fahrenkrug</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Diurnal variation of hematology parameters in healthy young males: The Bispebjerg study of diurnal variations</article-title><source>Scandinavian Journal of Clinical and Laboratory Investigation</source><volume>71</volume><fpage>532</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.3109/00365513.2011.602422</pub-id><pub-id pub-id-type="pmid">21988588</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohail</surname><given-names>M</given-names></name><name><surname>Maier</surname><given-names>RM</given-names></name><name><surname>Ganna</surname><given-names>A</given-names></name><name><surname>Bloemendal</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>AR</given-names></name><name><surname>Turchin</surname><given-names>MC</given-names></name><name><surname>Chiang</surname><given-names>CW</given-names></name><name><surname>Hirschhorn</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><name><surname>Patterson</surname><given-names>N</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Mathieson</surname><given-names>I</given-names></name><name><surname>Reich</surname><given-names>D</given-names></name><name><surname>Sunyaev</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Polygenic adaptation on height is overestimated due to uncorrected stratification in genome-wide association studies</article-title><source>eLife</source><volume>8</volume><elocation-id>e39702</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.39702</pub-id><pub-id pub-id-type="pmid">30895926</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundararaman</surname><given-names>SA</given-names></name><name><surname>Plenderleith</surname><given-names>LJ</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Loy</surname><given-names>DE</given-names></name><name><surname>Learn</surname><given-names>GH</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Shaw</surname><given-names>KS</given-names></name><name><surname>Ayouba</surname><given-names>A</given-names></name><name><surname>Peeters</surname><given-names>M</given-names></name><name><surname>Speede</surname><given-names>S</given-names></name><name><surname>Shaw</surname><given-names>GM</given-names></name><name><surname>Bushman</surname><given-names>FD</given-names></name><name><surname>Brisson</surname><given-names>D</given-names></name><name><surname>Rayner</surname><given-names>JC</given-names></name><name><surname>Sharp</surname><given-names>PM</given-names></name><name><surname>Hahn</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genomes of cryptic chimpanzee plasmodium species reveal key evolutionary events leading to human malaria</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>11078</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms11078</pub-id><pub-id pub-id-type="pmid">27002652</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Supek</surname><given-names>F</given-names></name><name><surname>MiÃ±ana</surname><given-names>B</given-names></name><name><surname>ValcÃ¡rcel</surname><given-names>J</given-names></name><name><surname>GabaldÃ³n</surname><given-names>T</given-names></name><name><surname>Lehner</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Synonymous mutations frequently act as driver mutations in human cancers</article-title><source>Cell</source><volume>156</volume><fpage>1324</fpage><lpage>1335</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.01.051</pub-id><pub-id pub-id-type="pmid">24630730</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarazona-Santos</surname><given-names>E</given-names></name><name><surname>Castilho</surname><given-names>L</given-names></name><name><surname>Amaral</surname><given-names>DRT</given-names></name><name><surname>Costa</surname><given-names>DC</given-names></name><name><surname>Furlani</surname><given-names>NG</given-names></name><name><surname>Zuccherato</surname><given-names>LW</given-names></name><name><surname>Machado</surname><given-names>M</given-names></name><name><surname>Reid</surname><given-names>ME</given-names></name><name><surname>Zalis</surname><given-names>MG</given-names></name><name><surname>Rossit</surname><given-names>AR</given-names></name><name><surname>Santos</surname><given-names>SEB</given-names></name><name><surname>Machado</surname><given-names>RL</given-names></name><name><surname>Lustigman</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Population genetics of GYPB and association study between GYPB*S/s polymorphism and susceptibility to <italic>P. falciparum</italic> infection in the Brazilian Amazon</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e16123</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0016123</pub-id><pub-id pub-id-type="pmid">21283638</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tibshirani</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Regression shrinkage and selection via the lasso</article-title><source>JSTOR</source><volume>58</volume><fpage>267</fpage><lpage>288</lpage></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiffert</surname><given-names>T</given-names></name><name><surname>Lew</surname><given-names>VL</given-names></name><name><surname>Ginsburg</surname><given-names>H</given-names></name><name><surname>Krugliak</surname><given-names>M</given-names></name><name><surname>Croisille</surname><given-names>L</given-names></name><name><surname>Mohandas</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The hydration state of human red blood cells and their susceptibility to invasion by <italic>Plasmodium falciparum</italic></article-title><source>Blood</source><volume>105</volume><fpage>4853</fpage><lpage>4860</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-12-4948</pub-id><pub-id pub-id-type="pmid">15728121</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timmann</surname><given-names>C</given-names></name><name><surname>Thye</surname><given-names>T</given-names></name><name><surname>Vens</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>J</given-names></name><name><surname>May</surname><given-names>J</given-names></name><name><surname>Ehmen</surname><given-names>C</given-names></name><name><surname>Sievertsen</surname><given-names>J</given-names></name><name><surname>Muntau</surname><given-names>B</given-names></name><name><surname>Ruge</surname><given-names>G</given-names></name><name><surname>Loag</surname><given-names>W</given-names></name><name><surname>Ansong</surname><given-names>D</given-names></name><name><surname>Antwi</surname><given-names>S</given-names></name><name><surname>Asafo-Adjei</surname><given-names>E</given-names></name><name><surname>Nguah</surname><given-names>SB</given-names></name><name><surname>Kwakye</surname><given-names>KO</given-names></name><name><surname>Akoto</surname><given-names>AOY</given-names></name><name><surname>Sylverken</surname><given-names>J</given-names></name><name><surname>Brendel</surname><given-names>M</given-names></name><name><surname>Schuldt</surname><given-names>K</given-names></name><name><surname>Loley</surname><given-names>C</given-names></name><name><surname>Franke</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>CG</given-names></name><name><surname>Agbenyega</surname><given-names>T</given-names></name><name><surname>Ziegler</surname><given-names>A</given-names></name><name><surname>Horstmann</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Genome-wide association study indicates two novel resistance loci for severe malaria</article-title><source>Nature</source><volume>489</volume><fpage>443</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1038/nature11334</pub-id><pub-id pub-id-type="pmid">22895189</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Auwera</surname><given-names>GA</given-names></name><name><surname>Carneiro</surname><given-names>MO</given-names></name><name><surname>Hartl</surname><given-names>C</given-names></name><name><surname>Poplin</surname><given-names>R</given-names></name><name><surname>Del Angel</surname><given-names>G</given-names></name><name><surname>Levy-Moonshine</surname><given-names>A</given-names></name><name><surname>Jordan</surname><given-names>T</given-names></name><name><surname>Shakir</surname><given-names>K</given-names></name><name><surname>Roazen</surname><given-names>D</given-names></name><name><surname>Thibault</surname><given-names>J</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>Garimella</surname><given-names>KV</given-names></name><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Gabriel</surname><given-names>S</given-names></name><name><surname>DePristo</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline</article-title><source>Current Protocols in Bioinformatics</source><volume>43</volume><elocation-id>bi1110s43</elocation-id><pub-id pub-id-type="doi">10.1002/0471250953.bi1110s43</pub-id><pub-id pub-id-type="pmid">25431634</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Harst</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Mateo Leach</surname><given-names>I</given-names></name><name><surname>Rendon</surname><given-names>A</given-names></name><name><surname>Verweij</surname><given-names>N</given-names></name><name><surname>Sehmi</surname><given-names>J</given-names></name><name><surname>Paul</surname><given-names>DS</given-names></name><name><surname>Elling</surname><given-names>U</given-names></name><name><surname>Allayee</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Radhakrishnan</surname><given-names>A</given-names></name><name><surname>Tan</surname><given-names>S-T</given-names></name><name><surname>Voss</surname><given-names>K</given-names></name><name><surname>Weichenberger</surname><given-names>CX</given-names></name><name><surname>Albers</surname><given-names>CA</given-names></name><name><surname>Al-Hussani</surname><given-names>A</given-names></name><name><surname>Asselbergs</surname><given-names>FW</given-names></name><name><surname>Ciullo</surname><given-names>M</given-names></name><name><surname>Danjou</surname><given-names>F</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Evans</surname><given-names>DM</given-names></name><name><surname>Franke</surname><given-names>L</given-names></name><name><surname>GÃ¶gele</surname><given-names>M</given-names></name><name><surname>Hartiala</surname><given-names>J</given-names></name><name><surname>Hersch</surname><given-names>M</given-names></name><name><surname>Holm</surname><given-names>H</given-names></name><name><surname>Hottenga</surname><given-names>J-J</given-names></name><name><surname>Kanoni</surname><given-names>S</given-names></name><name><surname>Kleber</surname><given-names>ME</given-names></name><name><surname>Lagou</surname><given-names>V</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Lopez</surname><given-names>LM</given-names></name><name><surname>LyytikÃ¤inen</surname><given-names>L-P</given-names></name><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Murgia</surname><given-names>F</given-names></name><name><surname>Nolte</surname><given-names>IM</given-names></name><name><surname>OâReilly</surname><given-names>PF</given-names></name><name><surname>Padmanabhan</surname><given-names>S</given-names></name><name><surname>Parsa</surname><given-names>A</given-names></name><name><surname>Pirastu</surname><given-names>N</given-names></name><name><surname>Porcu</surname><given-names>E</given-names></name><name><surname>Portas</surname><given-names>L</given-names></name><name><surname>Prokopenko</surname><given-names>I</given-names></name><name><surname>Ried</surname><given-names>JS</given-names></name><name><surname>Shin</surname><given-names>S-Y</given-names></name><name><surname>Tang</surname><given-names>CS</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Traglia</surname><given-names>M</given-names></name><name><surname>Ulivi</surname><given-names>S</given-names></name><name><surname>Westra</surname><given-names>H-J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>JH</given-names></name><name><surname>Anni</surname><given-names>F</given-names></name><name><surname>Abdellaoui</surname><given-names>A</given-names></name><name><surname>Attwood</surname><given-names>A</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Bandinelli</surname><given-names>S</given-names></name><name><surname>Bastardot</surname><given-names>F</given-names></name><name><surname>Benyamin</surname><given-names>B</given-names></name><name><surname>Boehm</surname><given-names>BO</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name><name><surname>Das</surname><given-names>D</given-names></name><name><surname>de Bakker</surname><given-names>PIW</given-names></name><name><surname>de Boer</surname><given-names>RA</given-names></name><name><surname>de Geus</surname><given-names>EJC</given-names></name><name><surname>de Moor</surname><given-names>MH</given-names></name><name><surname>Dimitriou</surname><given-names>M</given-names></name><name><surname>Domingues</surname><given-names>FS</given-names></name><name><surname>DÃ¶ring</surname><given-names>A</given-names></name><name><surname>EngstrÃ¶m</surname><given-names>G</given-names></name><name><surname>Eyjolfsson</surname><given-names>GI</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Galanello</surname><given-names>R</given-names></name><name><surname>Garner</surname><given-names>SF</given-names></name><name><surname>Genser</surname><given-names>B</given-names></name><name><surname>Gibson</surname><given-names>QD</given-names></name><name><surname>Girotto</surname><given-names>G</given-names></name><name><surname>Gudbjartsson</surname><given-names>DF</given-names></name><name><surname>Harris</surname><given-names>SE</given-names></name><name><surname>Hartikainen</surname><given-names>A-L</given-names></name><name><surname>Hastie</surname><given-names>CE</given-names></name><name><surname>Hedblad</surname><given-names>B</given-names></name><name><surname>Illig</surname><given-names>T</given-names></name><name><surname>Jolley</surname><given-names>J</given-names></name><name><surname>KÃ¤hÃ¶nen</surname><given-names>M</given-names></name><name><surname>Kema</surname><given-names>IP</given-names></name><name><surname>Kemp</surname><given-names>JP</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Lloyd-Jones</surname><given-names>H</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Meacham</surname><given-names>S</given-names></name><name><surname>Medland</surname><given-names>SE</given-names></name><name><surname>Meisinger</surname><given-names>C</given-names></name><name><surname>Memari</surname><given-names>Y</given-names></name><name><surname>Mihailov</surname><given-names>E</given-names></name><name><surname>Miller</surname><given-names>K</given-names></name><name><surname>Moffatt</surname><given-names>MF</given-names></name><name><surname>Nauck</surname><given-names>M</given-names></name><name><surname>Novatchkova</surname><given-names>M</given-names></name><name><surname>Nutile</surname><given-names>T</given-names></name><name><surname>Olafsson</surname><given-names>I</given-names></name><name><surname>Onundarson</surname><given-names>PT</given-names></name><name><surname>Parracciani</surname><given-names>D</given-names></name><name><surname>Penninx</surname><given-names>BW</given-names></name><name><surname>Perseu</surname><given-names>L</given-names></name><name><surname>Piga</surname><given-names>A</given-names></name><name><surname>Pistis</surname><given-names>G</given-names></name><name><surname>Pouta</surname><given-names>A</given-names></name><name><surname>Puc</surname><given-names>U</given-names></name><name><surname>Raitakari</surname><given-names>O</given-names></name><name><surname>Ring</surname><given-names>SM</given-names></name><name><surname>Robino</surname><given-names>A</given-names></name><name><surname>Ruggiero</surname><given-names>D</given-names></name><name><surname>Ruokonen</surname><given-names>A</given-names></name><name><surname>Saint-Pierre</surname><given-names>A</given-names></name><name><surname>Sala</surname><given-names>C</given-names></name><name><surname>Salumets</surname><given-names>A</given-names></name><name><surname>Sambrook</surname><given-names>J</given-names></name><name><surname>Schepers</surname><given-names>H</given-names></name><name><surname>Schmidt</surname><given-names>CO</given-names></name><name><surname>SilljÃ©</surname><given-names>HHW</given-names></name><name><surname>Sladek</surname><given-names>R</given-names></name><name><surname>Smit</surname><given-names>JH</given-names></name><name><surname>Starr</surname><given-names>JM</given-names></name><name><surname>Stephens</surname><given-names>J</given-names></name><name><surname>Sulem</surname><given-names>P</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Tragante</surname><given-names>V</given-names></name><name><surname>van Gilst</surname><given-names>WH</given-names></name><name><surname>van Pelt</surname><given-names>LJ</given-names></name><name><surname>van Veldhuisen</surname><given-names>DJ</given-names></name><name><surname>VÃ¶lker</surname><given-names>U</given-names></name><name><surname>Whitfield</surname><given-names>JB</given-names></name><name><surname>Willemsen</surname><given-names>G</given-names></name><name><surname>Winkelmann</surname><given-names>BR</given-names></name><name><surname>Wirnsberger</surname><given-names>G</given-names></name><name><surname>Algra</surname><given-names>A</given-names></name><name><surname>Cucca</surname><given-names>F</given-names></name><name><surname>dâAdamo</surname><given-names>AP</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Deary</surname><given-names>IJ</given-names></name><name><surname>Dominiczak</surname><given-names>AF</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Fortina</surname><given-names>P</given-names></name><name><surname>Froguel</surname><given-names>P</given-names></name><name><surname>Gasparini</surname><given-names>P</given-names></name><name><surname>Greinacher</surname><given-names>A</given-names></name><name><surname>Hazen</surname><given-names>SL</given-names></name><name><surname>Jarvelin</surname><given-names>M-R</given-names></name><name><surname>Khaw</surname><given-names>KT</given-names></name><name><surname>LehtimÃ¤ki</surname><given-names>T</given-names></name><name><surname>Maerz</surname><given-names>W</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>Metspalu</surname><given-names>A</given-names></name><name><surname>Mitchell</surname><given-names>BD</given-names></name><name><surname>Montgomery</surname><given-names>GW</given-names></name><name><surname>Moore</surname><given-names>C</given-names></name><name><surname>Navis</surname><given-names>G</given-names></name><name><surname>Pirastu</surname><given-names>M</given-names></name><name><surname>Pramstaller</surname><given-names>PP</given-names></name><name><surname>Ramirez-Solis</surname><given-names>R</given-names></name><name><surname>Schadt</surname><given-names>E</given-names></name><name><surname>Scott</surname><given-names>J</given-names></name><name><surname>Shuldiner</surname><given-names>AR</given-names></name><name><surname>Smith</surname><given-names>GD</given-names></name><name><surname>Smith</surname><given-names>JG</given-names></name><name><surname>Snieder</surname><given-names>H</given-names></name><name><surname>Sorice</surname><given-names>R</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Stumvoll</surname><given-names>M</given-names></name><name><surname>Tang</surname><given-names>WHW</given-names></name><name><surname>Toniolo</surname><given-names>D</given-names></name><name><surname>TÃ¶njes</surname><given-names>A</given-names></name><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Vollenweider</surname><given-names>P</given-names></name><name><surname>Wareham</surname><given-names>NJ</given-names></name><name><surname>Wolffenbuttel</surname><given-names>BHR</given-names></name><name><surname>Boomsma</surname><given-names>DI</given-names></name><name><surname>Beckmann</surname><given-names>JS</given-names></name><name><surname>Dedoussis</surname><given-names>GV</given-names></name><name><surname>Deloukas</surname><given-names>P</given-names></name><name><surname>Ferreira</surname><given-names>MA</given-names></name><name><surname>Sanna</surname><given-names>S</given-names></name><name><surname>Uda</surname><given-names>M</given-names></name><name><surname>Hicks</surname><given-names>AA</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name><name><surname>Gieger</surname><given-names>C</given-names></name><name><surname>Kooner</surname><given-names>JS</given-names></name><name><surname>Ouwehand</surname><given-names>WH</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name><name><surname>Chambers</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Seventy-five genetic loci influencing the human red blood cell</article-title><source>Nature</source><volume>492</volume><fpage>369</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1038/nature11677</pub-id><pub-id pub-id-type="pmid">23222517</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vuckovic</surname><given-names>D</given-names></name><name><surname>Bao</surname><given-names>EL</given-names></name><name><surname>Akbari</surname><given-names>P</given-names></name><name><surname>Lareau</surname><given-names>CA</given-names></name><name><surname>Mousas</surname><given-names>A</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>MH</given-names></name><name><surname>Raffield</surname><given-names>LM</given-names></name><name><surname>Tardaguila</surname><given-names>M</given-names></name><name><surname>Huffman</surname><given-names>JE</given-names></name><name><surname>Ritchie</surname><given-names>SC</given-names></name><name><surname>Megy</surname><given-names>K</given-names></name><name><surname>Ponstingl</surname><given-names>H</given-names></name><name><surname>Penkett</surname><given-names>CJ</given-names></name><name><surname>Albers</surname><given-names>PK</given-names></name><name><surname>Wigdor</surname><given-names>EM</given-names></name><name><surname>Sakaue</surname><given-names>S</given-names></name><name><surname>Moscati</surname><given-names>A</given-names></name><name><surname>Manansala</surname><given-names>R</given-names></name><name><surname>Lo</surname><given-names>KS</given-names></name><name><surname>Qian</surname><given-names>H</given-names></name><name><surname>Akiyama</surname><given-names>M</given-names></name><name><surname>Bartz</surname><given-names>TM</given-names></name><name><surname>Ben-Shlomo</surname><given-names>Y</given-names></name><name><surname>Beswick</surname><given-names>A</given-names></name><name><surname>Bork-Jensen</surname><given-names>J</given-names></name><name><surname>Bottinger</surname><given-names>EP</given-names></name><name><surname>Brody</surname><given-names>JA</given-names></name><name><surname>van Rooij</surname><given-names>FJA</given-names></name><name><surname>Chitrala</surname><given-names>KN</given-names></name><name><surname>Wilson</surname><given-names>PWF</given-names></name><name><surname>Choquet</surname><given-names>H</given-names></name><name><surname>Danesh</surname><given-names>J</given-names></name><name><surname>Di Angelantonio</surname><given-names>E</given-names></name><name><surname>Dimou</surname><given-names>N</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Elliott</surname><given-names>P</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Evans</surname><given-names>MK</given-names></name><name><surname>Felix</surname><given-names>SB</given-names></name><name><surname>Floyd</surname><given-names>JS</given-names></name><name><surname>Broer</surname><given-names>L</given-names></name><name><surname>Grarup</surname><given-names>N</given-names></name><name><surname>Guo</surname><given-names>MH</given-names></name><name><surname>Guo</surname><given-names>Q</given-names></name><name><surname>Greinacher</surname><given-names>A</given-names></name><name><surname>Haessler</surname><given-names>J</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Howson</surname><given-names>JMM</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Jorgenson</surname><given-names>E</given-names></name><name><surname>Kacprowski</surname><given-names>T</given-names></name><name><surname>KÃ¤hÃ¶nen</surname><given-names>M</given-names></name><name><surname>Kamatani</surname><given-names>Y</given-names></name><name><surname>Kanai</surname><given-names>M</given-names></name><name><surname>Karthikeyan</surname><given-names>S</given-names></name><name><surname>Koskeridis</surname><given-names>F</given-names></name><name><surname>Lange</surname><given-names>LA</given-names></name><name><surname>LehtimÃ¤ki</surname><given-names>T</given-names></name><name><surname>Linneberg</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>LyytikÃ¤inen</surname><given-names>LP</given-names></name><name><surname>Manichaikul</surname><given-names>A</given-names></name><name><surname>Matsuda</surname><given-names>K</given-names></name><name><surname>Mohlke</surname><given-names>KL</given-names></name><name><surname>Mononen</surname><given-names>N</given-names></name><name><surname>Murakami</surname><given-names>Y</given-names></name><name><surname>Nadkarni</surname><given-names>GN</given-names></name><name><surname>Nikus</surname><given-names>K</given-names></name><name><surname>Pankratz</surname><given-names>N</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Preuss</surname><given-names>M</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Raitakari</surname><given-names>OT</given-names></name><name><surname>Rich</surname><given-names>SS</given-names></name><name><surname>Rodriguez</surname><given-names>BAT</given-names></name><name><surname>Rosen</surname><given-names>JD</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Schubert</surname><given-names>P</given-names></name><name><surname>Spracklen</surname><given-names>CN</given-names></name><name><surname>Surendran</surname><given-names>P</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Tardif</surname><given-names>JC</given-names></name><name><surname>Ghanbari</surname><given-names>M</given-names></name><name><surname>VÃ¶lker</surname><given-names>U</given-names></name><name><surname>VÃ¶lzke</surname><given-names>H</given-names></name><name><surname>Watkins</surname><given-names>NA</given-names></name><name><surname>Weiss</surname><given-names>S</given-names></name><collab>VA Million Veteran Program</collab><name><surname>Cai</surname><given-names>N</given-names></name><name><surname>Kundu</surname><given-names>K</given-names></name><name><surname>Watt</surname><given-names>SB</given-names></name><name><surname>Walter</surname><given-names>K</given-names></name><name><surname>Zonderman</surname><given-names>AB</given-names></name><name><surname>Cho</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Knight</surname><given-names>JC</given-names></name><name><surname>Georges</surname><given-names>M</given-names></name><name><surname>Stegle</surname><given-names>O</given-names></name><name><surname>Evangelou</surname><given-names>E</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Roberts</surname><given-names>DJ</given-names></name><name><surname>Inouye</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>AD</given-names></name><name><surname>Auer</surname><given-names>PL</given-names></name><name><surname>Astle</surname><given-names>WJ</given-names></name><name><surname>Reiner</surname><given-names>AP</given-names></name><name><surname>Butterworth</surname><given-names>AS</given-names></name><name><surname>Ouwehand</surname><given-names>WH</given-names></name><name><surname>Lettre</surname><given-names>G</given-names></name><name><surname>Sankaran</surname><given-names>VG</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The polygenic and monogenic basis of blood traits and diseases</article-title><source>Cell</source><volume>182</volume><fpage>1214</fpage><lpage>1231</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.08.008</pub-id><pub-id pub-id-type="pmid">32888494</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walliker</surname><given-names>D</given-names></name><name><surname>Quakyi</surname><given-names>IA</given-names></name><name><surname>Wellems</surname><given-names>TE</given-names></name><name><surname>McCutchan</surname><given-names>TF</given-names></name><name><surname>Szarfman</surname><given-names>A</given-names></name><name><surname>London</surname><given-names>WT</given-names></name><name><surname>Corcoran</surname><given-names>LM</given-names></name><name><surname>Burkot</surname><given-names>TR</given-names></name><name><surname>Carter</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Genetic analysis of the human malaria parasite <italic>Plasmodium falciparum</italic></article-title><source>Science</source><volume>236</volume><fpage>1661</fpage><lpage>1666</lpage><pub-id pub-id-type="doi">10.1126/SCIENCE.3299700</pub-id><pub-id pub-id-type="pmid">3299700</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Hakonarson</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data</article-title><source>Nucleic Acids Research</source><volume>38</volume><elocation-id>e164</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id><pub-id pub-id-type="pmid">20601685</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weatherall</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Phenotype-genotype relationships in monogenic disease: Lessons from the thalassaemias</article-title><source>Nature Reviews. Genetics</source><volume>2</volume><fpage>245</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1038/35066048</pub-id><pub-id pub-id-type="pmid">11283697</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitfield</surname><given-names>JB</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name><name><surname>Rao</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Genetic and environmental influences on the size and number of cells in the blood</article-title><source>Genetic Epidemiology</source><volume>2</volume><fpage>133</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1002/gepi.1370020204</pub-id><pub-id pub-id-type="pmid">4054596</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="web"><person-group person-group-type="author"><collab>WHO</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Malaria eradication: Benefits, future scenarios and feasibility. Executive summary, who strategic advisory group on malaria eradication</article-title><ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications/i/item/who-cds-gmp-2019-10">https://www.who.int/publications/i/item/who-cds-gmp-2019-10</ext-link><date-in-citation iso-8601-date="2021-08-07">August 7, 2021</date-in-citation></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>TN</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Human red blood cell polymorphisms and malaria</article-title><source>Current Opinion in Microbiology</source><volume>9</volume><fpage>388</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2006.06.009</pub-id><pub-id pub-id-type="pmid">16815736</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>GJ</given-names></name><name><surname>Rayner</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title><italic>Plasmodium falciparum</italic> erythrocyte invasion: Combining function with immune evasion</article-title><source>PLOS Pathogens</source><volume>10</volume><elocation-id>e1003943</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003943</pub-id><pub-id pub-id-type="pmid">24651270</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>A</given-names></name><name><surname>Beutler</surname><given-names>E</given-names></name><name><surname>Motulsky</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="1971">1971</year><article-title>Human glucose-6-phosphate dehydrogenase variants bulletin of the World Health Organization</article-title><source>World Health Organization</source><volume>45</volume><fpage>243</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">5316621</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ZÃ¡mbÃ³</surname><given-names>B</given-names></name><name><surname>VÃ¡rady</surname><given-names>G</given-names></name><name><surname>PadÃ¡nyi</surname><given-names>R</given-names></name><name><surname>SzabÃ³</surname><given-names>E</given-names></name><name><surname>NÃ©meth</surname><given-names>A</given-names></name><name><surname>LangÃ³</surname><given-names>T</given-names></name><name><surname>Enyedi</surname><given-names>Ã</given-names></name><name><surname>Sarkadi</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Decreased calcium pump expression in human erythrocytes is connected to a minor haplotype in the atp2b4 gene</article-title><source>Cell Calcium</source><volume>65</volume><fpage>73</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.ceca.2017.02.001</pub-id><pub-id pub-id-type="pmid">28216081</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Multiple stiffening effects of nanoscale knobs on human red blood cells infected with <italic>Plasmodium falciparum</italic> malaria parasite</article-title><source>PNAS</source><volume>112</volume><fpage>6068</fpage><lpage>6073</lpage><pub-id pub-id-type="doi">10.1073/pnas.1505584112</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69808.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Tung</surname><given-names>Jenny</given-names></name><role>Reviewing Editor</role><aff><institution>Duke University</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2020.10.08.332494">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2020.10.08.332494v3">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This paper finds that common red blood cell phenotypic and genetic variation predicts susceptibility to malarial parasites. Contrary to hypotheses about ancestry-associated malaria selection, however, these variants are not more common in African ancestry populations. Overall, this work presents convincing evidence that in vitro assays of malarial invasion and growth are a practical, effective complement to large-scale genome-wide association studies for understanding the genetics of malarial infection.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Common host variation drives malaria parasite fitness in healthy human red cells&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by George Perry as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1. Demonstrate the robustness of the results to removing the children from the single large family (one mother and five children) currently included in the analysis. More generally, demonstrate that genotype-based prediction is not confounded with family membership/relatedness.</p><p>2. Demonstrate that the LASSO model retains high accuracy when predicting Plasmodium invasion and growth phenotypes out-of-sample. Here, it will be crucial to completely separate the training set for the model from the test set to which it is applied (beyond internal cross-validation), either by cleanly stratifying the current sample or ideally by extending to new samples.</p><p>3. Evaluate the invasion measurements at 72 hours (the &quot;re-invasion&quot; phenotype); consider whether this reduces the very large amount of noise associated with the original 24-hour invasion phenotype.</p><p>4. Discuss the generalizability of the current findings to strains beyond the two strains (one lab, one clinical isolate) used in this study, including the rationale for the choice of these strains and the differences in results between them.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1. I'm most concerned about the estimates of predictive accuracy/generalization error. The permutations used to assess predictive accuracy confirm that the particular set of variants chosen by LASSO are more predictive than randomly chosen variants, in this particular sample. However, they don't provide insight into the predictive accuracy of the model out of sample. Although cross-validation should help with that problem, the CV procedure used in glmnet was not clear (also, I assume that Î± was fixed to 1 throughout; i.e., the authors only used LASSO, not the elastic net-it would be helpful to provide the exact parameters used). As reflected in my public review, I'm also surprised to see such strong predictive accuracy when the repeatability of growth and invasion measures from the same individuals sampled in different weeks (Figure S1) is modest to low. Is the repeatability much higher after controlling for batch and technical effects (which appear to be very substantial based on Table S1)?</p><p>2. Related, the predictive accuracy is so good that the results and methods would be very compelling if the model truly generalizes. Towards that end, I think it is essential to use a true out-of-sample test set. Ideally, this could be done by collecting additional samples and phenotyping/genotyping them. Minimally, a cleaner training/test split could be accomplished, e.g., by fitting the model with n = 50 (using internal CV) and then predicting out of sample in the remaining n = 23-although this compromises sample size in the training set, the model prediction accuracy is so high that it should be robust (note that if this approach is used, it will be important not to leak information from the training set into the test set during data normalization-that is, the values from the training set should not be allowed to influence the values from the test set at all). An additional approach would be to predict the repeated sample phenotype values (from n = 11 donors) based on the n = 73 non-carrier donors with one sample represented per donor (not as good, because the samples in the test set would not be truly independent, but still instructive).</p><p>3. If the predictive accuracy does hold up, I think the remarkably large effect sizes need to be reconciled with the difficulty of identifying large effect hits in malaria GWAS. Is this expected based on the strength of the correlation between replication rates in vivo and malaria infection/progression? Are the variants identified in the LASSO model strongly enriched for low p-values in GWAS (beyond linkage to known hits for some subset of variants)?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Awesome paper! It was a pleasure to read and very well written. The attention to detail was greatly appreciated. Most of my private recommendations are mainly suggestions for how to improve the presentation of data, but none of them are vital to the manuscript.</p><p>1. This isn't necessary, but I would like to suggest a figure that shows the association (pairwise) by carrier status for all of the RBC traits and invasion/growth rate statuses. This could be a heatmap where you would be able to show that certain carriers have a certain pattern of outcomes. You have this already in the text, but it may be easier for the reader to see it in figure format.</p><p>2. Most of my private recs are just about figures. Would it be possible to also include the association of RBC traits and African ancestry in Figure 6? I think these are really interesting and not having them in Figure 6 undersells the findings.</p><p>3. The scatterplots with the transparent dots are a little confusing to see. I would suggest something like a beeswarm plot for plots like Figure 2A-B, with a separate column for the replicates to show the tight distribution.</p><p>4. The first sentence of the discussion reads that &quot;healthy red blood cells (RBCs) harbor extensive phenotypic and genetic variation,&quot;. RBCs have no nucleus and therefore no DNA.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>1. The invasion measurements (fold change parasitaemia over 24 hours) were subject to a tremendous amount of variation, perhaps owing to culture conditions affecting schizont egress and subsequent merozoite invasion of RBCs. The authors acknowledged that these environmental effects could lead to greater experimental noise. How would their invasion measurements and analyses change if they took the parasitaemia measurements of parasites that had already gone through one life-cycle in the test RBCs, e.g. at 72 hours (re-invasion measurements)?</p><p>2. Limitations in targeted gene approach: could there be non-identified &quot;disease alleles&quot; in non-carriers that explain the overlap in RBC phenotypes and parasite fitness with carriers? They categorised carriers as those with known RBC disease alleles, mainly in haemoglobin and G6PD genes, while non-carriers as those not carrying these alleles. The genetic variants that they added to their analysis were limited to membrane protein genes. The non-carriers could carry a spectrum of additional gene variants that impact the RBC phenotypes observed, which could therefore influence parasite fitness.</p><p>3. The authors used one lab parasite strain and one field parasite isolate for their study, wouldn't it have been beneficial to also select a variety of parasite strains representing different invasion pathways and growth patterns, to check if these genetic and RBC phenotypic factors hold true across different strains? Given the limitations with the field isolate, wouldn't it be worthwhile to test other lab strains that use alternative invasion pathways? Also, it would be good to provide a sentence or two explaining the choice of lab and field strains in the study.</p><p>4. It was surprising that no variants in the glycophorins and haemoglobin genes were detected, given their important roles in the function of the RBC, and in parasite invasion (in the case of the glycophorins). They have previously been found to have large effect sizes in populations living in malaria endemic regions. Could the authors discuss this?</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;Common host variation drives malaria parasite fitness in healthy human red cells&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by George Perry as the Senior Editor, and a Reviewing Editor.</p><p>The manuscript and response to the previous reviews address nearly all the original reviewer comments and concerns and, overall, represent an excellent contribution to the literature. Revisions to the LASSO prediction analysis now present convincing and realistic evidence that red blood cell phenotypes and common RBC alleles help predict in vitro growth phenotypes.</p><p>The remaining issue to be addressed is the inclusion of statistics on training set variance explained as a major result in the text, and as key parts of Figures 4 and 5 (parts B and C of each figure). As the reduction in explanatory power in the external test sets shows, these estimates are over-optimistic and likely a result of overfitting. We ask that you remove the training set statistics from the results and figures, as the test set results alone provide a clearer, more accurate view of model performance to readers, and likely mitigate concerns from readers who are experienced with (and concerned about) overfitting in predictive modeling.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69808.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. Demonstrate the robustness of the results to removing the children from the single large family (one mother and five children) currently included in the analysis. More generally, demonstrate that genotype-based prediction is not confounded with family membership/relatedness.</p></disp-quote><p>We have repeated all the statistical analyses and updated the results after excluding the five children. The major genotypic and phenotypic predictors of <italic>P. falciparum</italic> replication remain basically the same, except for the family-specific PCs. We interpret this to mean that population structure from the family is unlikely to have biased the results, although some features of those samples are clearly associated with parasite fitness. We now note throughout the manuscript that the children are omitted from the figures and association analyses. To further protect from family confounding, we have also calculated pairwise kinship coefficients using ~400,000 SNPs (Methods) to confirm that no other related individuals were present in our data set.</p><disp-quote content-type="editor-comment"><p>2. Demonstrate that the LASSO model retains high accuracy when predicting Plasmodium invasion and growth phenotypes out-of-sample. Here, it will be crucial to completely separate the training set for the model from the test set to which it is applied (beyond internal cross-validation), either by cleanly stratifying the current sample or ideally by extending to new samples.</p></disp-quote><p>As suggested, we have performed k-fold cross validation on training and test sets to demonstrate that the LASSO model retains high accuracy. We have substantially revised the code, Methods, Results, and two main figures to reflect the suggested re-analysis. Over 1000 random splits of the non-carrier data into 10 folds, we found that RBC traits/genotypes selected from âtrainâ data have prediction accuracy in the separate âtestâ fold that is significantly higher than expected from shuffled data or random genes. Many of the specific RBC predictors remain the same as in the earlier analysis, although the absolute variance explained in the test data is much smaller than in the train data (max R<sup>2</sup> ~ 15% with N ~ 7 vs. ~80% with N ~60). We agree that this true cross-validation approach helps avoid overfitting while still identifying important RBC predictors of <italic>P. falciparum</italic> growth rate. Overall, the fact that our model retains significant predictive power in out-of-sample data provides strong support for our experimental approach and will stimulate additional research in this area using new and larger groups of samples.</p><disp-quote content-type="editor-comment"><p>3. Evaluate the invasion measurements at 72 hours (the &quot;re-invasion&quot; phenotype); consider whether this reduces the very large amount of noise associated with the original 24-hour invasion phenotype.</p></disp-quote><p>We agree that the manuscript would be improved if the measurements of <italic>P. falciparum</italic> invasion (24 hour timepoint) were less noisy. In line with the reviewerâs suggestion, we measured the parasitemia at 72 hours (the âre-invasionâ phenotype), though please note that this was referred to as âgrowthâ in the original manuscript because it reflects the growth of a ring stage parasite through a complete life cycle of development, egress, and re-invasion. We have altered our experimental diagram in Figure 1C to more clearly indicate that âre-invasionâ is part of our âgrowthâ measurement. Notably, we found genetic variants in well-known invasion receptors to be associated only with growth (Figure 5A). We discuss that several RBC phenotypes are significantly associated with both invasion and growth (Figure 4A), although invasion is noisier for both technical and biological reasons. The discussion now acknowledges our limitations in measuring invasion and offers suggestions for future experiments (lines 551-564).</p><disp-quote content-type="editor-comment"><p>4. Discuss the generalizability of the current findings to strains beyond the two strains (one lab, one clinical isolate) used in this study, including the rationale for the choice of these strains and the differences in results between them.</p></disp-quote><p>We have included more details and citations for the two divergent strains in the results and methods (Lines 146-150, 747-749). We now discuss the strong correlations between the strains, including for specific phenotypes and genotypes, which suggest that our results may be generalizable (Lines 565-575). Given some interesting differences between the strains, we acknowledge that future work would benefit from assaying additional parasite diversity linked to specific invasion pathways.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>1. I'm most concerned about the estimates of predictive accuracy/generalization error. The permutations used to assess predictive accuracy confirm that the particular set of variants chosen by LASSO are more predictive than randomly chosen variants, in this particular sample. However, they don't provide insight into the predictive accuracy of the model out of sample. Although cross-validation should help with that problem, the CV procedure used in glmnet was not clear (also, I assume that Î± was fixed to 1 throughout; i.e., the authors only used LASSO, not the elastic net-it would be helpful to provide the exact parameters used). As reflected in my public review, I'm also surprised to see such strong predictive accuracy when the repeatability of growth and invasion measures from the same individuals sampled in different weeks (Figure S1) is modest to low. Is the repeatability much higher after controlling for batch and technical effects (which appear to be very substantial based on Table S1)?</p></disp-quote><p>We thank the reviewer for this important critique. As suggested, we have performed k-fold cross validation on training and test sets to demonstrate that the LASSO model retains high accuracy out-of-sample. Over 1000 random splits of the non-carrier data into 10 folds, we found that RBC traits/genotypes selected from âtrainâ data have prediction accuracy in separate âtestâ folds that is significantly higher than expected from shuffled data or random genes. This analysis adds insight into the predictive accuracy of the selected phenotypes and genotypes in true out-of-sample data, which as expected, is lower than in the same data used to train the models. We have updated Figures 4 and 5 and the accompanying Results text (Lines 253-354, 392-413) to reflect the change in analysis. We apologize for the lack of clarity in the Methods, which have been revised to better explain all cross-validation procedures and parameters used (Lines 824-850). We have also revised the discussion (Lines 507-509; 554-559) to clarify that both biological and technical variation are expected to produce noise across samples from the same individuals collected over weeks to months. Finally, we have clarified the caption of Figure 2âfigure supplement 2 to indicate that the data are shown after batch correction.</p><disp-quote content-type="editor-comment"><p>2. Related, the predictive accuracy is so good that the results and methods would be very compelling if the model truly generalizes. Towards that end, I think it is essential to use a true out-of-sample test set. Ideally, this could be done by collecting additional samples and phenotyping/genotyping them. Minimally, a cleaner training/test split could be accomplished, e.g., by fitting the model with n = 50 (using internal CV) and then predicting out of sample in the remaining n = 23-although this compromises sample size in the training set, the model prediction accuracy is so high that it should be robust (note that if this approach is used, it will be important not to leak information from the training set into the test set during data normalization-that is, the values from the training set should not be allowed to influence the values from the test set at all). An additional approach would be to predict the repeated sample phenotype values (from n = 11 donors) based on the n = 73 non-carrier donors with one sample represented per donor (not as good, because the samples in the test set would not be truly independent, but still instructive).</p></disp-quote><p>We appreciate this comment, which inspired a thorough re-analysis of the non-carrier data in a k-folds cross-validation framework. In addition to the previous responses, we here note that model performance on held-out test data was highly dependent on which samples were randomly allocated into the (small) test set. To avoid bias from a single randomization of the data into one test and one train set, we performed 1,000 random divisions of the data into 10 folds and treated each fold in turn as a left-out test set. We now report the mean performance in 10*1,000 = 10,000 test sets and 10,000 train sets, which should be more representative of the predictive power of the selected variables.</p><p>With respect to leaking information from the test set to the train set, we agree that it is critical to ensure that the parasite values in each set are not unduly influenced by each other. To that end, the parasite data from non-carriers besides the repeated control (1111) were not used to batch-correct the parasite data of other samples (see Figure 2âfigure supplement 1 and the updated description of parasite normalization, Lines 776-785).</p><p>Unlike with the parasite data, we performed a median-based normalization of RBC phenotypes only once using all the non-carrier data. This was a different type of normalization based on equalizing weekly medians, which we chose because we lacked weekly control data (from sample 1111) for about half the weeks for most RBC phenotypes. If this phenotype normalization produced significant leakage across test and train sets, we might expect a spurious signal in models combining phenotypes with random genes. Importantly, we do not detect this (Figure 5), suggesting any leakage from phenotype normalization is minor.</p><p>Finally, we have added text to clarify that RBC phenotypes from the same individual are expected to vary over time (Lines 507-509). Unfortunately, we were unable to directly test our models on the repeated samples because we only collected parasite data (without other RBC phenotypes) for repeated samples after the first assay. We agree that intra-sample variability is an interesting avenue for future, more comprehensive research.</p><p>Overall, we appreciate this collection of important and thoughtful recommendations. They motivated a re-analysis that strongly increases our confidence in the RBC phenotypes and genotypes associated with <italic>P. falciparum</italic> replication and strengthens the manuscript.</p><disp-quote content-type="editor-comment"><p>3. If the predictive accuracy does hold up, I think the remarkably large effect sizes need to be reconciled with the difficulty of identifying large effect hits in malaria GWAS. Is this expected based on the strength of the correlation between replication rates in vivo and malaria infection/progression? Are the variants identified in the LASSO model strongly enriched for low p-values in GWAS (beyond linkage to known hits for some subset of variants)?</p></disp-quote><p>RBCs are certainly important for malaria, and we agree that future studies should take further advantage of existing GWAS data. Nevertheless, we would not expect large RBC effects on parasites in our experiments to translate to large effects in severe malaria GWAS (SM-GWAS). This is primarily because individual immune response, shaped by malaria exposure and age, is a major factor determining SM risk. Interestingly, the main new locus discovered by SM-GWAS (which changes expression of the RBC ion channel <italic>ATP2B4</italic>) has been associated with both immune cell and RBC phenotypes. A disconnect in <italic>ATP2B4</italic> effect sizes for SM-GWAS and RBC traits has also been noted in recent work (Band et al., 2019; Villegas-Mendez et al., 2021). The present association study is the first of its kind in RBCs, and we are reassured that more than half of our growth-associated variants have already been associated with other RBC traits by GWAS, suggesting they are functional or linked to functional variants.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Awesome paper! It was a pleasure to read and very well written. The attention to detail was greatly appreciated. Most of my private recommendations are mainly suggestions for how to improve the presentation of data, but none of them are vital to the manuscript.</p><p>1. This isn't necessary, but I would like to suggest a figure that shows the association (pairwise) by carrier status for all of the RBC traits and invasion/growth rate statuses. This could be a heatmap where you would be able to show that certain carriers have a certain pattern of outcomes. You have this already in the text, but it may be easier for the reader to see it in figure format.</p></disp-quote><p>Thank you for this suggestion. We have added a heatmap showing the phenotypic patterns for each carrier group as a supplement for Figure 3.</p><disp-quote content-type="editor-comment"><p>2. Most of my private recs are just about figures. Would it be possible to also include the association of RBC traits and African ancestry in Figure 6? I think these are really interesting and not having them in Figure 6 undersells the findings.</p></disp-quote><p>We agree that the relationship between RBC and African ancestry is very interesting. We have added three of these panels to Figure 6, with the rest available in the figure supplement.</p><disp-quote content-type="editor-comment"><p>3. The scatterplots with the transparent dots are a little confusing to see. I would suggest something like a beeswarm plot for plots like Figure 2A-B, with a separate column for the replicates to show the tight distribution.</p></disp-quote><p>Thank you for this suggestion. We agree that beeswarm plots are very effective for comparing two groups, such as in the new Figure 5âfigure supplement 2 and Figure 5âfigure supplement 5. When comparing multiple groups, such as in Figures 2 and 3, we found beeswarm plots awkwardly wide when disallowing overlapping points. We now show similar points overlapping at the edges of each column (option âgutterâ), which we agree offers a more accurate representation of the distributions than the transparent points.</p><disp-quote content-type="editor-comment"><p>4. The first sentence of the discussion reads that &quot;healthy red blood cells (RBCs) harbor extensive phenotypic and genetic variation,&quot;. RBCs have no nucleus and therefore no DNA.</p></disp-quote><p>We have changed âgeneticâ to âproteomicâ in this sentence to avoid confusion.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>1. The invasion measurements (fold change parasitaemia over 24 hours) were subject to a tremendous amount of variation, perhaps owing to culture conditions affecting schizont egress and subsequent merozoite invasion of RBCs. The authors acknowledged that these environmental effects could lead to greater experimental noise. How would their invasion measurements and analyses change if they took the parasitaemia measurements of parasites that had already gone through one life-cycle in the test RBCs, e.g. at 72 hours (re-invasion measurements)?</p></disp-quote><p>We agree that the manuscript would be improved if the measurements of <italic>P. falciparum</italic> invasion (24 hour timepoint) were less noisy. In line with the reviewerâs suggestion, we measured the parasitemia at 72 hours (the âre-invasionâ phenotype), though we referred to this as âgrowthâ because it reflects the growth of a ring stage parasite through a complete life cycle of development, egress, and re-invasion. We have altered our experimental diagram in Figure 1C to more clearly indicate that âre-invasionâ is part of our âgrowthâ measurement.</p><p>We agree in the discussion (Lines 551-564) that re-invasion might be less noisy than invasion for many reasons, both experimental (e.g. recent time out of the incubator) and biological (e.g. invading host cells of a new genotype). New text in the discussion acknowledges our limitations in measuring invasion and offers suggestions for future experiments.</p><disp-quote content-type="editor-comment"><p>2. Limitations in targeted gene approach: could there be non-identified &quot;disease alleles&quot; in non-carriers that explain the overlap in RBC phenotypes and parasite fitness with carriers? They categorised carriers as those with known RBC disease alleles, mainly in haemoglobin and G6PD genes, while non-carriers as those not carrying these alleles. The genetic variants that they added to their analysis were limited to membrane protein genes. The non-carriers could carry a spectrum of additional gene variants that impact the RBC phenotypes observed, which could therefore influence parasite fitness.</p></disp-quote><p>We agree that unknown âdisease allelesâ could contribute to the overlap between non-carriers and carriers (Lines 503-507). We analyzed 23 RBC proteins with strong links to <italic>P. falciparum</italic> in the literature, of which 5 were not membrane proteins <italic>(HBB, HBA1, HBA2, G6PD</italic>, and <italic>HP</italic>). We agree that other RBC proteins besides these 23 are likely to contain genetic variation that impacts parasite fitness, although we believe that testing many other, previously unknown proteins would require a much larger sample size (Lines 534-544).</p><disp-quote content-type="editor-comment"><p>3. The authors used one lab parasite strain and one field parasite isolate for their study, wouldn't it have been beneficial to also select a variety of parasite strains representing different invasion pathways and growth patterns, to check if these genetic and RBC phenotypic factors hold true across different strains? Given the limitations with the field isolate, wouldn't it be worthwhile to test other lab strains that use alternative invasion pathways? Also, it would be good to provide a sentence or two explaining the choice of lab and field strains in the study.</p></disp-quote><p>We agree that repeating these experiments with additional strains is a worthwhile endeavor. The current study was primarily limited by our ability to simultaneously culture multiple strains in a limited supply of fresh donor RBCs. For the two divergent strains used, we have included additional details and citations in the results and methods (Lines 146-150, 747-749). We also discuss the strong correlations between the strains, including for specific geneotypes and phenotypes, that suggest that our results may be generalizable (Lines 565-575). Given the interesting differences between the strains in their preference for RBCs with for African ancestry, we acknowledge that future work would benefit from assaying additional parasite diversity linked to specific invasion pathways.</p><disp-quote content-type="editor-comment"><p>4. It was surprising that no variants in the glycophorins and haemoglobin genes were detected, given their important roles in the function of the RBC, and in parasite invasion (in the case of the glycophorins). They have previously been found to have large effect sizes in populations living in malaria endemic regions. Could the authors discuss this?</p></disp-quote><p>In the hemoglobin genes, we did detect the variants that cause Î±-thalassemia, sickle cell disease, and hemoglobin C disease (Figure 1B). In non-carriers, we found one common, synonymous variant in <italic>HBB</italic> that was rarely selected by LASSO and was not associated with any GWAS data (Figure 5-Source data 3). Only one other common variant in <italic>HBB</italic> exons is present in gnomAD, and though it was not present in our filtered SNP set, it is classified as benign. To clarify the exome variants that we sequenced and analyzed, we have added Figure 1-Source Data 1, which contains annotations and frequencies for all exome variants that passed quality filters.</p><p>In the glycophorins, variants with large effect include GYPB*S (Tarazona-Santos et al., 2011), Dantu (Leffler et al., 2017; Field et al., 1994), and deficiencies of GYPA, GYPB, or GYPC. All but GYPB*S are rare in African populations, and we do detect GYPB*S (rs143997559) associated with 3D7 growth. We now point out this specific finding in the results (Lines 402-404).</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>Thank you for resubmitting your work entitled &quot;Common host variation drives malaria parasite fitness in healthy human red cells&quot; for further consideration by eLife. Your revised article has been evaluated by George Perry as the Senior Editor, and a Reviewing Editor.</p><p>The manuscript and response to the previous reviews address nearly all the original reviewer comments and concerns and, overall, represent an excellent contribution to the literature. Revisions to the LASSO prediction analysis now present convincing and realistic evidence that red blood cell phenotypes and common RBC alleles help predict in vitro growth phenotypes.</p><p>The remaining issue to be addressed is the inclusion of statistics on training set variance explained as a major result in the text, and as key parts of Figures 4 and 5 (parts B and C of each figure). As the reduction in explanatory power in the external test sets shows, these estimates are over-optimistic and likely a result of overfitting. We ask that you remove the training set statistics from the results and figures, as the test set results alone provide a clearer, more accurate view of model performance to readers, and likely mitigate concerns from readers who are experienced with (and concerned about) overfitting in predictive modeling.</p></disp-quote><p>As suggested, we have removed the training set statistics from the results, Figures 4 and 5, and Figure 5 supplementary Figure 1, and now only present the test set statistics.</p></body></sub-article></article>